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5ABSTRACT
Hypertensive pregnancy disorders complicate approximately 10% of all pregnancies.
They may compromise placental functioning and, thus, affect the fetal developmental
milieu. It is therefore highly plausible that they have consequences for the
developmental outcomes of the offspring. However, their role in the developmental
plasticity phenomenon dubbed ‘programming’ remains relatively unexplored.
This thesis examines whether adult offspring born to mothers with hypertensive
pregnancy disorders differ from their counterparts born to normotensive mothers in
mental health and cognitive functioning, and whether the potential group differences
vary according to sex, length of gestation, parity, and childhood socio-economic status.
This  thesis  capitalizes  on  the  Helsinki  Birth  Cohort  Study.  The  study  cohort
comprises 13 345 individuals born in Helsinki between 1934 and 1944. Maternal
hypertension status was defined based upon blood pressure and urinary protein
measurements during pregnancy and was available for 6410 individuals. Data on mental
disorders come from validated national registers extending over four decades (n = 5970
eligible for this study; Study II). Depressive symptoms were measured with a
standardized questionnaire (BDI) in conjunction with a clinical follow-up study at a
mean age of 62 years (n = 788; Study I) and in conjunction with a further follow-up
including a more detailed psychological survey at a mean age of 64 years (n = 661;
Study I). Cognitive test scores were obtained from the Finnish defence forces basic
ability test taken during military service at a mean age of 20 years (n = 1196; Study III)
and  in  a  re-test  at  a  mean age  of  69  years  (n  =  398;  Study  IV).  Cognitive  impairment
was measured with psychological questionnaires (DFQ and DEX) in conjunction with a
further follow-up at a mean age of 69 years (n = 876; Study V).
In comparison to the offspring born to normotensive mothers, offspring born to pre-
eclamptic mothers showed higher self-reported cognitive impairment (Study V).
Offspring born to mothers with hypertension without proteinuria showed a higher risk
of  mental  disorders  (Study  II),  although  they  did  not  differ  in  the  severity  of  self-
reported depressive symptoms. Maternal hypertensive pregnancy disorders as a
diagnostic entity were associated with lower cognitive functioning (Sudy III and IV)
and higher cognitive decline (Study IV). Sex, parity and childhood socio-economic
6status modified some of associations. Maternal pre-eclampsia was associated with
higher self-reported depressive symptom scores in primiparous, but not in multiparous,
offspring (Study I),  and with a lower risk of mental  disorders in male,  but not female,
offspring (Study II). Maternal hypertension without proteinuria was associated with
self-reported cognitive impairment in female, but not male, offspring (Study V). Finally,
the associations between maternal hypertensive pregnancy disorders as a diagnostic
entity and lower cognitive functioning (verbal reasoning) in young adulthood were most
evident in primiparous offspring and in offspring with a high childhood socio-economic
status (Study III).
These study findings showed that maternal hypertensive pregnancy disorders were
associated with all studied mental health and cognitive functioning outcomes. Overall,
maternal hypertensive disorders during pregnancy carried an increased risk of a wide
spectrum of problems in mental well-being and cognitive functioning among the
offspring several decades later. However, protective effects were also observed, and, in
future studies, it will be important to unravel the developmental pathways and
underlying biological mechanisms. Being the longest follow-up on the transgenerational
consequences of maternal hypertensive disorders reported thus far, the findings
highlight the role of the prenatal environment in developmental programming.
7TIIVISTELMÄ
Hypertensiivisiin raskaushäiriöihin (eli raskaudenaikaisen verenpaineen nousuun)
sairastuu 10% kaikista raskaana olevista. Ne voivat vaikuttaa istukan toimintaan ja siten
merkittävästi sikiön kasvuympäristöön. Onkin hyvin todennäköistä, että äidin
hypertensiiviset raskaushäiriöt ovat syy-yhteydessä lapsen myöhempään kehitykseen.
Kuitenkin niiden merkitystä lapsen myöhemmän kehityksen kannalta on tutkittu
suhteellisen vähän. Sikiön kasvuymäristön tutkiminen tarjoaa mielenkiintoisen
mahdollisuuden tutkimukselle, jossa korostetaan elinten rakenteen ja toiminnan
muotoutuvuutta, ja joka on nimetty sikiöaikaisen ohjelmoitumisen tutkimussuunnaksi.
Tässä väitöskirjassa tutkitaan, eroavatko aikuiset lapset, joiden äideillä on ollut
raskauteen liittyvä kohonnut verenpaine, mielenterveyden ja kognitiivisten taitojen
osalta ikätovereistaan, joiden äideillä ei ole on ollut raskauteen liittyvää kohonnutta
verenpainetta. Lisäksi tutkitaan, vaikuttavatko sukupuoli, raskauden kesto,
synnyttäneisyys tai lapsuuden sosioekonominen asema mahdollisiin eroihin ryhmien
välillä.
Tämä väitöskirja pohjautuu Helsingin syntymäkohortti -tutkimukseen (engl. Helsinki
Birth Cohort Study). Tutkimuskohorttiin kuuluu 13345 miestä ja naista, jotka syntyivät
Helsingissä vuosien 1934–1944 aikana. Äitien verenpaine- ja virtsan
valkuaispituisuustiedot saatiin raskausaikana kirjattujen mittausten perusteella. Ne
olivat saatavilla 6410 äidiltä. Tiedot mielenterveyshäiriödiagnooseista saatiin
kansallisista rekistereistä, ja ne kattoivat yli neljä vuosikymmentä (n = 5970 kelpoista
tähän tutkimukseen; Osajulkaisu II). Masennusoireita mitattiin psykologisella
kyselylomakkeella (BDI) seurannan yhteydessä, joka toteutettiin 62 vuoden keski-iässä
(n = 788; Osajulkaisu I) ja lisäksi seurannan yhteydessä, joka toteutettiin 64 vuoden
keski-iässä (n = 661; Osajulkaisu I). Kognitiiviset testitulokset saatiin puolustusvoimien
kognitiivisia kykyjä mittaavasta testistä, joka toteutettiin varusmiespalveluksen aikana
20 vuoden keski-iässä (n = 1196; Osajulkaisu III) ja uusintatestissä 69 vuoden keski-
iässä (n = 398; Osajulkaisu IV). Kognitiivista heikkenemistä mitattiin lisäksi
psykologisilla kyselylomakkeilla (CFQ ja DEX) psykologisen seurannan yhteydessä,
joka toteutettiin 69 vuoden keski-iässä (n = 876; Osajulkaisu V).
8Äidin pre-eklampsia (raskausmyrkytys) oli yhteydessä korkeampaan itseraportoituun
kognitiiviseen heikkenemiseen (Osajulkaisu V). Äidin raskauteen liittyvä kohonnut
verenpaine ilman valkuaisvirtsaisuutta oli yhteydessä kohonneeseen riskiin sairastua
mielenterveyshäiriöihin (Osajulkaisu II), mutta ei itseraportoituihin masennusoireisiin.
Äidin hypertensiiviset raskaushäiriöt yhtenä diagnostisena kokonaisuutena olivat
yhteydessä heikompaan kognitiiviseen suoriutumiseen (Osajulkaisut III ja IV) ja
suurempaan kognitiivisten taitojen heikentymiseen (Osajulkaisu IV). Sukupuoli,
pariteetti ja lapsuuden sosioekonominen asema vaikuttivat osiin yhteyksistä. Äidin pre-
eklampsia oli yhteydessä yleisimpiin ja vakavimpiin masennusoireisiin esikoislapsilla,
muttei toisilla tai sitä seuraavilla lapsilla (Osajulkaisu I), ja pienentyneeseen
mielenterveyshäiriöiden riskiin miehillä, muttei naisilla (Osajulkaisu II). Äidin
raskauteen liittyvä kohonnut verenpaine ilman valkuaisvirtsaisuutta oli yhteydessä
suurempaan kognitiivisten taitojen heikentymiseen naisilla, muttei miehillä (Osajulkaisu
V). Lisäksi äidin hypertensiivisten raskaushäiriöiden ja heikomman kognitiivisen
suoriutumisen yhteydet varhaisessa aikuisuudessa tulivat selkeimmin esiin
esikoislapsilla ja heillä, joiden lapsuuden sosioekonominen asema oli korkea
(Osajulkaisu III).
Tässä väitöstutkimuksessa äidin hypertensiiviset raskaushäiriöt olivat yhteydessä
kaikkiin tutkittuihin mielenterveyden ja kognitiivisten taitojen osa-alueisiin.
Sikiöaikainen altistuminen äidin hypertensiivisille raskaushäiriöille ennusti yleisesti
ottaen heikompaa mielenterveyttä ja kognitiivista suoriutumista vuosikymmeniä
myöhemmin. Kuitenkin myös suojaavia vaikutuksia löydettiin, ja näiden myönteisten
kehityspolkujen tunnistaminen onkin jatkossa tärkeää. Tämä tutkimus on pisin seuranta
äidin raskauteen liittyvän kohonneen verenpaineen ja lapsen myöhemmän psykologisen
kehityksen yhteyksistä. Löydökset tukevat sikiöaikaisen ohjelmoitumisen näkökulmaa
ja varhaisen ympäristön merkitystä myöhemmän kehityksen kannalta.
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1 INTRODUCTION
Children and adults born preterm or with a small body size are at a higher risk for any
mental  disorders  (Abel  et  al.,  2010),  as  well  as  specific  mental  disorders  including
schizophrenia (Abel et al., 2010; Byrne, Agerbo, Bennedsen, Eaton, & Mortensen, 2007;
Cannon, Jones, & Murray, 2002; Nilsson et al., 2005; St Clair et al., 2005; Wahlbeck,
Forsén, Osmond, Barker, & Eriksson, 2001), personality disorder (Hoek et al., 1996; M.
Lahti et al., 2010; Neugebauer, Hoek, & Susser, 1999), mood disorder (Abel et al., 2010;
Costello, Worthman, Erkanli, & Angold, 2007; Patton, Coffey, Carlin, Olsson, &
Morley, 2004; Räikkönen et al., 2008) and substance use disorder (Abel et al., 2010),
and show higher depressive symptoms (Alati et al., 2007; Cheung, Khoo, Karlberg, &
Machin, 2002; Gale & Martyn, 2004; Mallen, Mottram, & Thomas, 2008; Nomura et al.,
2007; Paile-Hyvärinen et al., 2007; Räikkönen et al., 2007; Thompson, Syddall, Rodin,
Osmond, & Barker,  2001) than their  peers born at  term or with a normal birth weight.
Children and adults born preterm or with a small  body size have also poorer cognitive
and executive functioning than their peer born at term or with a normal birth weight
(Bhutta, Cleves, Casey, Cradock, & Anand, 2002; Erickson, Kritz-Silverstein, Wingard,
& Barrett-Connor, 2010; Martyn, Gale, Sayer, & Fall, 1996; Matte, Bresnahan, Begg, &
Susser, 2001; Pyhälä et al., 2011; Räikkönen, Forsén et al., 2009; Richards, Hardy, Kuh,
& Wadsworth, 2002; Shenkin et al., 2001; Shenkin, Starr, & Deary, 2004; Sommerfelt,
Markestad, & Ellertsen, 1998; H. T. Sørensen et al., 1997; Strang-Karlsson et al., 2010).
Recent evidence suggests that those born small also show a greater cognitive decline up
to old age (Räikkönen et al., 2013). Although contradictory ﬁndings also exist, the
existing evidence is in favour of negative rather than no associations.
While prematurity and small body size at birth have been extensively studied as
proxies of prenatal environmental adversities, they do not inform what the underlying
specific adversities are. A key factor that may underlie prematurity and restricted fetal
growth is maternal hypertensive pregnancy disorders (J. M. Roberts, Pearson, Cutler,
Lindheimer, & NHLBI Working Group on Research on Hypertension During
Pregnancy, 2003; Villar et al., 2006). These disorders include chronic hypertension,
gestational hypertension and (pre-)eclampsia. Together they complicate approximately
10%  of  all  pregnancies  (C.  L.  Roberts  et  al.,  2011).  Pre-eclampsia,  which  is  a  severe
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form of these disorders, comprises up to 4% of maternal hypertensive pregnancy
disorders. These disorders are characterised by elevated blood pressure where
proteinuria is an additional characteristic of pre-eclampsia. While these disorders may
not  always  result  in  prematurity  or  a  small  body size  at  birth,  they  may have  a  major
impact on later development.
Although maternal hypertensive pregnancy disorders are very likely to compromise
the fetal developmental milieu, they have attracted relatively little research interest in
relation to the psychological outcomes of the offspring. This is surprising, since they are
strong candidates for causing permanent developmental programming effects
manifesting in mental health and cognitive functioning even decades later. Therefore,
the overarching aim of this thesis is to test whether maternal hypertensive disorders
during pregnancy are associated with the mental health and cognitive functioning of the
offspring by capitalising on the large epidemiological Helsinki Birth Cohort Study
(HBCS).
1.1 Developmental origins of health and disease
It is widely accepted that development during prenatal life may have long-lasting effects.
This relationship reflects the plastic responses made by a developing organism whereby
it changes its phenotype in response to changes in the environment (e.g. Price,
Qvarnstrom, & Irwin, 2003). The Development Origins of Health and Disease (DOHaD)
hypothesis emphasises the importance of developmental plasticity in phenotypic
variability, but this idea is also rooted in other theories.
Kermack, McKendrick and McKinlay (1934) published a noteworthy paper in Lancet
in 1934 which initiated the discussion of birth cohort influences on adult disease risk.
They showed that death rates in Europe from 1751 to 1930 fell with each successive
year-of-birth cohort. They proposed that the health of an individual during his/her entire
life is affected by their environment in the period between 0 to 15 years of age rather
than by later living conditions. Thus, infant death rates were considered a marker of
early living conditions. Similarly, in 1977, Forsdahl discovered considerable variations
in rates of heart disease mortality in 1964–1967 between Norwegian counties. The
variations were not explained by present-day differences in standards of living, but by
differences in the past as shown by infant mortality rates 70 years earlier.
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A series of independent observations made in the UK and Sweden a decade later by
Wadsworth, Cripps, Midwinter and Colley (1985), Gennser, Rymark and Isberg (1988)
and Barker, Winter, Osmond, Margetts and Simmonds (1989) have also given impetus
to the idea that developmental factors might influence susceptibility to disease later in
life. Each showed a relationship between birth size and cardiovascular and/or metabolic
health later in life. Studies by Barker and coworkers have been the most influential in
the field. Originally, they showed that differences in neonatal mortality in 1921–1925 in
the UK predicted death rates from stroke and heart disease in 1968–1978 (Barker &
Osmond, 1986). The normal cause of death in newborn babies at that time was low birth
weight. Subsequently, they presented direct evidence of the associations between low
birth weight (and weight at 1 year) and an increased risk of death from cardiovascular
disease in a study of men born in Hertfordshire where birth records have been kept since
1911 (Barker et al., 1989). Based on these findings, Barker put forward a theory
suggesting that cardiovascular disease is associated with specific patterns of
disproportionate fetal growth that result from fetal under-nutrition (Barker, 1994;
Barker, 1995).
These original findings have since been replicated in several epidemiological studies
around  the  world  (Barker,  Osmond,  Forsén,  Kajantie,  &  Eriksson,  2005;  Eriksson,
Forsén, Tuomilehto, Osmond, & Barker, 2000; Frankel, Elwood, Sweetnam, Yarnell, &
Smith, 1996; Hyppönen, Leon, Kenward, & Lithell, 2001; Lawlor, Ronalds, Clark,
Smith, & Leon, 2005; Leon et al., 1998; Martyn, Barker, & Osmond, 1996; Stein et al.,
1996).  Low  birth  weight  has  also  been  associated  with  an  increased  risk  of  a  wide
spectrum of other health outcomes in later life, including type 2 diabetes (Barker et al.,
1993), chronic lung disease (Edwards, Osman, Godden, Campbell, & Douglas, 2003)
and  osteoporosis  (Cooper  et  al.,  2002).  Further  studies  have  led  to  a  new  branch  of
scientific knowledge and the hypothesis has further developed into the DOHaD
hypothesis. According to this hypothesis, a suboptimal prenatal environment (and early
postnatal life) may permanently alter organ structure and function, and render an
individual susceptible to diseases (Barker, 2004). In line with this hypothesis, a wide
range of behavioural and cognitive problems has also been associated with early life
adversities. Indeed, as stated previously, prematurity and a small body size at birth are
associated  with  any  mental  disorder  (Abel  et  al.,  2010)  as  well  as  specific  mental
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disorders, including schizophrenia (Abel et al., 2010; Byrne et al., 2007; Cannon et al.,
2002; Nilsson et al., 2005; St Clair et al., 2005; Wahlbeck et al., 2001), personality
disorder (Hoek et al., 1996; M. Lahti et al., 2010; Neugebauer et al., 1999), mood
disorder (Abel et al., 2010; Costello et al., 2007; Patton et al., 2004; Räikkönen et al.,
2008) and substance use disorder (Abel et al., 2010) in adulthood and with depressive
symptoms in populations of various ages (Alati et al., 2007; Cheung et al., 2002; Gale &
Martyn, 2004; Mallen et al., 2008; Nomura et al., 2007; Paile-Hyvärinen et al., 2007;
Räikkönen et al., 2007; Thompson et al., 2001). Furthermore, prematurity and a small
body size at birth are associated with lower cognitive and executive functioning in
childhood, adolescence and adulthood (Bhutta et al., 2002; Erickson et al., 2010;
Martyn, Gale et al., 1996; Matte et al., 2001; Pyhälä et al., 2011; Räikkönen et al., 2009;
Richards et al., 2002; Shenkin et al., 2001; Shenkin et al., 2004; Sommerfelt et al., 1998;
H. T. Sørensen et al., 1997; Strang-Karlsson et al., 2010), and a small body size at birth
is also associated with a greater cognitive decline up to old age (Räikkönen et al., 2013).
While it was fortuitous that a relationship between birth size and later disease risk
was found, the existing evidence strongly suggests that size itself is not part of the
causal pathway leading to disease. Birth weight acts as a crude proxy for the fetal
environment. Disease risk can be elevated even in those with an apparently normal birth
weight. Barker and co-workers suggested that the phenomenon being observed reflects
the operation of the developmentally plastic responses rather than being pathological.
They later showed that the relationship between birth size and disease outcome was not
restricted to those with the lowest birth weight, but that death rates from cardiovascular
disease fell progressively between those with the lowest and highest birth weights
(Barker et al., 1989; Osmond, Barker, Winter, Fall, & Simmonds, 1993). Indeed, the
theory is not based on a causal role of birth size, but on the consequences of fetal
responses to its environment. That is, while birth weight as a crude proxy of an adverse
fetal environment is most studied, other factors may also be involved. These may
include maternal hypertensive pregnancy disorders despite not gaining much research
attention. Such disorders are common causes of a low birth weight; and, while they may
not always result in a small body size at birth, they may have a major effect on later
development.
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The validity of the DOHaD hypothesis is largely based upon epidemiological
associations, but the model is also supported by extensive clinical and experimental data
and has both a conceptual and mechanistic basis (of these, the mechanistic basis, which
is related to epigenetic evidence, is discussed in detail in section 1.4.4). Experimental
data allow for the examination of causal effects of early life adversity on the outcomes
of offspring later in life while keeping covariate effects constant. Animal models have
indeed shown that early life adversities—exposures such as nutritional manipulation,
maternal stress and exogenously administered glucocorticoids—have long-term effects
on  an  offspring’s  physiology  (for  reviews,  see  Bertram & Hanson,  2001;  McMillen  &
Robinson, 2005; Nuyt & Alexander, 2009) and behavioural and cognitive performance
(Vallee et al., 1999; Wang et al., 2012; Weaver, Meaney, & Szyf, 2006). In humans, the
cause and effect associations of prenatal adversity are generally impossible to study for
ethical reasons. However, the circumstances of the Dutch famine of 1944–1945
provided a natural experiment allowing for the examination of how maternal
undernutrition during gestation may affect the subsequent life course of offspring who
experienced the famine in utero. The findings have consistently shown associations
between prenatal famine and adult body size, diabetes and schizophrenia (Roseboom,
Painter, van Abeelen, Veenendaal, & de Rooij, 2011).
Two conceptual models are suggested as the basis of such associations. The thrifty
phenotype hypothesis (Hales & Barker, 1992) states that a fetus adapts in utero to
survive maternal undernutrition or other environmental stressors, one possible
consequence being a reduction in fetal growth of either the whole body or some organs.
Later, Gluckman and Hanson (2004) modified the model and termed it the predictive
adaptive response model. This model proposes that many of the adaptive responses
made by the fetus are not made for immediate advantage, but rather in expectation of
the future postnatal environment. Successful adaptation to the predicted environment
improves biological fitness. However, this normative human developmental experience
may be associated with adverse health outcomes when there is a mismatch between the
predicted environment and the actual environment into which the fetus is born.
The window of developmental plasticity extends from the preconception or prenatal
period to life afterwards. A life cycle model has been developed to explain why
different disorders emerge in individuals exposed to a stress and/or adversities at
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different times in their lives (Lupien, McEwen, Gunnar, & Heim, 2009). This model
proposes a link between the different phases of brain development in humans and the
impact  of  a  stress  and/or  adversities  at  key  timepoints  (Lupien  et  al.,  2009).  Different
regions of the brain that are sensitive to stress hormones develop at different times in an
individual's life. The effects of a stress and/or adversity at different stages in life depend
on the brain areas that are developing or declining at the time of the exposure. The data
obtained in animals and humans suggest that chronic or repeated exposure to a stress
has enduring effects on the brain through the activation of the hypothalamic–pituitary–
adrenal axis (HPAA) and the release of glucocorticoids (reviewed in more detail in
section 1.4.3).
In humans, maximal brain growth and most of the neuroendocrine maturation occurs
in utero (Dobbing & Sands, 1979; Lupien et al., 2009). HPAA is highly responsive at
birth,  but  the  brain  continues  to  develop.  Lupien  et  al.  (2009)  summarise  the
development of the brain regions that are involved in regulating HPAA (the
hippocampus, the frontal cortex and the amygdala). The volume of the hippocampal
formation increases sharply until the age of 2 years, whereas amygdale volume
continues to increase slowly until the late 20s. By contrast, the development of the
frontal cortex in humans takes place mostly between the ages of 8 and 14 years. Thus,
from  the  prenatal  period  onwards,  all  areas  of  the  brain  that  are  still  developing  are
sensitive to the effects of stress hormones, while exposure to a stress during a particular
period should have major effects on areas that undergo rapid growth during that period.
In a similar vein, although significant decreases in brain volume have been reported in
aged animals and humans, different brain regions are differently affected by aging and
the impact of a stress exposure is highest on those structures that are undergoing the
most rapid age-related changes during a particular period. Accordingly, depending on
the  timing  (and  duration)  of  exposure  to  a  stress  and/or  adversity,  varying  effects  on
behaviour and cognition may be observed.
Finally, it seems that individuals differ in terms of developmental plasticity. Some
individuals are more vulnerable to the adverse effects of negative experiences because
of their biological, temperamental and/or behavioural characteristics, whereas others are
relatively resilient to them. The idea that individuals vary in their responsivity to
qualities of the environment is framed in diathesis-stress (Monroe & Simons, 1991;
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Zuckerman, 1999) or dual-risk terms (Sameroff, 1983). An alternative view is Belsky’s
differential susceptibility hypothesis, which suggests that individuals vary not only in
the degree to which they are vulnerable to the negative effects of an adverse experience,
but  also  with  respect  to  their  susceptibility  to  the  beneficial  effects  of  supportive  and
enriching environments (Belsky & Pluess, 2009). Boyce and Ellis (2005) provided a
related notion known as biological sensitivity to context. Several susceptibility factors,
including a negative emotion or difficult temperament and endophenotypic and genetic
markers, have been identified (Belsky & Pluess, 2009). Interestingly, fetal programming
(e.g. maternal prenatal distress) appears to influence several of these factors (Pluess &
Belsky, 2011). These findings have led to the proposition that postnatal plasticity (vs.
later development) may be programmed by the prenatal environment (Pluess & Belsky,
2011).
All of these theories suggest that early life effects within even a normative range of
developmental exposures have lifelong consequences on human health.
1.2 Hypertensive disorders during pregnancy: Definitions and
epidemiology
Pre-eclampsia: A sudden flash or development (derived from the Greek eklampsis)
Globally, hypertensive pregnancy disorders complicate approximately 6–16% of all
pregnancies, with pre-eclampsia accounting for 3–7% (National High Blood Pressure
Education Program Working Group on High Blood Pressure in Pregnancy, 2000; C. L.
Roberts, Algert, Morris, Ford, & Henderson-Smart, 2005). In high-income countries,
the rates are around 10%, with pre-eclampsia accounting for ~4% (C. L. Roberts et al.,
2011). These disorders are the leading causes of maternal, fetal and neonatal morbidity
and mortality. Overall, 10–15% of maternal deaths from pregnancy-related causes are
associated with pre-eclampsia and eclampsia (Duley, 2009). While most of these deaths
occur in low- and middle-income countries, the proportion associated with pre-
eclampsia and eclampsia is similar between countries (Duley, 2009). Pre-eclampsia and
eclampsia also drastically increase the risk of maternal morbidity (Carty, Delles, &
Dominiczak,  2010)  as  well  as  the  risks  to  the  infant.  Immediate  risks  to  the  infant
include perinatal death, poor growth and prematurity (reviewed in section 1.2.6). Less
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information  is  available  on  the  long-term  implications  of  these  disorders.  As  well  as
pre-eclampsia, gestational hypertension may increase the risk of adverse perinatal and
long-term outcomes (Villar et al., 2006).
1.2.1 Classification
Hypertensive pregnancy disorders are characterised by elevated blood pressure where
proteinuria is an additional characteristic in pre-eclampsia. Table 1 describes the
diagnostic criteria according to the National High Blood Pressure Education Program
Working Group on High Blood Pressure in Pregnancy (National High Blood Pressure
Education Program Working Group on High Blood Pressure in Pregnancy, 2000) and
the American College of Obstetricians and Gynecologists and Task Force on
Hypertension in Pregnancy (American College of Obstetricians and Gynecologists &
Task Force on Hypertension in Pregnancy, 2013).
Table 1. Classification of hypertensive pregnancy disorders
Category Definition
Chronic hypertension HT ≥140/90 mmHg present before pregnancy or diagnosed
before 20th week of gestation or does not resolve post-partum
Gestational hypertension HT ≥140/90 mmHg on ≥2  occasions  at  least  4  h  apart  in  a
women who was normotensive before 20th week of gestation
and whose blood pressure returns to normal post-partum
Pre-eclampsia-eclampsia HT ≥140/90 mmHg on ≥2 occasions at least 4 h apart in a
women who was normotensive before 20th week of gestation
with proteinuria ≥300 mg/ 24 h
Pre-eclampsia superimposed on
chronic hypertension
HT ≥140/90 mmHg present before pregnancy or diagnosed
before 20th week of gestation with (new-onset) proteinuria ≥300
mg/ 24 h
(American College of Obstetricians and Gynecologists & Task Force on Hypertension in Pregnancy,
2013; National High Blood Pressure Education Program Working Group on High Blood Pressure in
Pregnancy, 2000)
HT, hypertension
According to the criteria, it is recommended that gestational blood pressure elevation is
defined on the basis of at least two measurements. Certainty regarding pre-eclampsia
diagnoses is indicated when blood pressure is ≥160/110 mmHg with proteinuria.
However, differentiating between mild and severe disease is the subject of debate
21
(Steegers, von Dadelszen, Duvekot, & Pijnenborg, 2010). Diagnosing proteinuria is
suggested on the basis of a 24-hour urine sample, but the excretion of ≥300 mg/24 h
usually correlates with ≥30 mg/dL (≥1+ reading on the dipstick). Furthermore, disease
is highly suspect when an increased blood pressure accompanies headache, blurred
vision and abdominal pain, or by abnormal laboratory test results, specifically low
platelet counts and abnormal liver enzyme values. Eclampsia is defined as the
occurrence of seizures that cannot be attributed to other causes in a woman with pre-
eclampsia. In past decades, the rates of eclampsia declined largely in relation to
improved medical care (Ness & Roberts, 2009). Accordingly, epidemiological research
has focused on pre-eclampsia and hypertension without proteinuria.
1.2.2 History of hypertensive pregnancy disorders
Hypertensive pregnancy disorders have a history of divergent diagnostic criteria. During
the 20th and 21st centuries, disease classifications have undergone various changes (Bell,
2010). In 1966, new criteria for the diagnosis of pre-eclampsia included the presence of
hypertension, edema or proteinuria after the 24th week of gestation. Women had to meet
only one of the three criteria to be diagnosed with pre-eclampsia. Ten years later, the
classification of pre-eclampsia included the development of hypertension with
proteinuria, edema or both commencing after 20 weeks of gestation. In 1988, mild and
moderate pre-eclampsia were classified as the presence of hypertension and edema,
while severe pre-eclampsia was classified as the presence of hypertension and
proteinuria with or without other symptoms such as edema. According to current
clinical criteria (Table 1), edema as a criterion for diagnosing pre-eclampsia is not
recommended (American College of Obstetricians and Gynecologists & Task Force on
Hypertension in Pregnancy, 2013; National High Blood Pressure Education Program
Working Group on High Blood Pressure in Pregnancy, 2000). In addition, while blood
pressure increases of 30 mmHg systolic or 15 mmHg diastolic with a blood pressure
<140/90 mmHg were considered diagnostic markers in the past, they are not included in
the current clinical criteria (American College of Obstetricians and Gynecologists &
Task Force on Hypertension in Pregnancy, 2013; National High Blood Pressure
Education Program Working Group on High Blood Pressure in Pregnancy, 2000).
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Only a few of the studies reviewed for this thesis have used the modern diagnostic
criteria. In the remaining, the criteria have varied or have not been reported. Some of
these studies have been able to define maternal hypertension status based on a true
maternal blood pressure and urinary protein measurements. Some studies have relied on
discharge diagnoses of pregnancy hypertension using different versions of the
International Statistical Classification of Diseases and Related Health Problems (ICD)
coding depending on the time, with the criteria differing even within a specific coding
version. Importantly, a validation study of medical records at New York Hospital
showed that 25% of ICD-9 codes incorrectly diagnosed pre-eclampsia and that 53% of
true cases were missed by ICD-9 coding (Ales & Charlson, 1991). Thus, studies that did
not report the exact criteria are not discussed in detail in this thesis. The divergent
diagnostic criteria may complicate interpretation of the data from follow-up studies.
1.2.3 Pharmacologic treatment
In addition to diagnostic criteria, the treatment of pre-eclampsia and hypertension has
evolved (Bell, 2010). In terms of the pharmacologic management of pre-eclampsia and
eclampsia (convulsions), magnesium sulfate was popularized during the 1920s (Chesley,
1984). However, the first treatments were given e.g. in Helsinki in 1943 (Tarkiainen,
1946). For mothers at risk of preterm birth, glucocorticoids came into widespread use
after 1972 in order to regulate fetal lung maturation (Liggins & Howie, 1972). Currently,
magnesium sulfate is recommended for the prevention of or to deter convulsions in
women with pre-eclampsia or eclampsia, glucocorticoids are administered to accelerate
fetal pulmonary maturity and antihypertensive therapy is used to treat acute
hypertensive episodes (Bell, 2010; National High Blood Pressure Education Program
Working Group on High Blood Pressure in Pregnancy, 2000). Pharmacologic
management may decrease the risk or severity of pre-eclampsia and hypertension and
promote fetal lung maturity, but it will also affect—either favourably or adversely—
fetal brain development (for studies on the use of methyldopa, labetalol and
glucocorticoid treatment during pregnancy and the effects on offspring neurologic or
behavioural outcomes, see Davis, Sandman, Buss, Wing, & Head, 2013; Koren, 2013;
Peltoniemi, Kari, & Hallman, 2011; Trautman, Meyer-Bahlburg, Postelnek, & New,
1995).
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1.2.4 Pathophysiology
The underlying causes of pre-eclampsia and gestational hypertension remain unknown.
Inadequate placentation due to deficient trophoblastic invasion of the uterine spiral
arteries is one probable underlying cause. This may result in the release of a variety of
factors into the circulatory system that alter endothelial function (Taylor, Davidge, &
Roberts, 2009). While the factors may differ between individuals, they may include
angiogenic factors, metabolic factors and inflammatory mediators. It is possible that
these give rise to oxidative stress and endothelial dysfunction, culminating in pre-
eclampsia (Taylor et al., 2009). Clinical manifestations result from systemic endothelial
dysfunction, in which the target organ may be the brain, the liver and/or the kidney. It is
of note that at least some forms of gestational hypertension may share certain
pathophysiologic and pathogenic mechanisms with pre-eclampsia (Levine et al., 2006;
Strevens et al., 2003).
1.2.5 Risk factors
The risk factors for hypertensive pregnancy disorders have been well documented
(Table 2), and the factors associated with a decreased risk for pre-eclampsia and
hypertension in pregnancy are also recognised (Table 3). These can be divided into
factors associated with a maternal predisposition to cardiovascular disease and factors
that represent the placental or pregnancy-related component of pre-eclampsia and
hypertension without proteinuria. In addition, it is possible that psychological risk
factors such as job stress, depression and anxiety have a positive association (Kurki,
Hiilesmaa, Raitasalo, Mattila, & Ylikorkala, 2000; Paarlberg, Vingerhoets, Passchier,
Dekker,  &  Van  Geijn,  1995;  Qiu,  Williams,  Calderon-Margalit,  Cripe,  &  Sorensen,
2009).
While poor placentation is commonly associated with disease, this is not always the
case. Maternal constitutional susceptibility may be a determining factor. This
assumption is consistent with the shared risk factors associated with both pre-eclampsia
and gestational hypertension and cardiovascular disease. In addition, although pre-
eclampsia is associated with intrauterine growth restriction (IUGR), most infants born
to pre-eclamptic women have a normal birth weight for gestational age (reviewed in
section 1.2.6). This may be explained by factors such as diabetes and obesity, which are
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risk factors for pre-eclampsia and gestational hypertension, yet are often associated with
larger babies (King, 2006).
Table 2. Risk factors for pre-eclampsia and hypertension in pregnancy
Risk factors for pre-eclampsia Risk factors for hypertension in pregnancy*
Higher maternal age
Primiparity
Previous pre-eclampsia
Family history of pre-eclampsia (mum)
Multifetal gestation
Pre-existing medical conditions
   Type 1diabetes
   Pre-existing hypertension
   Renal disease
   Chronic autoimmune disease
Longer time between pregnancies
Changing paternity
Raised body mass index
African ethnicity
Use of ovulation induction
Higher maternal age
Elevated body mass index
African ethnicity
Previous preeclampsia
Family history of pre-eclampsia (mum)
Primiparity
Multifetal gestation
(Duckitt & Harrington, 2005; Poon, Kametas, Chelemen, Leal, & Nicolaides, 2010)
*Note that all risk factors for pre-eclampsia may also apply to gestational hypertension despite lack of
published data
Table 3. Associates with decreased risk for pre-eclampsia and hypertension in pregnancy
Placenta praevia
Smoking
Summer births
Low-dose aspirin and calcium supplementation
Treatment of gestational diabetes
Use of antihypertensive medication
Early elective delivery
(Conde-Agudelo, Althabe, Belizan, & Kafury-Goeta, 1999; C. L. Roberts et al., 2011)
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1.2.6 Geographic and temporal variations
Trends for hypertensive pregnancy disorders in part reflect the effects of changes in risk
and protective factors. Geographic variations may be due to different diagnostic criteria
as discussed above and methods of data collection, but may also reflect true variations.
All of these factors pose challenges for the comparison of epidemiological studies.
Temporal variations are easier to interpret, at least when methods of reporting rates do
not change. Based on an international comparative study of population-based trends in
pregnancy hypertension from 1997 to 2007, surprisingly rates are decreasing in northern
Europe and Australia, but are increasing in Massachusetts (C. L. Roberts et al., 2011). A
rise in rates of pre-eclampsia in the USA as a whole is also supported by an individual
study showing a 25% increase in rates from 1987 to 2004 when the indicated rate was
3.2  (Wallis,  Saftlas,  Hsia,  &  Atrash,  2008).  In  Finland,  according  to  a  large  national
study conducted between 2000 and 2001, the incidence of pre-eclampsia was 5%, while
that of elevated blood pressure was almost 19% among pregnant women (Kaaja &
Luoto, 2004). Some evidence shows that women in northern Finland may be at a higher
risk of both pre-eclampsia and gestational hypertension compared to women in southern
Finland (Kaaja, Kinnunen, & Luoto, 2005).
Since the etiology of hypertensive pregnancy disorders remains unclear and the
prevention  and  prediction  of  them  are  still  not  possible  (Steegers  et  al.,  2010),  it  is
important not only to recognise mothers at risk for adverse outcomes, but to also
understand the risks for the offspring.
1.2.7 Perinatal outcomes: Prematurity, low birth weight, still birth and
infant death
Past studies have attempted to quantify the effect of hypertensive pregnancy disorders
on adverse perinatal outcomes. Pregnancies complicated by hypertension with or
without proteinuria are characterised by an increased rate of preterm delivery (Ananth,
Savitz, Luther, & Bowes, 1997; Bakker, Steegers, Hofman, & Jaddoe, 2011; Ferrazzani
et  al.,  2011;  C.  L.  Roberts  et  al.,  2005;  Villar  et  al.,  2006),  but  the  rates  vary
considerably across studies. The higher rate is at least partly due to delivery being the
only curative treatment for pre-eclampsia. Indeed, due to medically indicated preterm
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births, pre-eclampsia is implicated in 10–15% of all preterm births (Ananth &
Vintzileos, 2006; J. M. Roberts et al., 2003).
Compared to children born after normotensive pregnancies, children born after
hypertensive pregnancy disorders often also have lower birth weights (Bakker et al.,
2011; Himmelmann, Himmelmann, Niklasson, & Svensson, 1996; Villar et al., 2006;
Zhang, Klebanoff, & Roberts, 2001) and a higher risk of being born with a birth weight
of less than 2500 g (Bakker et al., 2011; Zhang et al., 2001). Naturally, this may in part
be explained by their increased risk of preterm birth or a shorter length of gestation. In
addition, it is intuitive that if placental blood flow is reduced with pre-eclampsia and
hypertension, it should result in decreased fetal growth. This should not only increase
the risk of low birth weight, but also intrauterine growth restriction. Poor fetal growth is,
indeed, often considered a characteristic of pregnancies complicated by hypertension
and supported by many studies (Allen, Joseph, Murphy, Magee, & Ohlsson, 2004;
Bakker et al., 2011; Ferrazzani et al., 2011; C. L. Roberts et al., 2005; Villar et al., 2006;
Zhang et al., 2001). The reported rates of IUGR reach up to 50% in hypertensive
pregnancy disorders. It has been suggested that approximately 10% of all cases of
IUGR are secondary to pre-eclampsia or gestational hypertension (Villar et al., 2006). A
few studies have reported an association between pre-eclampsia and/or gestational
hypertension and with large-for-gestational age births (Eskild, Romundstad, & Vatten,
2009; Xiong, Demianczuk, Buekens, & Saunders, 2000). This may reflect the
involvement of multiple pathophysiologic processes. Birth outcomes may also depend
on gestational age at the time of onset of the disease (Xiong, Demianczuk, Saunders,
Wang, & Fraser, 2002) and the severity of the disease (Buchbinder et al., 2002). In
general, outcomes are usually more favorable when hypertension is mild or develops
beyond 36 weeks of gestation (Sibai, Dekker, & Kupferminc, 2005).
Hypertensive pregnancy disorders are also important contributors to stillbirth
worldwide and one of the most important factors in high-income countries. A recent
meta-analytic review revealed that pre-eclampsia was associated with a 60% increase in
the odds of a stillbirth in high-income countries over the past two decades (Flenady et
al., 2011). Gestational hypertension was associated with a 30% increase in the odds.
The risk associated with pre-existing hypertension was even higher than that for pre-
eclampsia or gestational hypertension. According to a Norwegian study, the rates of
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survival from pre-eclamptic pregnancies have improved from 1967 to 2003: the risk
was 4.2 times higher with pre-eclampsia in earlier years and 1.3 times higher during
more recent years in the follow-up (Basso et al., 2006). However, the risk of neonatal
death is still twofold with pre-eclampsia and has changed little over time (Basso et al.,
2006). In Finland, in 1936 and 1937 when infant death rates during the first year of life
were up to 7%, eclampsia accounted for 0.3–0.5% (Central Statistical Office of Finland,
1939). This is indicative of high infant mortality among eclamptic mothers. During
1990–1994, eclampsia led to fetal death in 5% of cases and neonatal death in 3.3% of
cases (Salmi, Ekholm, Polo, & Erkkola, 1999). Selection related to variations in
survival across (location and) time may introduce a bias and challenge comparisons
between different studies.
This thesis is based upon men and women who were born in Helsinki between 1934
and 1944. During that time, the pre-eclamptic state was recognised, but pre-eclampsia-
eclampsia was not restricted to an obstetric definition. Nephrogestosis was clinically
classified as (1) albuminuria,  a small  amount of sediment in the urine (Esback: >1‰);
(2)  nephropathy,  a  large  amount  of  sediment  in  the  urine  and  ambie  edema,  which
usually flares up during the third trimester of pregnancy; (3) eclapcism, imminent
eclampsia; or (4) eclampsia, a convulsion (Teräsvuori, 1933). Eclampsia rates were
0.6% of all pregnancies in Helsinki and up to 1.7% in Viipuri in Eastern Finland
(Parviainen, 1946). Blood pressure and proteinuria were not included in the diagnostic
criteria for the prenatal nephrogestosis disorder, although they were recognised as a part
of the disorder and were recorded (Figure 1). Based on archival data, studying the
consequences of maternal hypertensive pregnancy disorders over many decades is
possible.
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Figure 1. Birth record from year 1935
1.3 Mental health and cognitive functioning
As stated above, prematurity and a small body size at birth have been associated with a
wide range of behavioural and cognitive problems later in life. Accordingly, it makes
sense to study whether exposure to maternal hypertensive disorders in utero is
associated with later mental health and cognitive functioning. Increasingly higher
proportions of the global burden of disease can be attributed to disorders of the brain
including mental, neurological and substance use disorders (Collins et al., 2011).
Disorders of the brain are the largest contributor to all causes of morbidity as measured
by disability adjusted life years in the European Union (Wittchen et al., 2011). Below, I
briefly describe the prevalence of mental disorders and cognitive impairment.
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1.3.1 Prevalence of mental health problems
According to the World Health Organization (WHO; WHO International Consortium in
Psychiatric Epidemiology, 2000), over one-third of all people in most countries report
problems at some time in their life which meet the diagnostic criteria for one or more of
the most common types of mental disorders. These disorders are burdensome because of
their high prevalence, chronicity, early age of onset and because they often result in
serious impairment (Demyttenaere et al., 2004; Whiteford et al., 2013; WHO
International Consortium in Psychiatric Epidemiology, 2000). The prevalence rates vary
widely across studies. According to a recent meta-analytic review of the global
prevalence of common mental disorders, the period prevalence of mood disorders is
5.4% (with an inter-quartile range of 3.4–8.4%), 6.7% (4.3–10.9%) for anxiety disorder
and 3.8% (2.1–6.4%) for substance use disorder (Steel et al., 2014). The corresponding
prevalence estimate for any personality disorder is 6.1% (Huang et al., 2009). Compared
to the estimated period prevalences, lifetime prevalences are higher. According to the
meta-analytic review, lifetime prevalences for mood, anxiety and substance use
disorders are 9.6% (6.1–17.8%), 12.9% (9.6–19.3%) and 3.4% (5.5–18.8%),
respectively (Steel et al., 2014). According to two population-based studies, any
psychotic disorders have a lifetime prevalence of approximately 3% (Bogren, Mattisson,
Isberg, & Nettelbladt, 2009; Perälä et al., 2007).
It has been suggested that depression is associated with higher mortality, morbidity
and financial costs than any other mental disorder (Murray & Lopez, 1996). In
particular, depression later in life is perhaps the most frequent cause of emotional
suffering that significantly decreases one’s quality of life (Blazer, 2003).
In this thesis, severe mental disorders over four decades and depressive symptoms in
late adulthood are studied.
1.3.2 Cognitive functioning and the prevalence of cognitive impairment
Cognitive impairment, including dementia and mild cognitive impairment, has a major
impact on cognitive ability and the capacity for independent living. The global
prevalence of dementia for those aged ≥60 years varies between 5% and 7% (Prince et
al., 2013). For mild cognitive impairment, which often leads to dementia, rates vary
from 0.5% to 42% (Ward, Arrighi, Michels, & Cedarbaum, 2012).
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In this thesis, cognitive ability in both young and late adulthood, and age-related
cognitive decline as well as self-reported cognitive impairment are studied. Importantly,
lower cognitive skills in childhood and young adulthood are associated with an
increased risk of late-onset dementia (McGurn, Deary, & Starr, 2008; Riley, Snowdon,
Desrosiers, & Markesbery, 2005; Whalley et al., 2000). Furthermore, low cognitive test
scores in late adulthood have been shown to predict the onset of cognitive decline and
dementia up to 4 years (Schmand, Smit, Geerlings, & Lindeboom, 1997) and a decade
(Cervilla, Prince, Joels, Lovestone, & Mann, 2004) later. Finally, self-reported cognitive
impairment in old age may be one of the earliest behavioural markers of dementia
(Geerlings, Jonker, Bouter, Ader, & Schmand, 1999; van Oijen, de Jong, Hofman,
Koudstaal, & Breteler, 2007).
Cognitive functioning not only predicts or is a marker for dementia, but it also affects
quality of life in other dimensions. Cognitive test scores are highly predictive of
educational performance (Deary, Strand, Smith, & Fernandes, 2007) and job
performance  (Hunter  &  Schmidt,  1996),  as  well  as  health  (Hart  et  al.,  2004)  and
survival (Whalley & Deary, 2001).
1.4 Mechanisms: Potential pathways linking maternal
hypertensive pregnancy disorders and the mental health and
cognitive functioning of the offspring
The long-term consequences of intrauterine exposure to maternal hypertensive disorders
may originate from several different underlying factors. These may be related to
physiological mechanisms in terms of placental implantation (and, hence, less placental
perfusion), inflammatory mechanisms, hormonal processes such as glucocorticoid
metabolism and genetic and epigenetic mechanisms. While not comprehensive,
glucocorticoids have drawn much research attention as a potential underlying factor. In
addition, while not reviewed in detail here, it is obvious that psychosocial mechanisms
relating to parenting and attachment development may also be involved.
Pre-eclampsia and hypertension without proteinuria may share certain
pathophysiologic and pathogenic mechanisms (Levine et al., 2006; Strevens et al.,
2003). In some cases of gestational hypertension, the risk of adverse outcomes may be
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similar to that for pre-eclampsia (Buchbinder et al., 2002). Furthermore, it is possible
that pre-eclampsia and hypertension without proteinuria exert effects on the developing
fetus through shared mechanisms, although this still needs confirmation. Pre-eclampsia
is the most studied condition and allows us to discuss the possible mechanisms linking
maternal hypertensive pregnancy disorders to the developmental sequelae for offspring.
The mechanisms discussed below may also apply to other hypertensive pregnancy
disorders despite the lack of published data. Figure 2 (page 37) shows the potential
factors and mechanisms that may affect and underlie the long-term psychological
consequences among offspring exposed intrauterine to maternal hypertensive disorders.
1.4.1 Placental functioning
The most obvious possible pathways linking maternal hypertensive pregnancy disorders
with adverse fetal development—brain development in particular—involve fetal growth
restriction and prematurity. Deficient trophoblastic invasion of the uterine spiral arteries
is probable in pre-eclampsia. This, in turn, leads to uteroplacental hypoperfusion, which
may results in inadequate fetal nutrition, hypoxic damage and adverse fetal development
and brain development in particular (J. P. Newnham, Moss, Nitsos, Sloboda, & Challis,
2002).
Both gestational hypertension and pre-eclampsia, if severe, may necessitate preterm
delivery of the fetus (e.g. Villar et al., 2006). In this pathway, the association between
maternal hypertensive disorders and adverse psychological outcomes in the offspring
may be mediated by prematurity.
1.4.2 Inflammatory mechanisms
An inflammatory state may be involved in several potential causal mechanisms that
connect gestational hypertensive disorders with the offspring’s brain development. Pre-
eclampsia involves a range of key immune responses at different stages of the syndrome
(Redman & Sargent, 2010). The final, symptomatic stage is characterised by a maternal
systemic inflammatory response without known infectious agents. It can be
hypothesised that the possible associations between maternal pre-eclampsia and
offspring developmental outcome may reflect the prenatal induction of systemic
inflammation. However, the exact factors remain unknown.
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1.4.3 Hormonal processes: Glucocorticoid metabolism
One major underlying hypothesis for early life programming is fetal glucocorticoid
exposure. Placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) protects the
fetus from high maternal glucocorticoid levels, and there is evidence that 11β-HSD2 is
down-regulated in pre-eclampsia.
The areas of the brain involved in regulating stress are particularly affected by early
life adversities (cp. the DOHaD hypothesis and the life cycle model of stress). These
include HPAA and its key limbic regulator, the hippocampus, as well as the amygdala
and frontal lobes. The activation of HPAA culminates in the production of
glucocorticoids. Furthermore, the secretion of glucocorticoids from the adrenal cortex is
controlled by HPAA in an endocrine negative feedback loop (Lupien et al., 2009)—
corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) are released
from the hypothalamus. This triggers the subsequent secretion of the
adrenocorticotropic hormone (ACTH) from the pituitary gland, leading to the
production  of  glucocorticoids  by  the  adrenal  cortex.  The  responsiveness  of  HPAA  to
stress is, in part, determined by the ability of the glucocorticoids to regulate ACTH and
the release of CRH by binding to two corticosteroid receptors, the glucocorticoid
receptors (GR) and miniralocorticoid receptors (MR). These receptors can act as
transcription factors and, thus, regulate gene expression (Lupien et al., 2009).
Glucocorticoids can have long-lasting effects on the functioning of the regions of the
brain that regulate their release. Anatomical connections between the hippocampus,
amygdala, frontal lobes and hypothalamus regulate the activation of HPAA through
their own glucocorticoid and miniralocorticoid receptors. Although glucocorticoids are
essential for brain development, elevated levels are detrimental and affect neuronal
division, maturation, migration, interactions and apoptosis (Harris & Seckl, 2011).
A suboptimal prenatal environment caused by overexposure to glucocorticoids can
influence HPAA development. Intrauterine exposure to excess glucocorticoids and
maternal stress have been associated with an increase in HPAA activity in animal
models (Harris & Seckl, 2011; Lupien et al., 2009) and changes in activity in humans
(Harris & Seckl, 2011; Kajantie & Räikkönen, 2010; Lupien et al., 2009). Recent
evidence in humans suggests that high maternal cortisol levels during pregnancy predict
higher pre-stress cortisol values and a blunted response to stress exposure in offspring in
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infancy (O'Connor, Bergman, Sarkar, & Glover, 2013). Furthermore, stress and
increased glucocorticoid concentrations can alter the hippocampal structure in young
and aged animals (Khulan & Drake, 2012; Wyrwoll & Holmes, 2012). In addition, a
low  birth  weight  combined  with  lower  levels  of  maternal  care  is  associated  with  a
reduced hippocampal volume in adulthood in humans (Buss et al., 2007). Effects on
other  brain  regions  have  also  been  found  (for  a  review  see  Lupien  et  al.,  2009).  As  a
consequence, over-exposure to glucocorticoids during prenatal life has been linked with
developmental and behavioural outcomes in both animal models and humans (for
reviews, see Lupien et al., 2009; Wyrwoll & Holmes, 2012).
One of the proposed mediators of glucocorticoid programming is 11β-HSD2. This
enzyme plays an important role in protecting the developing fetus from the mother’s
relatively high glucocorticoid levels by catalysing the conversion of cortisol to inactive
cortisone (Benediktsson, Calder, Edwards, & Seckl, 1997), thus preventing the
activation of glucocorticoid receptors. There is evidence that pre-eclampsia may down-
regulate placental 11β-HSD2 activity leading to greater fetal exposure to maternal
prenatal glucocorticoids (Aufdenblatten et al., 2009; Kajantie et al., 2003; McCalla,
Nacharaju, Muneyyirci-Delale, Glasgow, & Feldman, 1998; Schoof et al., 2001).
In animal models, placental 11β-HSD2 deficiency has been associated with defective
brain functioning later in life (Benediktsson et al., 1997; Holmes et al., 2006; Holmes &
Seckl, 2006; Langley-Evans et al., 1996; Leao et al., 2007; Welberg, Seckl, & Holmes,
2000). Recent evidence in humans suggests that the potential inhibition of placental
11β-HSD2 activity by glycyrrhizin in liquorice confectionery (Benediktsson et al., 1997)
is associated with poorer verbal and visuospatial abilities and narrative memory in the
offspring at 8 years (Räikkönen, Pesonen et al., 2009). These findings suggest that the
transcriptional activity of the 11β-HSD2 enzyme may be predicted by maternal
adversity or pre-eclampsia and predictive of high-risk long-term outcomes (see section
1.4.4 below).
In addition to the reduced activity of 11β-HSD2, a hypothesised mechanism linking
maternal pre-eclampsia to fetal over-exposure to glucocorticoids may be related to
maternal distress conditions. Psychological distress conditions may lead to the
development of pre-eclampsia (Kurki et al., 2000; Paarlberg et al., 1995; Qiu et al.,
2009) by enhancing cortisol levels (Vianna, Bauer, Dornfeld, & Chies, 2011), and pre-
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eclampsia may, in turn, induce further psychological changes (Vianna et al., 2011). In
the presence of high maternal glucocorticoid levels, fetal exposure is also substantially
high. A positive correlation between maternal and amniotic fluid cortisol levels has
been reported (Sarkar, Bergman, Fisk, O'Connor, & Glover, 2007) notwithstanding the
role of 11β-HSD2.
Finally, other factors may also be involved. A tentative mechanism underlying the
associations between maternal hypertensive disorders and offspring development could
be associated with the renin–angiotensin–aldosterone system (RAAS), an important
regulator of blood pressure and blood volume in the body. Alterations in components of
RAAS  are  seen  in  pre-eclampsia  (Conti  et  al.,  2013;  Verdonk,  Visser,  Van  Den
Meiracker, & Danser, 2014); however, alterations in components of RAAS may also be
associated with decreased 11β-HSD2 activity (Lanz et al., 2003) and restricted fetal
growth (Mistry, Kurlak, & Broughton Pipkin, 2013).
All of these influences have the potential to cause life-long changes in the body’s
organ structure and functioning, as well as epigenetic changes affecting gene expression,
which persist into the adult life of the offspring and may increase the risk of adverse
outcomes.
1.4.4 Epigenetic mechanisms
The hypothesised effects reflect a specific biological mechanism possibly associated
with the effects on the epigenome. The epigenome can be conceived of as a series of
switches that cause various parts of the genome to be expressed or not. This alteration
of gene expression takes place without affecting the DNA sequence. The factors that
contribute to the epigenetic regulation of transcriptional activity (epigenetic marks) are
numerous, but DNA methylation and histone modifications are the most studied. These
are increasingly explored within the context of environmentally induced changes
resulting in later disease risk (Waterland & Michels, 2007).
Studies on the associations between early experiences and its epigenetic effects were
given impetus from the studies by Meaney and colleagues. They showed that, in rats,
low levels of maternal care were linked to an increased methylation of the promoter
region of the glucocorticoid receptor (GR) gene, as well as to changes in behaviour and
HPAA functioning (Weaver et al., 2004). In addition, in humans, early life adversity has
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been  linked  to  methylation  changes  in  genes  regulating  the  stress  system  (Mueller  &
Bale, 2008; Oberlander et al., 2008; Tyrka, Price, Marsit, Walters, & Carpenter, 2012).
Epigenetic dysregulation of various genes have also been associated with mental
disorders,  depression  (Lester,  Conradt,  &  Marsit,  2013;  Sabunciyan  et  al.,  2012)  and
schizophrenia (e.g. Aberg et al., 2014).
The period while the fetus is in utero may be particularly important for altering gene
expression (Heijmans et al., 2008). The effects may be mediated by the placenta. Thus,
the epigenetic status of the placenta predicts corresponding changes in the fetal brain
(Jensen Pena, Monk, & Champagne, 2012). In pre-eclampsia, placental stress pathways
may be altered. Hogg, Blair, von Dadelszen and Robinson (2013) found DNA
methylation plasticity of many genes involved in cortisol signaling, cortisol
bioavailability and placental hormonal signaling associated with early onset pre-
eclampsia. While null findings in relation to the methylation of the HSD11B2 gene
encoding the 11β-HSD2 were reported in Hogg and colleagues’ study, other studies
have shown that maternal prenatal stress alters the methylation of this gene (Conradt,
Lester,  Appleton,  Armstrong,  & Marsit,  2013;  Jensen  Pena  et  al.,  2012).  It  seems that
maternal adversity during gestation can induce epigenetic changes in the placenta and
fetal tissues related to stress regulation. The evidence shows that maternal adversity
during gestation accounts not only for the heightened HPAA reactivity among offspring
(Oberlander et al., 2008), but also for poorer neurodevelopmental outcomes (Conradt et
al., 2013; Marsit, Maccani, Padbury, & Lester, 2012). It is also possible that other
epigenetic influences related to pre-eclampsia and/or gestational hypertension cause
life-long changes in the offspring at  the level of the epigenome and transcriptome and
the body’s organ structure and functioning (e.g. see Sundrani et al., 2013 on methylation
changes in the vascular endothelial growth factor (VEGF) promoter region related to
pre-eclampsia).
1.4.5 Common underlying factors
It is also possible that a common genetic background for hypertensive pregnancy
disorders and later adversities in mental health and cognitive functioning exist. These
conditions are probably genetically heterogeneous, yet their genetic architecture remains
poorly known. Supporting the role of genes, formerly pre-eclamptic women scored
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lower on cognitive tests (Brusse, Duvekot, Jongerling, Steegers, & De Koning, 2008).
However, this impairment is probably attributable to the presence of lesions on the brain
of pre-eclamptic women due to cerebral ischemia and edema in the clinical phase of the
disease rather than a genetic susceptibility. Furthermore, psychological distress
conditions may predispose a mother to pre-eclampsia and hypertension and it seems
plausible that these women also carry a higher risk of postpartum depression (Duley,
2009). Finally, the offspring of pre-eclamptic mothers are themselves at a higher risk of
stroke (Kajantie, Eriksson, Osmond, Thornburg, & Barker, 2009). However, the role of
genes versus environmental factors remains unknown. Genetic variants probably play a
role, but their relative roles in the modulation of adaptive responses to environmental
factors and adverse consequences in adulthood are yet to be determined. Common
environmental factors such as lifestyle factors may also explain the associations.
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Figure 2. Potential factors and mechanisms that may affect and underlie the long-term psychological
consequences among offspring exposed intrauterine to maternal hypertensive disorders
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1.5 Maternal hypertensive disorders during pregnancy and
developmental sequelae for the offspring: A review of previous
findings
In order to gain a deeper understanding of the previous findings, this thesis summarises
the available evidence from human studies that have tested the effects of maternal
hypertensive disorders during pregnancy on the mental health and cognitive ability of
the offspring later in life. The literature search strategy and study selection are described
in detail in the Appendix.
1.5.1 Maternal hypertensive disorders during pregnancy and the mental
health of the offspring
Schizophrenia is the most studied adult mental disorder as an outcome of prenatal
exposure to maternal hypertensive pregnancy disorders. Geddes et al. (1999) performed
a meta-analysis of individual data based on studies published up to May 1996 which
reported associations between obstetric complications and schizophrenia. They found
no statistically significant associations between maternal pre-eclampsia and
schizophrenia (likelihood ratio statistics = 13.88, df = 8, p = 0.09). However, in a more
recent meta-analytic review based on five studies (Byrne et al., 2007; Dalman et al.,
2001; Jones, Rantakallio, Hartikainen, Isohanni, & Sipilä, 1998; Kendell, McInneny,
Juszczak, & Bain, 2000), Cannon et al. (2002) highlighted the importance of the
associations between obstetric complications and schizophrenia. Their meta-analytic
synthesis revealed three groups of complications that were significantly associated with
schizophrenia, one of which was complications in pregnancy; pre-eclampsia was more
common in the mothers of children with schizophrenia compared to the mothers of
healthy control children (odds ratio (OR) = 1.36, 95% confidence interval (CI): 0.99–
1.85, p = 0.05). Maternal hypertensive pregnancy disorders may also play a role in the
etiology of other mental health outcomes.
Sixteen studies have been published where associations between maternal
hypertensive pregnancy disorders and mental disorders and symptoms of the offspring
later in life have been studied. The findings from these studies have varied. Some of the
studies found that maternal hypertensive pregnancy disorders are associated with a
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higher risk of mental disorders or more severe symptoms of these disorders later in life,
while some of the studies reported null associations or positive effects. Tables 4a and 4b
summarise the findings from these studies. Table 4a summarises register-based
longitudinal studies that measure lifetime risk for severe mental disorders, and Table 4b
summarises studies that have assessed sub-clinical symptoms and mental disorders at
single time points by parental or self-ratings or psychiatric interviews. Both tables are
organised according to the year of birth of the offspring, reflecting changes in disease
classification between past and present. In addition, Table 4b is organised within two
broad categories—namely, whether the offspring was followed-up a) to childhood or b)
to adulthood. Tables 4a and 4b show that, in these studies, the criteria used to define
maternal hypertensive pregnancy disorders varied from that presented in Table 1 or
were not reported. Tables 4a and 4b also provide the details of these studies including
sample sizes. With the exception of three studies (Dalman, Allebeck, Cullberg,
Grunewald, & Koster, 1999; Eide et al., 2013; H. J. Sørensen, Mortensen, Reinisch, &
Mednick, 2003), the register-based longitudinal studies are retrospective case-control
studies  where  cases  and  controls  differ  in  the  outcomes,  but  not  in  terms  of  exposure.
Naturally, compared to prospective cohort studies, these offer a greater power to detect
differences  (if  they  exist).  All  of  the  studies  that  have  assessed  sub-clinical  symptoms
and mental disorders are cohort follow-up analyses conducted in general populations.
Below, the findings from these studies are reviewed.
First, I review the findings from studies that focused on pre-eclampsia. I then
describe the findings from studies that focused on gestational hypertension without
proteinuria. Finally, I review the findings from studies that did not differentiate between
the specific diagnoses, but which treated maternal hypertensive disorders as a single
diagnostic entity.
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Table 4a. Severe mental disorders of the offspring born after pregnancies complicated by hypertensive pregnancy disorders
First author,
publishing
year/
Reference
Country
and birth
year
Study
design
Sample size Definition of
hypertensive spectrum
disorders (obtained
from)
Offspring
character-
istics
Offspring
age at
follow-up
Mental health
outcome
Diagnostic
criteria
(obtained from)
Main findings on
maternal hypertensive
disorders and mental
health outcome (95%
CI)
PRE-ECLAMPSIA
Suvisaari et
al., 2013
Finland
1941–77
Case-
control
63 cases, 208
controls;
8 PE
Hypertension: BP ≥150/
95 mm Hg at least once
with proteinuria
Mothers
with
psychotic
disorder
<60 Schizophrenia,
other mental
disorders
DSM-IV
(Hospital
Discharge
Register)
No associations*
Sørensen et
al., 2003
Denmark
1959–61
Follow-up
of the
Copenhagen
Perinatal
Cohort
313 PE, total
7866; 84
schizophrenic,
7782 no
schizophrenic
BP ≥140/90 mm Hg on
≥2 occasion with edema
and proteinuria after
20th week of gestation
irrespective of previous
BP
<35 Schizophrenia,
psychosis
ICD-8
(Psychiatric
Central Register)
No associations; 4% vs.
1.2% affected with
schizoprenia
Jones et al.,
1998
Finland
1966
Case-
control
70 cases, 1074
controls;
33 PE 1111
non-PE
Diastolic BP >105 mm
Hg and albuminuria
<28 Schizophrenia DSM-III-R
criteria
No associations; AOR
for pre-eclampsia 0.5
(0.1 to 4.0)
Eide et al.,
2013
Norway
1967–82
Cohort
follow-up
15 622 PE,
857990 non-
PE
BP ≥140/90 mm Hg
after 20th week of
gestation or rise in BP
≥30/15 mm Hg from the
level measured before
20th week, combined
with proteinuria ≥300
mg/d
Adulthood Schizophrenia  ICD-9/ ICD-10
(National
Insurance
Scheme)
OR for schizophrenia
1.3 (1.0, 1.8)
Kendell et al.,
2000
Scotland
1971–74
Case-
control
296 case-
control pairs
ICD-8 (Scottish
Morbidity Record)
<26 Schizophrenia ICD-9/ ICD-10
(Morbidity
Record)
No associations; OR for
pre-eclampsia 1.12
(0.65, 1.92)
Kendell et al.,
2000
Scotland
1975–78
Case-
control
156 case-
control pairs
ICD-8 (Scottish
Morbidity Record)
<22 Schizophrenia ICD-9/ ICD-10
(Morbidity
Record)
No associations; OR for
pre-eclampsia 0.85
(0.45, 1.62)
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Dalman et al.,
1999
Sweden
1973–77
Cohort
follow-up
238
schizophrenic,
507278 no
schizophrenic
ICD-8 <22 Schizophrenia ICD-8 RR for schizophrenia
2.5 (1.4, 4.5)
Dalman et al.,
2001
Sweden
1960–
Case-
control
524 cases,
1043 controls;
25 PE, 1542
non-PE
BP ≥140/90 mm Hg and
proteinuria
<34 y Schizophrenia ICD-8/ ICD-9 No associations; OR for
schizophrenia 1.6 (0.7,
3.5)
Byrne et al.,
2007
Denmark
1978–83
Case-
control
227 cases,
5416 controls
5643
ICD-8 (Medical Birth
Register)
15-20 Schizophrenia ICD-8/ ICD-10
(Psychiatric
Central Register)
AIRR for pre-eclampsia
2.72 (1.0, 7.3)
Fazel et al.
2012
Sweden
1973–86
Case-
control
150 cases, 97
offender
controls, 1498
general
population
controls;
127 PE-E
ICD-8 (code 637;
Medical Birth Register)
Offenders 15-27 Personality
disorders
Forensic
psychiatric
evaluation: ICD-
9/ DSM-IV
AOR for pre-eclampsia
1.7 (1.0, 3.0) when
compared with general
populations controls;
No other associations
O'Dwyer et
al., 1997
UK
N/A
Case-
control
50 cases, 50
controls
N/A (interview or
obstetric case notes)
Intellectual
disability
N/A Schizophrenia DSM-IV
(interview or case
notes)
PE associated with an
increased risk of
schizophrenia
HYPERTENSION WITHOUT PROTEINURIA
Suvisaari et
al., 2013
Finland
1941–77
Case-
control
63 cases, 208
controls;
18 HT
BP ≥150/ 95 mm Hg at
least once
Mothers
with
psychotic
disorder
<60 Schizophrenia,
other mental
disorders
DSM-IV
(Hospital
Discharge
Register)
HRR for schizophrenia
4.10 (1.15, 14.59)
No other associations*
Sørensen et
al., 2003
Denmark
1959–61
Follow-up
of the
Copenhagen
Perinatal
Cohort
1457 HT, total
7866; 84
schizophrenic,
7782 no
schizophrenic
BP ≥140/90 mm Hg on
≥2 occasion
<35 Schizophrenia,
psychosis
ICD-8
(Psychiatric
Central Register)
AOR for schizophrenia
1.69 (1.02, 2.80)/
hypertension
No other associations*
*No association refers to p > 0.05
BP, blood pressure; HT, hypertension; PE, pre-eclampsia; PE-E, pre-eclampsia/eclampsia
AIRR, adjusted incidence rate ratio; AOR, adjusted odds ratio; HRR, hazard rate ratio; OR, odds ratio; RR, relative risk
DSM, Diagnostic and Statistical Manual for Mental Disorder; ICD, International Statistical Classification of Diseases and Related Health Problems
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Table 4b. Subclinical symptoms and mental disorders of the offspring born after pregnancies complicated by hypertensive pregnancy disorders
First author,
publishing
year/
Reference
Country
and
birth
year
Study design  Sample size Definition of
hypertensive
spectrum
disorders
(obtained from)
Offspring
characteristics
Offspring
age at
follow-up
Mental health outcome Outcome
measure
Main findings
on maternal
hypertensive
disorders and
cognitive
outcome (95%
CI)
PRE-ECLAMPSIA
FOLLOW-UP TO CHILDHOOD
Robinson et
al., 2009
Australia
1989–92
Follow-up of
the Western
Australian
Pregnancy
Cohort Study
80 PE, 2804
NT
BP ≥140/90 mm
Hg after 24th week
of pregnancy with
proteinuria  ≥300
mg/24h
2,5,8,10
and 14 y
Total behaviour score,
internalizing behaviour,
externalizing behaviour
ASEBA -
CBCL
(parent
report)
Pre-eclampsia
reduced
internalizing
morbidity at ages
5 and 8 years
No other
associations*
Zammit et al.,
2009
UK
1991–92
Follow-up of
the Avon
Longitudinal
Study of
Parents and
Children
Cohort
33 PE, 1536
non-PE
BP ≥140/90 mm
Hg with
proteinuria + on at
least 2 occasions
Term born
only
12 y Non-clinical psychotic
symptoms
PLIKSi
(interview)
No associations;
OR for suspected
or definite
PLIKS 1.07
(0.52 to 2.20)
FOLLOW-UP TO ADULTHOOD
Tuovinen et
al., 2014
Finland
1934–44
Follow-up of
the Helsinki
Birth Cohort
Study
24 PE, 494 NT BP ≥140/ 90 mm
with proteinuria +
69.3 y Adaptive functioning and
psychiatric and
psychological problems
ASEBA -
OASR
AOR for total
problems 4.00
(1.64 to 9.77),
AOR for critical
items 5.28 (1.87
to 14.96)
Wiles et al.,
2005
UK
1950–56
Follow-up of
the Aberdeen
Children of the
1950s Cohort
Study
57 severe PE,
121 moderate
PE, 4557 NT
N/A (Aberdeen
Maternal and
Neonatal
Databank)
45–51 y Psychological distress GHQ: 4
items (self-
report)
No associations;
fully adjusted
OR 1.17 (0.74,
1.85)/ moderate
PE, 1.59 (0.86,
43
2.97)/ severe PE
Berle et al.,
2006
Norway
1967–74
Follow-up of
the Nord-
Trøndelag
Health Study
155 PE, 1029
non-PE
N/A (Medical
Birth Register)
20–30 y Anxiety disorder,
depression
HADS (self-
report)
No associations;
fully adjusted
OR 1.45 (0.97,
2.16)
HYPERTENSION WITHOUT PROTEINURIA
FOLLOW-UP TO CHILDHOOD
Robinson et
al., 2009
Australia
1989–92
Follow-up of
the Western
Australian
Pregnancy
Cohort Study
605 HT, 2804
NT
BP ≥140/90 mm
Hg after 24th week
of pregnancy, in
pre-eclampsia
additionally
proteinuria  ≥300
mg/24h
2,5,8,10
and 14 y
Total behaviour score,
internalizing behaviour,
externalizing behaviour
ASEBA-
CBCL
(parent
report)
Gestational
hypertension
associated with
externalizing
behaviour from
age 8 to 14 years
and for
internalizing
behaviour at age
14 years
No other
associations*
FOLLOW-UP TO ADULTHOOD
Tuovinen et
al., 2014
Finland
1934–44
Follow-up of
the Helsinki
Birth Cohort
Study
260 HT, 494
NT
BP ≥140/ 90 mm mean 69.3
y
Adaptive functioning and
psychiatric and
psychological problems
ASEBA -
OASR
No associations*
Wiles et al.,
2005
UK
1950–56
Follow-up of
the Aberdeen
Children of the
1950s Cohort
Study
837 HT, 4557
NT
N/A (Aberdeen
Maternal and
Neonatal
Databank)
45–51 y Psychological distress GHQ: 4
items (self-
report)
No associations:
fully adjusted
OR 1.09 (0.90,
1.32)
HYPERTENSIVE PREGNANCY DISORDERS AS A SINGLE DIAGNOSTIC ENTITY
FOLLOW-UP TO CHILDHOOD
Hirsfeld-
Becker et al.,
2004
USA
N/A
Follow-up 138 parental
PD and MD, 26
parental PD, 47
parental MD,
N/A (interview) At risk for
anxiety
disorder
because of
mean 6.8
y (range
5–25 y)
Anxiety disorders KSADS-E
(interview
with or
without
OR for multiple
anxiety disorders
3.9 (1.8, 8.5)
44
95 neither
parental PD nor
MD
having at least
one parent with
panic disorder
mothers)
*No association refers to p > 0.05
BP, blood pressure; HT, hypertension; NT, normotension; PE, pre-eclampsia
AOR, adjusted odds ratio; OR, odds ratio
MD, major depression; PD, panic disorder
ASEBA - CBCL, Achenbach System of Empirically Based Assessment - Child Behavior Checklist; ASEBA - OASR, Achenbach System of Empirically Based Assessment - Older Adult
Self-Report; GHQ, General Health Questionnaire; HADS, Hospital Anxiety and Depression Rating Scale; KSADS-E, Schedule for Affective Disorders and Schizophrenia -
Epidemiologic version; PLIKSi, Psychosis-like symptoms semistructured interview
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Register-based longitudinal studies: Lifetime risk for mental disorders
Pre-eclampsia
Ten studies examined whether maternal pre-eclampsia was associated with a risk of any
or a specific mental disorder in the offspring (Table 4a). Of these studies, five reported
that maternal pre-eclampsia was associated with a higher risk of mental disorders in the
offspring (Byrne et al., 2007; Dalman et al., 1999; Eide et al., 2013; Fazel et al., 2012;
O'Dwyer, 1997), while five found no associations (Dalman et al., 2001; Jones et al.,
1998; Kendell et al., 2000; H. J. Sørensen et al., 2003; Suvisaari et al., 2013).
In four of the studies reporting negative associations (Byrne et al., 2007; Dalman et
al., 1999; Fazel et al., 2012; O'Dwyer, 1997) and in one of the studies reporting no
associations (Kendell et al., 2000), detailed methodological information—namely, the
exact diagnostic criteria for pre-eclampsia and/or the number of exposed offspring—
were not reported. The findings from these studies are, thus, not discussed in any further
detail.
The  study  that  reported  associations  with  a  higher  risk  for  mental  disorders  was  a
cohort follow-up. The findings from this study suggest that, compared to the offspring
born to non-pre-eclamptic mothers, offspring born to pre-eclamptic mothers have a
higher risk for schizophrenia (adjusted odds ratio (AOR) = 1.3, 95% CI: 1.0–1.8) (Eide
et al., 2013). Adjustments were made for maternal age and education, parity, marital
status, sex and birth year of the child. The results also showed that the effect of pre-
eclampsia on schizophrenia was stronger among preterm (OR = 2.0, 95% CI: 1.0–4.0)
rather than full-term (OR = 1.3, 95% CI: 1.0–1.7) offspring.
One of the studies reporting null associations was a cohort follow-up (H. J. Sørensen
et al., 2003), while the remainder were case-control studies (Dalman et al., 2001; Jones
et al., 1998; Suvisaari et al., 2013).
The covariates and confounders accounted for between the study where maternal pre-
eclampsia  was  associated  with  a  higher  risk  of  mental  disorders  in  the  offspring  and
studies reporting no associations vary. Table 15 in the Appendix presents a detailed list
of the covariates and confounders taken into account in these studies. It is also worth
nothing  that  all  of  these  studies  used  the  offspring  of  non-pre-eclamptic  mothers  as  a
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comparison group to the offspring of pre-eclamptic mothers, i.e., the comparison group
may include offspring born to mothers with gestational or chronic hypertension.
Gestational hypertension without proteinuria
Two studies tested whether maternal hypertension during pregnancy without proteinuria
was associated with a risk of mental disorders in the offspring (Table 4a). Both report
associations with a higher risk for any or more specific mental disorders (H. J. Sørensen
et al., 2003; Suvisaari et al., 2013). The findings from these studies were reported in
conjunction  with  the  findings  on  maternal  pre-eclampsia  and  the  risk  of  mental
disorders in the offspring reviewed above.
Suvisaari et al. (2013) reported that schizophrenic offspring are more often born to
hypertensive mothers (17.2%) compared to the healthy comparison offspring (5.4%, p =
0.04). The study found no differences in the risk for other mental disorders, however.
Sørensen et al. (2003) found that, compared to the offspring of normotensive mothers,
the offspring of hypertensive mothers had an odds ratio of 1.69 (95% CI: 1.02–2.80) for
having schizophrenia. However, when the authors further studied whether diuretic
treatment explains the associations, they found that the combination of both maternal
hypertension and diuretic treatment in the third trimester was a significant predictor of
schizophrenia in the offspring (AOR = 4.10, 95% CI: 1.41–11.40).
Sub-clinical symptoms and mental disorders measured by parental or
self-ratings or psychiatric interviews
Pre-eclampsia
Follow-up studies to childhood
Two studies tested whether maternal pre-eclampsia is associated with sub-clinical
mental health symptoms among the offspring in childhood. One study found no
significant associations between maternal pre-eclampsia and psychotic symptoms
(Zammit et al., 2009), while the other study reported that maternal pre-eclampsia was
associated with lower internalising symptoms (Robinson et al., 2009).
In the study that reported positive effects, pre-eclampsia was associated with lower
internalising behaviour scores (AOR for clinically significant scores at age 5 years: 0.22,
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95% CI: 0.05–0.97; and 8 years: 0.33, 95% CI: 0.11–0.98) (Robinson et al., 2009).
However, maternal pre-eclampsia was not associated with externalising symptoms in
the offspring (p > 0.41). The covariates and confounders aacounted for included sex,
gestational age and proportion of optimal birth weight, maternal age, education,
smoking and experiencing stressful events during pregnancy, total family income, the
presence of the biological father and the family functioning score.
Follow-up studies to adulthood
Three studies tested whether maternal pre-eclampsia was associated with sub-clinical
symptoms  or  mental  disorders  in  the  offspring  in  adulthood.  One  of  these  studies
reported that maternal pre-eclampsia was associated with more severe psychiatric or
psychological symptoms in the offspring (Tuovinen et al., 2014), while two found no
significant associations (Berle, Mykletun, Daltveit, Rasmussen, & Dahl, 2006; Wiles,
Peters, Leon, & Lewis, 2005).
In the two studies reporting a lack of associations, the exact diagnostic criteria were
not reported (Berle et al., 2006; Wiles et al., 2005). The findings from these studies are,
therefore, not discussed in any further detail.
In the study that reported negative associations, maternal pre-eclampsia was
associated with an increased odds of reporting total problems (AOR = 4.00, 95% CI:
1.64–9.77) and problems of particular concern to clinicians (critical items) (AOR = 5.28,
95% CI: 1.87–14.96) at a mean age of 69 years (Tuovinen et al., 2014). These scales tap
problems across all scales measuring problems. Maternal pre-eclampsia was also
associated with anxious/depressed, functional impairment, memory, thought and
irritable/disinhibited problems on syndrome scales; and depressive, somatic and
psychotic problems on Diagnostic and Statistical Manual of Mental Disorders (DSM) -
oriented scales;  and adjustment problems with regards to relationship satisfaction with
one’s spouse or partner. The covariates and confounders accounted for in the analysis
included sex, year of birth (1934–38 versus 1939–44), gestational age, weight for
gestational age and head circumference at birth, placental weight, father’s occupational
status during the subject’s childhood, parity, mother’s age and body mass index (BMI)
at delivery and breastfeeding, maximum level of education in adulthood and age at
completion of the questionnaire.
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Gestational hypertension without proteinuria
Findings from studies focusing on maternal hypertension without proteinuria were
reported in conjunction with the findings on maternal pre-eclampsia and sub-clinical
mental health symptoms or disorders in the offspring reviewed above. Table 4b
provides further details of these comparisons.
Follow-up studies to childhood
One study tested whether maternal hypertension without proteinuria was associated
with mental health symptoms in the offspring in childhood (Table 4b). The findings
from that study showed that maternal gestational hypertension was associated with
higher externalising behaviour scores in the offspring from the age of 8 to 14 years and
for higher internalising behaviour scores at the age of 14 years (Robinson et al., 2009).
In addition, maternal hypertension was predictive of clinically significant Child
Behavior Checklist scores from ages 8 to 14 years, with the largest risk seen at 14 years
(AOR = 1.83, 95% CI: 1.21–2.77).
Follow-up studies to adulthood
Two studies tested whether maternal hypertension without proteinuria was associated
with mental health symptoms in the offspring in adulthood (Table 4b). Neither of these
studies found significant associations (Tuovinen et al., 2014; Wiles et al., 2005). Wiles
et al. (2005) did not report the exact diagnostic criteria, and the findings from their
study are, therefore, not discussed in any further detail.
Hypertensive pregnancy disorders
Follow-up studies to childhood
Finally, one study on sub-clinical symptoms and mental disorders in the offspring
focused on hypertensive pregnancy disorders as a single diagnostic entity. The study
reported significant associations with a higher risk of anxiety disorders at the mean age
of 7 years (Hirshfeld-Becker et al., 2004). In that study, the exact diagnostic criteria
were not reported, and the findings are, therefore, not discussed in any further detail.
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1.5.2 Maternal hypertensive disorders during pregnancy and the cognitive
functioning of the offspring
The oldest study examining the associations between maternal hypertensive disorders
and the cognitive functioning of the offspring was that of Barker and Edwards (1967)
(Table 5). In this population-based study, 3321 children born after toxemic and 46 735
children  born  after  non-toxemic  pregnancies  were  followed  to  11  years  of  age.  The
verbal reasoning test scores of those children born after toxemic pregnancies were
above the population mean. This was consistent across birth ranks when compared to
the mean for all children in the same birth rank. However, in further analyses using the
same dataset, the authors compared siblings born to the same mother after a pregnancy
that was complicated by toxaemia and after a pregnancy that was not. The affected
siblings scored lower on verbal reasoning when compared with their unaffected siblings.
This difference was most obvious among those born at term. The authors did not report
the diagnostic criteria for toxemia. However, in cohorts born before the late 1990s, the
diagnostic criteria for pre-eclampsia and hypertension did not follow the current
diagnostic criteria.
After the study by Barker and Edwards, 22 studies were published where
associations between maternal hypertension spectrum disorders and the cognitive
functioning of the offspring later in life were studied. The findings vary. Some of these
studies found that maternal hypertensive pregnancy disorders were associated with
poorer cognitive functioning among the offspring later in life, while some of the studies
reported null or positive effects. Table 5 summarises the findings from these studies.
The data are organised according to the year of birth of the sample reflecting changes in
disease classification between past and present and within two major categories, namely
whether the offspring were followed-up to a) childhood or b) adulthood, and whether
the childhood and adulthood follow-up studies were conducted in a) a general
population  or  b)  in  samples  born  preterm  or  with  a  small  body  size  at  birth.  Table  5
shows that, of these studies, only three used the current diagnostic criteria described in
Table 1 (Leversen et al., 2011; Schlapbach et al., 2010; Silveira, Procianoy, Koch,
Benjamin, & Schlindwein, 2007), while the criteria used in the remaining studies varied
or were not reported at all. Table 5 also provides the details of these studies including
the sample sizes. Below, these findings are reviewed in more detail.
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First, I review studies that focused on pre-eclampsia. I then describe studies that
focused on gestational hypertension without proteinuria. Finally, I review studies that
did not differentiate between the specific diagnoses, but which treated maternal
hypertensive pregnancy disorders as a single diagnostic entity.
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Table 5. Cognitive functioning of the offspring born after pregnancies complicated by hypertensive pregnancy disorders
First
author,
publishing
year/
Reference
Country
and birth
year
Study
design
Sample
size
Definition of
hypertensive spectrum
disorders (obtained
from)
Offspring
characteristic
s at birth
Offspring
age at
follow-up
Cognitive outcome Outcome
measure
Main findings on
maternal hypertensive
disorders and
cognitive outcome
(95% CI/ SD)
PRE-ECLAMPSIA
FOLLOW-UP TO CHILDHOOD
Population-based cohort studies
Barker &
Edwards,
1967
UK
1950–1954
Population
based study
3321 PE,
50046
non-PE
N/A (Birth records) 11 y Verbal reasoning N/A (Eleven-
plus)
Toxemia/PE associated
with lower verbal
reasoning within
sibpairs
Seidman et
al., 1991
Israel
1964–1971
Follow-up
of the
Jerusalem
Perinatal
Study
428 PE
33117
non-PE
BP ≥140/ 90mm Hg or
rise in BP ≥30/ 15 mm
Hg (two readings, ≥6
hour apart) or
significant proteinuria
or edema or any
combination of two or
more after 24th week
gestation
17 y IQ (mean 100, SD
15)
Verbal Otis
test, matrices
test
No associations; Mean
109.3 (1.2) vs. 110.9
(0.1)/ females, 101.9
(1.0) vs. 103.1 (0.1)/
males
Heikura et
al., 2012
Finland,
1985–1986
Follow-up
of the
Northern
Finland
Birth Cohort
258 PE,
6761 NT
BP ≥140/ 90 mm Hg
after 20th weeks of
gestation twice after a 5
min rest plus proteinuria
≥300 mg/L
11.5 y Mild cognitive
limitations (IQ 50–
85)
Psychological
tests (WISC-R
for 78%) in
routine
clinical care,
individual
data reviewed
by study
authors
No associations; Crude
OR 1.7 (0.9, 3.4), OR
adjusted for parental
characteristics 1.2 (0.5,
2.8)
Whitehouse
et al., 2012
Australia
1989–1992
Follow-up
of the
Western
Australian
Pregnancy
34 PE,
1076 NT
BP ≥140/ 90mm Hg
after 24th weeks of
gestation in women
whose BP had
previously been normal
10 y Verbal (mean 100,
SD 15) and non-
verbal (range 0-60)
ability
PPVT-R,
RCPM
No associations; MD
for verbal ability -3.53
(-8.41, 1.35), for non-
verbal ability -1.82
(-12.59, 8.95)
52
Cohort
Study
plus proteinuria  ≥300
mg/d
Studies in clinical populations
Szymonowi
cz & Yu,
1987
Australia
1982–1984
Case-
control
35 PE, 35
non-PE
BP ≥140/ 90 mm Hg,
persistent proteinuria
with urinary tract
infection and
generalised edema
before 32 weeks of
gestation
VLBW 2 y CA Mental
developmental
index (normative
mean 100, SD 15)
BSID PE associated with
lower mean mental
developmental index;
Mean 94 (25) vs. 106
(21)
Spinillo et
al., 1994
Italy
1986–1990
Case-
control
68 PE,
184 non-
PIH
Diastolic BP ≥110
mmHg or in 2
consecutive measures
≥90 mmHg plus
proteinuria  ≥300 mg/d
GL 24–35
weeks
2 y CA Mental
developmental
index (normative
mean 100, SD 15)
BSID ORs for minor
neurodevelopmental
impairment 4.0 (1.61,
10.2)
Spinillo et
al., 2009
Italy
1990–2004
Cohort
follow-up
185 PE,
569 NT
Diastolic BP ≥ 110 mm
Hg or in 2 consecutive
measures ≥ 90 mm Hg
at any time during
pregnancy plus
proteinuria  ≥ 300 mg/d
GL 24–35
weeks
2 y CA Mental
developmental
index (normative
mean 100, SD 15)
BSID-II OR for
neurodevelopmental
impairment 0.52 (0.32,
0.85)
Many et al.,
2003
Israel
1992–1993
Cohort
follow-up
11 PE, 64
non-PE
Persistent BP ≥140/ 90
mm Hg with proteinuria
of either 100 mg/dL or
>500 mg/d
Severe FGR
(birth weight
<5th
percentile)
3 y IQ (normative mean
100, SD 15)
Stanford-
Binner IQ test
PE associated with
lower IQ; Mean 85.5 vs.
96.9
Leitner et
al., 2012
Israel
1992–1993
Cohort
follow-up
17 PE, 78
NT
BP ≥140/ 90mmHg
after 20th weeks of
gestation in women
whose BP had
previously been normal
plus proteinuria  ≥300
mg/d or +2
IUGR (birth
weight <10th
percentile)
9 to 10 y IQ, school
achievement
WISC-R95,
K-ABC
No associations; Mean
IQ 101.2 (18.4) vs.
101.7 (13.4), mean
school achievement
score 612.9 (98.9) vs.
602.9 (80.4)
Cheng et al.,
2004
Taiwan
1997–1999
Follow-up 28 PE, 61
NT
Diastolic BP ≥ 110 mm
Hg or in two
consecutive measures
≥90 mm Hg at any time
during pregnancy plus
proteinuria  ≥ 300 mg/d
GL <32
weeks
2 y CA Mental
developmental
index (normative
mean 100, SD 15)
BSID-II PE associated with
lower MDI score; AOR
for mildly delayed MDI
10.9 (1.4–84.9)
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Morsing &
Maršál,
2014
Sweden,
1998–2004
Case-
control
11 PE-
IUGR, 23
non-PE-
IUGR, 34
non-PE
AGA
Diastolic BP ≥90
mmHg in ≥ two
measures plus
proteinuria ≥300 ml/L
GA <30
weeks
5–8 y IQ (normative mean
100, SD 15)
WPPSI-III,
WISC-III
PE associated with
lower IQ; Mean 70.1
(19) vs. 83.3 (14)/ 90.1
(14)
Leversen et
al., 2011
Norway
1999–2000
Cohort
follow-up
73 PE,
233 non-
PE
Current clinical criteria/
Medical Birth Register
GL 22–27
weeks
5 y 10 m Full-scale IQ
(normative mean
100, SD 15)
WPPSI-R MD -7.7 (-12.7, -2.7) in
IQ
Schlapbach
et al., 2010
Switzerland
2002–2005
Case-
control
33 PE, 33
non-PE
(no
chorioamn
ionitis)
Current clinical criteria GL 25–32
weeks
2 y CA Mental
developmental
index (normative
mean 100, SD 15)
BSID-II PE associated with a
lower MDI in an
unadjusted model, after
adjustment for multiple
factors no significant
association; Median 86
vs. 96 in the unadjusted
model
Silveira et
al., 2007
Brazil
2003–2005
Cohort
follow-up
40 PE, 46
non-PE
Current clinical criteria VLBW
(<1500 g)
12 and 18 m
CA
Mental
developmental
index (normative
mean 100, SD 15)
BSID-II No associations; Mean
79.6 (0.4) vs. 79 (0.5)/ 6
m, 82.9 (0.5) vs. 81.1
(0.7)/ 12 m
FOLLOW-UP TO ADULTHOOD
Population-based cohort studies
Ehrenstein
et al., 2009
Denmark
1978–1983
Follow-up 604 PE,
16 555
NT
BP ≥140/ 90 mmHg
after 20 weeks of
pregnancy with
proteinuria >300 mg/d
or edema; severe pre-
eclampsia BP ≥ 180/
110 mmHg and/or
proteinuria >5000 mg/d
+ subjective symptoms/
Medical Birth Register
19 y IQ (mean 100, SD
15); low cognitive
functioning (IQ <
85)
BPP ORs for scoring below
1 SD 1.22 (1.02 to
1.44); No evidence of a
severity associated
dose-response pattern of
association.
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HYPERTENSION WITHOUT PROTEINURIA
FOLLOW-UP TO CHILDHOOD
Population-based cohort studies
Heikura et
al., 2012
Finland,
1985–1986
Follow-up
of the
Northern
Finland
Birth Cohort
423 HT,
6761 NT
BP ≥140/ 90 mmHg
after 20th weeks of
gestation twice after a 5
min rest with no
proteinuria
11.5 y Mild cognitive
limitations (IQ 50–
85)
Psychological
tests
AOR 2.4 (1.4, 3.9)
Whitehouse
et al., 2012
Australia
1989–1992
Follow-up
of the
Western
Australian
Pregnancy
Cohort
Study
279 HT,
1076 NT
BP ≥140/ 90mmHg
after 24th weeks of
gestation with no
proteinuria
10 y Verbal (mean 100,
SD 15) and non-
verbal (range 0-60)
ability
PPVT-R,
RCPM
MD for verbal ability -
1.71 (-3.39, -0.03)
No other associations;
MD for non-verbal
ability 0.15 (-3.60, 3.90)
Studies in clinical populations
Spinillo et
al., 1994
Italy
1986–1990
Case-
control
52 severe
HT, 184
non-PIH
Diastolic BP ≥110
mmHg or in two
consecutive measures
≥90 mm Hg at any time
during pregnancy with
no proteinuria
GL 24–35
weeks
2 y CA Mental
developmental
index (normative
mean 100, SD 15)
BSID AORs for minor
neurodevelopmental
impairment 4.0 (1.34,
12.1)
Leitner et
al., 2012
Israel
1992–1993
Cohort
follow-up
25 HT, 78
NT
BP ≥140/ 90mmHg
after 20th weeks of
gestation on at least
once occasion with no
proteinuria
IUGR (birth
weight <10th
percentile)
9 to 10 y IQ (normative mean
100, SD 15), school
achievement
WISC-R95,
K-ABC
No associations; Mean
IQ 99.6 (9.7) vs. 101.7
(13.4), mean school
achievement score
598.2 (79.1) vs. 602.9
(80.4)
FOLLOW-UP TO ADULTHOOD
Population-based cohort studies
Ehrenstein
et al., 2009
Denmark
1978–1983
Follow-up 287 HT,
16 555
NT
BP ≥140/ 90 mmHg
after 20 weeks of
pregnancy on at least
once occasion with no
19 y IQ (mean 100, SD
15); low cognitive
functioning (IQ
<85)
BPP ORs for scoring below
1 SD 1.28, (1.01 to
1.62)
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proteinuria/
Medical Birth Register
HYPERTENSIVE PREGNANCY DISORDERS AS A SINGLE DIAGNOSTIC ENTITY
FOLLOW-UP TO CHILDHOOD
Population-based cohort studies
Lawlor et
al., 2005
Scotland
1950–1956
Follow-up
of the
Aberdeen
Children of
the 1950s
cohort study
1979 PIH,
9702 non-
PIH
N/A (Aberdeen
Maternal and Neonatal
Databank)
7,9,11 y IQ  (normative
mean 100, SD 15)
The Moray
house
intelligence
test/ the
Schonell and
Adams
essential
intelligence
test
Mean difference 2.35
IQ points  (1.56, 3.14),
attenuated to null when
adjusted for parental
characteristics
Studies in clinical populations
Mutch et al.,
1977
England
1970–1973
Case-
control
100
treated
HT, 101
untreated
HT, 151
NT
BP ≥140/ 90 mmHg in
two consequtive
measures 24 h apart and
before 28 weeks of
gestation
Comparison
group:
offspring born
AGA to
normotensive
mothers
6 and 12 m Language
development, social
skills
DDST No associations*
Ounsted et
al., 1980
England
1970–1973
Cohort
follow-up
86 treated
HT, 82
untreated
HT, 107
NT
BP ≥140/ 90 mmHg in
two consequtive
measures 24 h apart and
before 28 weeks of
gestation
Comparison
group:
offspring born
AGA to
normotensive
mothers
4 y Language
development
DDST No associations*
Ounsted et
al., 1986
England
1970–74
Cohort
follow-up
N/A;
118 SGA,
137 AGA,
181 LGA
BP ≥140/ 90 mmHg on
at least one occasion
Comparison
group:
offspring born
AGA to
normotensive
mothers
7 y Verbal ability,
practical reasoning
DDST Hypertension associated
with lower verbal
ability and practical
reasoning scores in the
SGA group No other
associations*
Winer et al.,
1982
USA
1973–1976
Follow-up 20 HT, 35
NT
As recommended by the
American College of
Obstetricians and
SGA 4 to 7 y Verbal,
performance and
full scale IQ
WPPSI-R/
WISC-R,
RCPM,
Hypertensive disorders
associated with better
verbal IQ; Mean for
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Gynecologist (normative mean
100, SD 15),
arithmetic skills,
reading
WRAT-Arith,
WRAT-Read
verbal IQ 105.8 (13.5)
vs. 93.7 (12.8)
No other associations;
Mean for non-verbal IQ
99.4 (14.4) vs. 93.9
(15.2)
Many et al.,
2005
Israel
1992–1993
Cohort
follow-up
22 HT, 70
NT
N/A (Many et al., 2003) Severe FGR
(birth weight
<5th
percentile)
6 y IQ (normative mean
100, SD 15)
WPPSI-R No associations; Mean
106 (11) vs. 101 (14)
Gray et al.,
1998
Australia
1992–1993
Cohort
follow-up
96
PE+HT,
101 NT
BP ≥140/ 90 mmHg at
any time during
pregnancy (two
readings, ≥6 hour apart)
or rise in BP ≥25/ 15
mm Hg
Very preterm
(24-32 weeks
of gestation)
2 y CA General quotient
(developmental
delay) (normative
mean 100, SD 15)
NSMDA,
Griffiths'
Infant Ability
Scale
No associations; Mean
96.9 (11.5) vs. 96.5
(11.1)
McCowan
et al., 2002
New
Zealand
1993–1997
Cohort
follow-up
88
PE+HT,
131 NT
BP ≥140/ 90 mmHg or
rise in diastolic BP ≥15
mm Hg (two readings,
≥4 hour apart) after
20th week of pregnancy
SGA (birth
weight <10th
percentile)
18 m CA Mental
developmental
index (normative
mean 100, SD 15)
BSID-II PIH associated with
lower risk to have
abnormal MDI scores;
Mean 98.6 (12.9) vs.
93.7 (15.1)
*No association refers to p > 0.05
BP, blood pressure; HT, hypertension; NT, normotension; PE, pre-eclampsia; PIH, pregnancy induced hypertension including pre-eclampsia and gestational hypertension
GL, gestational length; AGA, appropriate for gestational age; FGR, fetal growth restriction; IUGR, intrauterine growth restriction; SGA, small for gestational age; VLBW, very low birth
weight; CA, corrected age
95% CI, 95% confidence interval; AOR, adjusted odds ratio; MD, mean difference; OR, odds ratio; SD, standard deviation
MDI, mental developmental index; IQ, intelligence quotient
BPP, Boerge Prien group intelligence test; BSID, Bayley Scales of Infant Development; DDST, Denver Developmental Screening Test; K-ABC, Kauffman Assessment Battery for
Children; NSMDA, Neurosensory  motor developmental assessment; PPVT, Peabody Picture Vocabulary Test; RCPM, Ravens Colored Progressive Matrices; WISC, Wechsler
Intelligence Scale for Children; WPPSI, Wechsler Preschool and Primary Scale of Intelligence; WRAT-Arith, Wide-range achievement tests in arithmetic; WRAT-Read, Wide-range
achievement tests in reading
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Pre-eclampsia
Follow-up studies to childhood
Thirteen studies examined whether pre-eclampsia was associated with poorer cognitive
functioning or the mental development of the offspring in childhood. Of these studies,
six reported an association between maternal pre-eclampsia and poorer cognitive
functioning in the offspring (Cheng, Chou, Tsou, Fang, & Tsao, 2004; Leversen et al.,
2011; Many et al., 2003; Morsing & Maršál, 2014; Spinillo et al., 1994; Szymonowicz
& Yu, 1987), six found no association or the association was rendered non-significant
when adjustments were made for important covariates and confounders (Heikura et al.,
2013; Leitner et al., 2012; Schlapbach et al., 2010; Seidman et al., 1991; Silveira et al.,
2007; Whitehouse, Robinson, Newnham, & Pennell, 2012) and one reported that
maternal pre-eclampsia was associated with better cognitive functioning or a lower
likelihood of impairment in mental development (Spinillo et al., 2009).
Those studies that reported an association between maternal pre-eclampsia and
poorer cognitive functioning in the offspring were conducted among clinical
populations. Szymonowicz and Yu (1987) reported that children born to pre-eclamptic
mothers had a significantly lower mental developmental index (MDI) (mean (m) = 94,
standard deviation (SD) = 25) compared to children born to non-pre-eclamptic mothers
(m = 106, SD = 21) at the age of 2 years even when the infants in the two groups were
appropriately matched for gestational length, male-to-female ratio and 2-year survival.
Spinillo et al. (1994) reported that, compared to children born to normotensive mothers,
children born to pre-eclamptic mothers had a higher risk for minor neurodevelopmental
impairment at the age of 2 years even after adjustments were made for the social class
of the family and maternal education (OR = 4.0, 95% CI: 1.61–0.2). Many et al. (2003)
reported that children born to pre-eclamptic mothers relative to those born to non-pre-
eclamptic mothers scored lower on an intelligence test at the age of 3 years (m = 85.5,
SD = 16 vs. m = 96.9, SD = 18). Covariates and confounders included gestational age,
birth weight and number of neonatal complications (such as respiratory problems,
convulsions, hyperbilirubinemia, abnormal temperature, late feeding, infection and
metabolic and blood disturbances). Cheng et al. (2004) reported that children born to
pre-eclamptic mothers had lower MDI index scores compared to children born to non-
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pre-eclamptic mothers at the age of 2 years. After adjusting for the use of antenatal
steroids, infant sex, gestation length, birth weight and parental education, AOR for
mildly delayed MDI was 10.9 (95% CI: 1.4–84.9). Morsing and Maršál (2014) reported
that full-scale intelligence (IQ) and verbal IQ scores were lower in IUGR children born
to pre-eclamptic mothers (70.1 ± 19) compared to IUGR children born to non-pre-
eclamptic mothers (83.3 ± 14; p = 0.03) and the non-IUGR control children (90.1 ± 14;
p = 0.001) at 5–8 years of age. The children of pre-eclamptic mothers also had lower
performance IQ scores compared to the control children. The groups were matched for
gestational age, sex of the infant and age at testing. The authors showed that the
associations remained the same after adjustment for gestation length and weight
deviations at birth and infant sex. Finally, Leversen et al. (2011) reported that children
born to pre-eclamptic mothers had lower intelligence test scores compared to the
children born to non-pre-eclamptic mothers at the mean age of 5 years (B = -7.7, 95%
CI:  -12.7  to  -2.7).  The  associations  were  adjusted  for  gestation  length,  small  for
gestational age status, the use of antenatal steroids, retinopathy of prematurity, infant
sex and maternal education.
The six studies that reported null associations between maternal pre-eclampsia and
cognitive functioning were conducted in both general and clinical study populations.
Three of the studies were conducted in general populations (Heikura et al., 2013;
Seidman et al., 1991; Whitehouse et al., 2012) and three in clinical populations (Leitner
et al., 2012; Schlapbach et al., 2010; Silveira et al., 2007).
Similar to the studies where maternal pre-eclampsia was associated with poorer
cognitive functioning in the offspring, the studies reporting a lack of association vary
greatly in covariates and confounders accounted for in the analyses. Table 16 in the
Appendix presents a detailed list regarding which covariates and confounder the studies
took into account. It is also important to note that the studies that used the offspring of
mothers  without  pre-eclampsia  as  a  comparison  group  may  include  offspring  born  to
mothers with gestational or chronic hypertension.
The only study that reported an association between maternal pre-eclampsia and a
lower risk of poor cognitive functioning in the offspring was conducted in a clinincal
population (Spinillo et al., 2009). Maternal pre-eclampsia was associated with a lower
risk of moderate-to-severe and overall neurodevelopmental impairment in the offspring
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at the age of 2 years (OR for overall impairment = 0.52, 95% CI: 0.32–0.85).
Adjustments were made for multiple births, infant sex, maternal lifestyle behaviours
during pregnancy and other parental characteristics. However, as the authors discussed,
the findings should be interpreted with caution because the group of normotensive
mothers included a large number of women who delivered preterm as a consequence of
premature rupture of the membranes or spontaneous preterm labour. Hence, it remains
possible that these factors may be associated with adverse cognitive outcomes in the
offspring rather than pre-eclampsia having any beneficial effects.
Follow-up studies to adulthood
One study which was conducted in a general population extended the follow-up of the
offspring born to mothers with pre-eclampsia into adulthood. Ehrenstein, Rothman,
Pedersen, Hatch and Sørensen (2009) showed that the crude mean difference in the
intelligence test scores associated with maternal pre-eclampsia at the mean age of 19
years was -2.7 (95% CI: -3.7 to -1.2). The prevalence rate for low cognitive functioning
associated with maternal pre-eclampsia was 1.22 (95% CI: 1.02–1.44). The estimates
changed little after restricting the analysis to those not born small for gestational age or
when adjusting for maternal age at delivery, parity, marital status, history of diabetes,
conscripts’ year of birth, county of birth, birth weight and being born large for
gestational age.
Gestational hypertension without proteinuria
Follow-up studies to childhood
Four studies—two carried out among the general population and two among clinical
study populations—tested whether maternal hypertension without proteinuria was
associated with cognitive outcomes among offspring in childhood (Table 5). Three of
these reported associations with a poorer cognitive functioning among the offspring
(Heikura et al., 2013; Spinillo et al., 1994; Whitehouse et al., 2012) and one reported no
association (Leitner et al., 2012). The findings from these studies were reported in
conjunction with the findings on maternal pre-eclampsia and the cognitive functioning
of the offspring reviewed above.
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The findings from studies reporting associations with a poorer cognitive functioning
suggest that, compared to the offspring born after normotensive pregnancies, offspring
born after pregnancies complicated by maternal hypertension without proteinuria carry
an increased risk of minor neurodevelopmental impairment at the age of 2 years (AOR
= 4.0, 95% CI: 1.34–12.1) (Spinillo et al., 1994), score lower on a verbal ability test at
the age of 10 years (B = -1.71, 95% CI: -3.39 to -0.03) (Whitehouse et al., 2012) and
have an increased risk of mild cognitive limitations at the age of 11 years (AOR = 2.4,
95% CI: 1.4–3.9) (Heikura et al., 2013).
The only study reporting null associations was conducted in a clinical sample
(Leitner et al., 2012).
Follow-up studies to adulthood
One study conducted in a general population tested whether maternal hypertension
without proteinuria is associated with cognitive functioning among offspring in
adulthood and reported the effects on poorer cognitive functioning (Table 5) (Ehrenstein
et al., 2009). The findings from that study showed that those offspring born after
hypertensive pregnancies tended to score lower on an intelligence test at the age of 19
years (mean difference in intelligence test score = -1.6, 95% CI: -3.5 to 0.2; odds for
scoring ‘low’ on cognitive functioning = 1.28, 95% CI: 1.01 to 1.62). This study was
also reported in conjunction with the findings on maternal pre-eclampsia and the
cognitive functioning of the offspring reviewed above.
Maternal hypertensive pregnancy disorders as a single diagnostic entity
Follow-up studies to childhood
Eight studies did not discriminate between maternal pre-eclampsia and gestational
hypertension, but focused on maternal hypertensive disorders as a single diagnostic
entity. One of these studies reported an association between maternal hypertensive
pregnancy disorders and poorer cognitive functioning among the offspring (Ounsted,
Moar, & Scott, 1986), five found no significant associations (Gray, O'Callaghan, Mohay,
Burns, & King, 1998; Lawlor et al., 2005; Many, Fattal-Valevski, & Leitner, 2005;
Mutch, Moar, Ounsted, & Redman, 1977; Ounsted, Moar, Good, & Redman, 1980) and
two reported an association between maternal hypertensive pregnancy disorders and
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better cognitive performance or a lower likelihood of impairment in mental
development (McCowan, Pryor, & Harding, 2002; Winer, Tejani, Atluru, DiGiuseppe,
& Borofsky, 1982).
In the only study reporting an effect on poorer cognitive functioning, the authors did
not provide data on the number of exposed offspring (Ounsted et al., 1986). Two of the
studies reporting no association turned out to be hypertensive medication treatment
trials mainly comparing offspring born to hypertensive mothers who did and who did
not receive hypertensive medication during pregnancy (Mutch et al., 1977; Ounsted et
al., 1980). In two of the studies reporting no association (Lawlor et al., 2005; Many et
al., 2005) and in one of the studies reporting beneficial effects (Winer et al., 1982), the
exact diagnostic criteria for maternal hypertensive pregnancy disorders were not
reported. The findings from these studies are, therefore, not discussed in any further
detail.
The study reporting no association was conducted among a clinical sample (Gray et
al., 1998).
The study that reported beneficial effects restricted the sample to those born small for
gestational  age  (SGA)  (McCowan  et  al.,  2002).  The  offspring  born  to  mothers  with
hypertensive disorders were less likely to have abnormal (<85 or <-1 SD) MDI scores at
the mean age of 18 months. The authors discussed the possibility that maternal
hypertension had a protective effect on neurodevelopment, but also acknowledged that
the many other causes of SGA may be associated with adverse neurodevelopmental
outcomes.
1.5.3 Summary
In summary, maternal hypertensive pregnancy disorders have gained relatively little
research attention in relation to the mental health and cognitive outcomes of the
offspring, although they may compromise placental functioning and, thus, affect the
fetal developmental milieu. Previous studies do not provide a consistent picture on the
associations. There is insufficient evidence to draw firm conclusion on the associations,
due in part to the varied criteria used across different studies to define maternal
hypertensive pregnancy disorders, the various definitions of the control groups and the
limited controls for significant covariates and confounders. Furthermore, no previous
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studies have taken into account that some subgroups of offspring may be particularly
vulnerable to the effects of maternal hypertensive disorders; yet, hypertensive
pregnancy disorders may differ in terms of frequency, severity and/or etiology based on
the  length  of  gestation  (Luo  et  al.,  2007;  Skjærven  et  al.,  2005),  parity  (Allen  et  al.,
2004; Luo et al., 2007) and socio-economic status (Gudmundsson, Björgvinsdóttir,
Molin, Gunnarsson, & Maršál, 1997; Silva et al., 2008). The occurrence of mental
disorders and cognitive decline may also vary by sex (Bijl, Ravelli, & van Zessen, 1998;
Kessler et al., 1994; Leray et al., 2011; Perrig-Chiello & Hutchison, 2010). Finally,
previous studies have been conducted among offspring that are much younger in age
than our follow-up extends. Thus, there is a need for future longitudinal studies in order
to clarify the associations.
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2 AIMS OF THE STUDY
The  primary  aim  of  this  thesis  was  to  evaluate  the  psychological  developmental
sequelae for the adult offspring born to mothers with hypertensive disorders during
pregnancy and to compare these with the offspring of normotensive mothers by
capitalising on a well-defined birth cohort. The secondary aim was to test whether any
potential associations between hypertensive disorders during pregnancy and the
outcomes  of  the  offspring  differ  according  to  sex,  length  of  gestation,  parity  and
childhood socio-economic status.
The focus was on the mental health and cognitive functioning of the offspring. Five
separate studies were conducted to evaluate the following outcomes:
Study I:   The severity of depressive symptoms in late adulthood.
Study II:  The risk of mental disorders in adulthood.
Study III:  Cognitive ability in early adulthood.
Study IV: Cognitive functioning in late adulthood and any change in cognitive
functioning from early up to late adulthood.
Study V: Cognitive impairment including cognitive failures and dysexecutive
functioning in late adulthood.
64
3 METHODS
3.1 Helsinki Birth Cohort Study 1934–1944
HBCS comprises 13 345 individuals (men, n = 6975; women, n = 6370) who were born
as singletons in one of the two maternity hospitals (the University Central Hospital and
the City Maternity Hospital), in Helsinki between 1934 and 1944. These men and
women attended child welfare clinics during childhood, and were living in Finland at
that time when a unique personal identification number was assigned to each resident of
the country. HBCS has been approved by the Ethics Committee of the National Public
Health Institute.
3.1.1 Follow-ups of HBCS utilized in this thesis
Since 1969 nationwide data on all inpatient episodes and deaths of residents in Finland
at an individual level have entered to the Finnish Hospital Discharge Register (HDR)
and the Finnish Causes of Death Register (CDR). Regarding to mental disorders, the
participants were followed up from year 1969 to their death, migration, onset of mental
disorders  or  December,  31,  2004.  In  other  words,  follow-up  data  from  these  registers
were available for the participants from between 24 and 35 years to between 60 and 70
years of age.
In 2001–2004, all 7078 people belonging to the original cohort (of 8760 born at
Helsinki  University  Central  Hospital)  who  were  still  alive  and  resident  in  Finland  in
year 2000 were sent a questionnaire. A total of 4515 individuals responded. In order to
achieve a sample size over 2000 people for a clinical study, random number tables were
used to select 2902 subjects. Of these, 2003 participated at a mean age of 61.5 years
(SD = 2.8, Range 56.7–69.8) (Ylihärsilä et al., 2007), referred as time 1. In conjunction
with the clinical examination, depressive symptoms were measured. In 2004, a more
detailed psychological survey, again including measures of depressive symptoms, was
sent to the randomly selected population, with 1735 returning the questionnaire at a
mean age of 63.4 years (SD = 2.9, Range = 59.7–70.7), referred as time 2.
Between 1952 and 1972, a subsample (n = 2786) of the HBCS male participants
served in the defense forces and completed the test on cognitive ability at an average
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age of 20.1 years (SD = 1.4; Range 17.0–28.1). In 2009, a subsample of them (n = 931)
were re-tested at an average age of 67.9 years (SD = 2.5; Range = 64.5–75.7). The mean
time interval between the two cognitive tests was 47.7 years (SD = 2.9, Range = 38.9–
54.7).
Between 2009 and 2010, a psychological questionnaire that included questions on
cognitive failures and executive function was administered to (1) a randomly selected
subsample of women and men who had between 2001 and 2004 participated in a
detailed clinical examination (n = 2003) and (2) a subsample of men only (n = 2786;
642 of whom belonged also to the randomly selected clinical subsample) who
participated in a testing of cognitive ability during their compulsory military service
between 1952 and 1972. At a mean age of 69.3 years (SD = 3.1, Range = 64.7–76.6),
1893 returned the questionnaire.
The antenatal clinics were introduced in Helsinki from 1928 onwards (Pelkonen,
1940), and all pregnant women were encouraged to attend these clinics. Of the 13 345
participants in the cohort, these maternal data were available for 6410 (48.0%).
In view of the above described selection related to different follow-ups, the
participant numbers vary between the individual studies of this thesis. The final
numbers and exclusion criteria used are described in detail in Figure 3. The participation
rates can be calculated on the basis of these numbers. The attrition analyses, including
representativeness of the subpopulation with data available on maternal hypertension
and proteinuria in relation to the entire Helsinki Birth Cohort study cohort and subsets
of each individual study participants, are described in the individual articles. The
descriptive statistics according to the individual studies are presented in Table 6. The
descriptive statistics according to maternal hypertension status during pregnancy for all
participants with maternal antenatal data available are presented in Table 7.
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Figure 3. Selection of the participants in the Helsinki Birth Cohort Study and the final participant
numbers included in the original studies of this thesis
Footnotes are on page 67.
Died n = 647
Declined participation n = 206
in subsequent follow-up
Lived abroad or further n = 183
than 200km from Helsinki
Missing, implausible
or pre- or post-term
length of gestation
2001–2004/ Time 1 n = 164
2004/ Time 2 n = 131
Chronic hypertension
2001–2004/ Time 1 n = 29
2004/ Time 2 n = 23
Maternal blood pressure n = 6933
and urinary protein
tests  not recorded
Psychological questionnaire
2001–2004/ Time 1               n = 2902
2004/ Time 2 n = 1975
Maternal blood pressure
and urinary protein
tests not recorded
2001–2004/ Time 1 n = 1022
2004/ Time 2 n = 920
Study I
participants
2001–2004/ Time 1 n = 788
2004/ Time 2 n = 661
Study II n = 5970
participants
Helsinki Birth Cohort Study (HBCS) 1934–1944 N = 13 345
Missing or implausible n = 233
length of gestation
Died and the year of n = 32
death was not recorded
Missing data on                       n = 173
childhood SES
Men n = 6975
Maternal blood pressure      n = 1436
and urinary protein
tests  not recorded
Cognitive testing                  n = 2786
in 1952–1972
Study III n = 1196
participants
Missing, implausible or           n = 154
post-term length of gestation
Data on mental                    n = 13341
disorders available
1969–2004
Psychological questionnaire n = 4147
in 2009–2010
Died n = 709
Declined participation n = 313
in subsequent follow-up
Lived abroad or had n = 192
an  unknown address
Did not return n = 1040
the questionnaire
Maternal blood pressure n = 987
and urinary protein
tests  not recorded
Missing or implausible n = 22
length of gestation
Missing data on targeting n = 8
outcome measures
Study V n = 876
participants
Cognitive testing                   n = 2786
in 2009
Did not return n = 819
the questionnaire
Maternal  blood pressure n = 489
and urinary protein
tests  not recorded
Study IV n = 398
participants
Missing, implausible or n = 44
post-term length of gestation
Not participated
2001–2004/ Time 1 n = 899
2004/ Time 2 n = 240
b
c
c
a
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Footnotes for Figure 3.
a Described in text
b Between 1952 and 1972 only men served in the compulsory military service
c In 2009–2010, a psychological questionnaire administered to those participated in a detailed clinical
examination (n = 2003) in 2001–2004 and to those participated in cognitive testing in 1952–1972
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Table 6. Characteristics of the participants according to the individual studies of this thesis
Study I Study II Study III Study IV Study V
n Time 1:
788
Time 2:
661
5970 1196 398 876
PE/HT 36 (4.6)
PE/
239 (30.3)
HT
27 (4.1)
PE/
194 (29.3)
HT
274 (4.6)
PE/
1733 (29.0)
HT
449 (37.5)
Any HT
146 (36.7)
Any HT
31 (3.5)
PE/
292 (33.3)
HT
Age at testing
(y), mean (SD)
62.2 (3.1) 64.1 (3.1) 24-70 20.1 (1.4) 68.5 (2.9) 69.3 (3.1)
Primiparous,
n (%)
390 (49.4) 327 (49.5) 3031 (50.8) 602 (50.3) 197 (49.5) 431 (49.2)
Men, n (%) 371 (47.1) 290 (43.9) 3131 (52.4) 1196 (100) 398 (100) 499 (57.0)
Preterm birth
(<37 weeks), n (%)
- - 347 (5.8) 74 (6.2) 27 (6.8) 54 (6.2)
Birth weight
<2500 g, n (%)
19 (2.4) 16 (2.4) 200 (3.4) 38 (3.2) 14 (3.5) 25 (2.9)
Manual working
father, n (%)
546
(70.2)a
454 (69.5)b 3826 (64.1) 794 (66.4) 247 (62.1) 593 (67.7)c
aBased on the latest available data on father’s occupation, n = 500 (63.5 %) for the highest achieved
occupation
bBased on the latest available data on father’s occupation, n = 415 (68.8 %) for the highest achieved
occupation
cBased on the latest available data on father’s occupation, n = 542 (61.9 %) for the highest achieved
occupation
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Table 7. Characteristics of the participants according to mothers’ hypertension status during pregnancy
Normotension Hypertension without
proteinuria
Pre-eclampsia
na 4271 (66.6%) 1855 (28.9%) 284 (4.4%)
Characteristic Mean (SD)/ n (%) Mean (SD)/ n (%) Mean (SD)/ n (%)
Maternal
Mother’s age at
delivery (years)
27.8 (5.2) 28.9 (5.7)*** 28.5 (5.6)*
Mother’s Body
Mass Index at
delivery (kg/m2)
26.0 (2.8) 26.8 (3.2)*** 26.9 (3.1)***
Parity
Primipara 2076 (48.6) 991 (53.5)*** 198 (70.0)***
Multipara 2195 (51.4) 863 (46.5) 85 (30.0)
Offspring
At birth or in
childhood
Sex
Men 2247 (52.6) 959 (51.7) 151 (53.2)
Women 2024 (47.4) 896 (48.3) 133 (46.8)
Birth year
1934-38 1084 (25.4) 444 (23.9) 97 (34.2)**
1939-44 3187 (74.6) 1411 (76.1) 187 (65.8)
Length of gestation
(days)
279.2 (12.8) 279.2 (12.7) 275.1 (16.0)***
Preterm birth
(<37 weeks)
238 (5.8) 97 (5.4) 30 (10.7)**
Birth weight (g) 3435.2 (468.4) 3395.8 (496.3)** 3030.0 (588.2)***
Birth weight
<2500 g
102 (2.4) 66 (3.6)* 50 (17.6)***
Head
circumference (cm)
35.0 (1.5) 35.1 (1.5)** 34.4 (1.7)***
Father’s highest
occupation in
subject’s childhood
Manual worker 2672 (64.4) 1193 (66.1) 163 (58.2)
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Junior clerical 990 (23.8) 410 (22.7) 72 (25.7)
Senior Clerical 489 (11.8) 203 (11.2) 45 (16.1)
In adulthood
Own maximum
level of education
in adulthood
Basic or less 1746 (44.3) 803 (46.5) 107 (42.5)
Upper
secondary
1007 (25.6) 434 (25.1) 59 (23.4)
Lower tertiary
(polytechnic,
vocational,
bachelors)
843 (21.4) 352 (20.4) 56 (22.2)
Upper tertiary
(masters or
higher)
344 (8.7) 137 (7.9) 30 (11.9)
Blood pressure
medication
795 (18.6) 412 (22.2)** 68 (23.9)*
Hospitalization for
coronary heart
disease
327 (7.7) 151 (8.1) 28 (9.9)
Hospitalization for
stroke
219 (5.1) 129 (7.0)** 20 (7.0)
*p < 0.05; **p < 0.01; ***p < 0.001 against the normotension group
aMaximum number of participants reported. Across the characteristic variables, the number of participants
varies slightly because of missing information.
3.2 Hypertensive disorders during pregnancy - Antenatal
records (All studies)
For identifying pregnancy hypertensive disorders we used mothers’ blood pressure and
urinary  protein  measurements  recorded  at  antenatal  clinics  or  at  birth  hospital.  For  the
mothers with antenatal data available, there were on average 2.0 blood pressure and 2.5
urinary protein measurements recorded in each pregnancy. Based on this information
we defined four groups of mothers: 1) mothers with hypertension, i.e. the highest
systolic blood pressure ≥140 mmHg or the highest diastolic blood pressure ≥90 mmHg
with  proteinuria  +  reading  on  dipstick  in  a  random  urine  sample;  2)  mothers  with
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gestational hypertension, with hypertension as in 1) after 20 weeks of pregnancy but no
proteinuria; 3) mothers with any systolic blood pressure ≥140 mmHg or any diastolic
blood pressure ≥90 mmHg before 20 weeks of pregnancy, considered to have chronic
hypertension; 4) normotensive mothers with neither a systolic pressure attaining 140
mmHg nor a diastolic pressure 90 mmHg during pregnancy. For the purpose of the
Studies III and IV, the three groups of mothers with any hypertensive disorder during
pregnancy were combined; for the purpose of the Study II and V the groups of mothers
with either gestational hypertension or chronic hypertension were combined.
These definitions are consistent with the current clinical criteria (American College
of Obstetricians and Gynecologists & Task Force on Hypertension in Pregnancy, 2013;
National High Blood Pressure Education Program Working Group on High Blood
Pressure in Pregnancy, 2000) with two exceptions: first, we considered one high blood
pressure measurement to be sufficient for diagnosis because our data did not allow us to
require two separate measurements, as the current clinical criteria do; second, our data
included only a qualitative measurement of protein; proteinuria + approximates to 1
mg/mL of albumin (National High Blood Pressure Education Program Working Group
on High Blood Pressure in Pregnancy, 2000; Pelkonen, 1940)
3.3 Depressive symptoms -questionnaire (Study I)
The Beck Depression Inventory (BDI) was used to evaluate the severity of depressive
symptoms (Beck, Steer, & Carbin, 1988). BDI consists of 21 items assessing symptoms
of depression during the previous 2 weeks. Each item contains four statements
reflecting varying degree of symptom severity. Respondents are instructed to circle the
number that corresponds with the statement that best describes them, ranging from zero
to three, indicating increasing severity. Ratings are summed to calculate a total BDI
score  which  can  range  from  0  to  63.  Although  BDI  is  designed  to  screen  but  not
diagnose depression, there exist commonly used and well indicative cut-off points: none
or minimal depression is <10; mild to moderate depression is 10–18; moderate to severe
depression is 19–29; and severe depression is 30–63 points (Beck et al., 1988). In this
thesis,  BDI  score  ≥10  for  mild  depressive  symptoms  were  used  as  the  cut-off.  The
internal reliability coefficients (Cronbach's alpha) of the BDI scores ranged from 0.84 to
0.87.
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3.4 Diagnoses of mental disorders - HDR and CDR (Study II)
Diagnoses on mental disorders severe enough to warrant or contribute to hospital
treatment were identified from HDR, and severe enough to be the underlying,
intermediate, or contributing cause of death from CDR. The diagnoses were entered
using  International  Statistical  Classification  of  Diseases  (ICD)  coding  system.  Table  8
presents the diagnostic codes. Cases with serious mental disorders were defined as
having a primary or subsidiary diagnosis for mental disorders in HDR or an underlying,
intermediate and contributing mental disorder as cause of death in CDR. The psychiatric
diagnostic classification used in Finland was ICD-8 until 1986; from 1987 to 1995, the
classification was ICD-9 based on DSM-III-R criteria, and from 1996, it was ICD-10.
For this study, we converted ICD-8 and ICD-9 diagnoses to current ICD-10 codes.
The principal outcome was first-ever diagnosis of a serious mental disorder, defined
as a HDR or CDR diagnosis convertible to an ICD-10 code for a mental or behavioural
disorder (ICD-10 codes F10–F69; for ICD-8 and ICD-9-codes, see Table 8). Our
definition of mental disorders excluded organic disorders (ICD-10: F0) and learning
disabilities (ICD-10: F7). Due to the age range of participants, disorders of development
and disorders typically occurring in childhood and adolescence (ICD-10: F8–F9) were
also not recorded. Sub-analyses were per protocol carried out for the following
diagnostic groups: mental and behavioural disorders due to psychoactive substance use
(ICD-codes F10–19), schizophrenia and other non-affective psychotic disorders (ICD-
codes F20–F29), mood disorders (ICD-codes F30–F39), anxiety disorders (ICD-codes
F40–F48), and personality disorders (F60–F61). However, in the case of acute
intoxication due to substance abuse (F1x.0 in ICD-10 and 305 in ICD-9), only the
primary diagnosis was used from both registers because alcohol intoxication is a
frequent subsidiary diagnosis in Finnish medical practice and does not necessarily
indicate a substance use disorder.
HDR (Keskimäki & Aro, 1991) and CDR (R. A. Lahti  & Penttilä,  2001) have been
found to be valid and reliable tools for epidemiological research. HDR has been
validated with regard to the diagnoses of bipolar disorder (Kieseppä, Partonen, Kaprio,
& Lönnqvist, 2000), any psychotic disorder (Perälä et al., 2007), and schizophrenia
(Mäkikyrö et al., 1998; Pihlajamaa et al., 2008). All these diagnoses show high levels of
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specificity in the register against medical records (Kieseppä et al., 2000; Mäkikyrö et al.,
1998;  Perälä  et  al.,  2007).  The  validity  of  the  alcohol  psychosis-  and  alcoholism  -
diagnoses in HDR during the usage of ICD-8 has also found support in one earlier study
(Poikolainen,  1983).  We  are  not  aware  of  studies  where  the  validity  of  the  other
substance use disorder, or depressive, anxiety, and personality disorder diagnoses in
HDR would have been formally examined against medical records.
Table 8. Mental disorders according to International Statistical Classification of Diseases (ICD) codes
used in the Finnish Hospital Discharge Register and the Finnish Causes of Death Register
Mental disorders:
International Classification of Diseases
10th (ICD-10; in use 1996–present), 9th (ICD-9;
in use between 1987–1995), and 8th (ICD-8; in
use between 1969–1986) diagnostic codes:
Anya ICD-10: F1–F6
ICD-9: 291–292, 295–298, 300–304, 305, 3071A,
3074, 3075A–3075B, 3078A, 3079X, 3090A,
3092C–3099X, 312
ICD-8: 291, 295, 296-305, 306.4–306.5, 306.8,
306.98, 307
Substance Use
(ICD-10: Mental and behavioural disorders due to
psychoactive substance use)
ICD-10: F10–F19
ICD-9: 291–292, 303–305
ICD-8: 291, 303–304
Psychotic
(ICD-10: Schizophrenia, schizotypal, and
delusional disorders)
ICD-10: F20–F29
ICD-9: 295, 297–298
ICD-8: 295, 297, 298.10–299.99
Mood
(ICD-10: Mood (affective))
ICD-10: F30–F39
ICD-9: 296, 3004A, 3011D
ICD-8: 296, 298.00, 300.40, 300.41, 301.10
Anxiety
(ICD-10: Neurotic, stress-related and somatoform
disorders)
ICD-10: F40–F48
ICD-9: 3000A–3003A, 3006A–3009X, 3078A,
309
ICD-8: 300.00–300.30, 300.50–300.99, 305,
306.80, 307.99
Personality
(ICD-10:  Specific and mixed personality
disorders)
ICD-10: F60–F61
ICD-9: 3010A, 3012A–3015A, 3016A–3018X
ICD-8: 301.00, 301.20–301.99
aA variety of behavioural syndromes (corresponding to codes F50–F59 or F62–F69 in ICD-10) were
included in the Any mental disorder –category, but due to heterogeneity and small sample size, we were
not able to treat it as a separate category.
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3.5 Cognitive ability test (Study III and IV)
The cognitive ability test scores were obtained from the Finnish Defence Forces Basic
Ability Test, which was developed at the Finnish Defence Forces Education
Development Centre (described in Tiihonen et al., 2005). The compulsory test is given
to all new recruits during the first two weeks of their military service and the results are
used when a proportion of the conscripts are selected for leadership training later during
their military service. The test battery is designed to measure general ability and logical
thinking, and is composed of verbal, arithmetic, and visuospatial reasoning subtests.
Each subtest is timed and consists of 40 multiple-choice questions in a series proceeding
from the easiest to the most complicated. Correct answers are summed to yield a test
score. The verbal and arithmetic subtests comprise 4 types of questions. In the verbal
reasoning test the subject has to choose synonyms or antonyms of a given word, select a
word  belonging  to  the  same  category  as  a  given  word  pair,  identify  which  word  of  a
word  list  does  not  belong  to  the  group,  and  discern  similar  relations  between  2  word
pairs. In the arithmetic reasoning test, the subject has to complete a series of numbers
that have been arranged to follow a certain rule, to solve verbally expressed short
problems, to complete simple arithmetic operations, and to choose similar relations
between  2  pairs  of  numbers.  The  visuospatial  reasoning  subtest  comprises  a  set  of
matrices containing a pattern problem with 1 part removed: it is analogous to Raven’s
Progressive  Matrices  (Raven,  Raven,  &  Court,  2000).  The  subject  is  asked  to  decide
which of the given single figures completes the matrix, and the test requires the subject
to conceptualize spatial relations ranging from the very obvious to the very abstract. The
total cognitive ability score, analysed as the mean of the three individual subtests, was
also used in this thesis. Tiihonen et al. (2005) have previously reported the test-retest
reliabilities of the subtests varying from 0.76 to 0.88.
3.6 Cognitive impairment -questionnaires (Study V)
Self-reported cognitive failures and executive function were measured with the
Cognitive Failures Questionnaire (CFQ) (Broadbent, Cooper, FitzGerald, & Parkes,
1982) and with the Dysexecutive Questionnaire (DEX) (Burgess, Alderman, Evans,
Emslie,  &  Wilson,  1998).  CFQ  is  composed  of  25  questions  that  inquire  about  basic
cognitive problems that people may have had in everyday activities in the past 6 months.
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The CFQ items are self-rated on a scale that ranges from 0 (never) to 4 (very often).
Sample items include “Do you fail to notice signposts on the road?” and “Do you find
you forget whether you've turned off a light or a fire or locked the door?” The scale
yields a total score and three subscale scores that measure forgetfulness, distractibility,
and false triggering (Rast, Zimprich, Van Boxtel, & Jolles, 2009). Higher scores reflect
more frequent complaints. The reliabilities (Cronbach's alpha) of the CFQ total score
and subscale scores were 0.92, 0.84, 0.79, and 0.79 for total score of forgetfulness,
distractibility, and false triggering, respectively.
DEX, which was derived from the Behavioral Assessment of Dysexecutive
Syndrome (Wilson, Alderman, Burgess, Emslie, & Evans, 1996), is a 20-item scale that
was designed to screen for changes in observable everyday manifestations of executive
function, such as abstract thinking, impulsivity, confabulation, and planning problems.
The DEX items are self-rated on a scale that ranges from 0 (never) to 4 (very often).
Sample items include “I have problems in understanding what other people mean unless
they keep things simple and straightforward,” “I have difficulties in planning for the
future,” and “I talk in one way but act in another.” The scale yields a total score and
three subscale scores that measure behavioural-emotional self-regulation, metacognition,
and executive cognition (Simblett & Bateman, 2011). Higher scores reflect more
frequent  complaints.  The  reliabilities  (Cronbach's  alpha)  of  the  DEX  total  score  and
subscale scores were 0.90, 0.78, 0.72, and 0.73 for total score, behavioural-emotional
self-regulation, metacognition, and executive cognition, respectively.
3.7 Covariates and moderating variables
Offspring’s  date  of  birth  (year)  and  weight  (g)  and  head  circumference  (cm)  at  birth,
mother's  age,  weight  (kg)  and  height  (cm)  at  delivery,  parity  and  date  of  last
menstruation were obtained from hospital birth records. Length of gestation was based
upon the date of mother’s last menstrual period. Mother’s BMI was calculated as weight
divided by height2 (kg/m2). Childhood socio-economic status, based on father’s
occupation (manual workers, junior clericals, senior clericals) was extracted from birth,
child welfare clinic, and school health care records. While in the studies I and V, latest
available data on father’s occupation was used as a variable (most data from school
records), in the studies II, III and IV, the variable was based on the father’s highest
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achieved occupation. The analyses of studies I and V were now re-run with the father’s
highest occupation as a covariate.
Adult socio-economic status was indicated by the level of educational attainment
determined in conjunction with the clinical examination in 2001-2004 (elementary
school, vocational school, senior high school, college/university degree; Study I) or by
the highest level of education achieved (basic or less/ upper secondary/ lower tertiary/
upper tertiary) from census data at 5-year intervals since 1970, obtained from Statistics
Finland (Study IV and V). Adult height (cm) was attained at military service (Study III)
and at a retest of cognitive ability (Study IV). Diagnoses of stroke (international
classification of disease codes 430–434 and 436–437 from ICD-8 and 9, 438 from ICD-
9, and I60–I69 from ICD-10) and coronary heart disease (codes 410–414 from ICD-8
and ICD-9 and I21–I25 from ICD-10) since 1969 were obtained from the Finnish
Hospital Discharge Register (until 2008) (Study IV). Blood pressure medication was
obtained from the national register of people receiving reimbursement from the state for
the costs of their medication (Study IV).
3.8 Statistical analyses
We used the Statistical Package for the Social Sciences (SPSS) version 17, Predictive
Analytics SoftWare (PASW) versions 17 to 18, and IBM SPSS Statistics (IBM SPSS)
19–22 to analyse the data.
We used linear and logistic regression analyses to test the differences between the
offspring of normotensive and hypertensive mothers in the severity of depressive
symptoms and cognitive functioning. We used Cox proportional hazard models to
examine the differences in the odds of mental disorders. The two-sided p-values were
obtained from the regression and hazard models and were based on comparison of the
coefficient and its standard error.
The associations were adjusted for the neonatal, maternal, and adult factors known to
be associated with an increased risk of hypertensive pregnancy disorders and/or
offspring psychological outcomes as follows: Maternal age and BMI at delivery, parity,
sex (Studies I, II, and V), year of birth (Studies II and III) and/or age at testing (Studies
I,  III,  IV  and  V),  length  of  gestation,  birth  weight  for  gestational  age,  and  father’s
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occupational status were treated as covariates in all the analyses; Sex and year of birth
were adjusted for in regression analyses and stratified for in hazard models.
In addition, analyses of all outcomes measured in late adulthood were adjusted for
own attained level of education (Studies I, IV and V). Analyses related to cognitive
ability were adjusted for head circumference at birth and adult height (Studies III and IV)
and also diagnoses of stroke and coronary heart disease and blood pressure medication
(Study IV). The covariates were included into the regression equation simultaneous to
hypertensive disorders.
To test whether sex, prematurity, parity or childhood socio-economic status moderate
any potential associations ‘sex, prematurity, parity, father’s occupation status (grouped
into manual workers and junior/senior clericals) x hypertensive disorder during
pregnancy’ -interactions were included in the regression equation or hazard models
followed by their main effects.
Due to skewness of distributions of some outcome variables, data transformations
were made. The BDI scores were log transformed to attain normality, with regression
coefficients reverse transformed and expressed as the percentage change in the
dependent variable for each unit change in the independent variable. The DEX and CFQ
scores were transformed into normalized z-scores with a mean of 0 and SD of 1. The
cognitive ability test scores were converted into z-scores with a mean of 0 and SD of 1
in Study III and with a mean of 100 and SD of 15 in Study IV. A z -score represents the
difference from the mean value for the whole cohort and is expressed in standard
deviations (SD). Change in cognitive ability was modelled in analyses by cognitive
ability at age 68 years used as the outcome and cognitive ability at age 20 years as the
predictor (Twisk, 2003).
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4 RESULTS
4.1 Maternal hypertensive disorders during pregnancy and the
mental health of the offspring (Studies I and II)
4.1.1 Depressive symptoms (Study I)
When we compared participants born after primiparous pregnancies complicated by pre-
eclampsia to the participants born after primiparous normotensive pregnancies with
adjustments for mother’s age and BMI at delivery, father’s occupational status in
childhood, participant’s sex, age at testing and level of education attained, the
depressive symptom scores were more than 30% higher at time 1 and time 2 among
offspring born after pre-eclamptic pregnancies (Table 9, Model A). Adding birth weight
adjusted  for  gestation  to  the  model  had  little  effect  on  the  results  (Table  9,  Model  B).
When length of gestation was added to the model the results were slightly attenuated
(time 1, p = 0.06; time 2, p = 0.04; average of time 1 and time 2, p = 0.08).
Table 9. Comparison of depression symptom scores in the offspring born at term to mothers with pre-
eclamptic versus normotensive (referent) pregnancies
Data presented as percent difference (95 % CI)
n Model A Model B
Primiparous
BDI at time 1 28 vs. 237 36.9 (2.0 to 71.8)* 36.5 (1.1 to 71.9)*
BDI at time 2 22 vs. 203 52.2 (7.8 to 96.6)* 49.1 (3.8 to 94.4)*
Average BDI 21 vs. 201 39.7 (1.6 to 77.7)* 38.4 (-0.4 to 77.1)
Multiparous
BDI at time 1 8 vs. 276 -15.8 (-71.5 to 40.0) -13.4 (-69.3 to 42.5)
BDI at time 2 5 vs. 237 -58.9 (-142.2 to 24.4) -54.8 (-138.7 to 29.0)
Average BDI 5 vs. 236 -41.7 (-109.2 to 25.8) -38.8 (-106.9 to 29.2)
*p < 0.05 against the normotension group
Both models are adjusted for gender, father’s occupational status in subject’s childhood, mother’s age
at delivery, mother’s BMI and age at clinical questionnaires and own attained level of education, and
Model B additionally for birth weight for gestational age.
When we applied the mild cut-off criterion for the BDI scores (≥10 versus <10), as
compared with those born after primiparous normotensive pregnancies, the participants
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born after primiparous pregnancies complicated by pre-eclampsia had an odds ratio of
3.7 for having depressive symptom scores above the cut-off (Table 10, Model A).
Further adjustment taking birth weight for gestation into account had little effect on the
results (Table 10, Model B). When length of gestation was added to the model the
results were slightly attenuated (p = 0.05). Pre-eclampsia was not associated with
depressive symptom scores in multiparous pregnancies (Tables 9 and 10).
Table 10. Comparison of the risk for having depressive symptoms scores above at least mild severity in
the offspring born at term to mothers with pre-eclamptic versus normotensive (referent) pregnancies
Data presented as odds ratio (95% CI)
Model A Model B
Primiparous
Average BDI < vs. ≥10 3.7 (1.2 to 11.3)* 3.8 (1.2 to 11.9)*
Multiparous
Average BDI < vs. ≥10 0.9 (0.1 to 8.6) 0.8 (0.1 to 8.3)
*p < 0.05 against the normotension group
BDI scores >10 indicate at least mild severity and are compared to scores <10 indicative of no
to low severity.
Both models are adjusted for gender, father’s occupational status, mother’s age at delivery,
mother’s BMI and age at clinical questionnaires and own attained level of education, and Model
B additionally for birth weight for gestational age.
Gestational hypertension did not have any significant effects on depressive symptoms
(ps > 0.34; data not shown). Analyses testing whether sex, birth weight, or father’s
occupational status in subject’s childhood modulated any associations between pre-
eclampsia/ gestational hypertension and depressive symptoms revealed no significant
results (ps > 0.19). The adjustment for father’s highest occupation (vs. latest available
data on father’s occupation) did not change any of the reported results.
4.1.2 Severe mental disorders (Study II)
Table 11 shows the associations between maternal hypertensive disorders during
pregnancy and the risk for severe mental disorders in the offspring after stratifications
for  sex  and  year  of  birth  and  adjustments  for  gestational  age,  weight  at  birth,  father’s
occupational status in childhood, parity, mother’s age and BMI at delivery. Because the
unadjusted and adjusted associations were virtually identical, the adjusted associations
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are only presented. When compared to the offspring born after normotensive
pregnancies, the offspring born after pregnancies complicated by hypertension without
proteinuria were at an increased risk of any mental disorder and mood disorder. They
were  also  at  an  increased  risk  of  anxiety  disorder,  which  approached  the  level  of
significance. Maternal hypertension without proteinuria was not associated with other
mental disorders. Maternal pre-eclampsia was not associated with any or the more
specific mental disorders.
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Table 11. Risk of severe mental disorder among the offspring born after hypertensive without proteinuria (n = 1733)/ pre-eclamptic (n = 274) versus normotensive (n =
3963, referent) pregnancies
Data presented as hazard ratios (95% CI)
Disorders n Normotension %a Hypertension %a Pre-eclampsia %a Hypertension vs.
normotensionb
Pre-eclampsia vs.
normotensionb
No disorders vs. 5264
Any 706c 11.4 13.2 8.8 1.19 (1.01, 1.41)* 0.75 (0.48, 1.17)
Substance use 379 6.6 7.4 4.7 1.11 (0.88, 1.40) 0.61 (0.32, 1.17)
Psychotic 142 2.4 3.2 2.5 1.38 (0.96, 1.99) 1.15 (0.49, 2.69)
Mood 266 4.4 5.9 4.1 1.44 (1.11, 1.88)** 0.96 (0.48, 1.91)
Anxiety 166 2.8 3.8 2.2 1.39 (0.99, 1.93) 0.86 (0.35, 2.16)
Personality 94 1.7 1.8 1.7 1.09 (0.68, 1.73) 1.12 (0.39, 3.17)
*p < 0.05; **p < 0.01 against the normotension group
a% refers to the cumulative incidence (calculated by the number of new cases during a period divided by the number of subjects at risk in the population at the
beginning of the study) of severe mental disorders according to mothers’ hypertensive disorder during pregnancy derived from models adjusting for sex, year of birth
and father’s occupational status in childhood.
bCox regression models are stratified for sex and year of birth and adjusted for gestational age, weight at birth, father’s occupational status in childhood, parity,
mother’s age and BMI at delivery.
cParticipants whose mental disorder diagnose changed over time or with co-morbid disorders were included in each specific mental disorder category and in any
mental disorder category. Thus, participants with specific mental disorders do not sum up to participants having any mental disorder.
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Modifying effects of sex, preterm/term length of gestation, parity and childhood
socio-economic status
Men born after pregnancies complicated by maternal pre-eclampsia (n = 145),
compared to men born after normotensive pregnancies (n = 2089) had a lower, a 0.45-
fold (95% CI: 0.23 to 0.88, p = 0.01) risk of any mental disorder and also had a lower,
0.44-fold (95% CI: 0.19 to 0.99, p = 0.04) risk of substance use disorder. In women,
maternal pre-eclampsia was not associated with mental disorders (p > 0.24). The
interaction ‘pre-eclampsia vs. normotension x sex’ was significant for any mental
disorder (p = 0.04) (Figure 4, Panel A) and approached significance in the analyses of
substance use disorder (p = 0.06) (Figure 4, Panel B). Other interactions ‘hypertension
without proteinuria/ pre-eclampsia vs. normotension x sex/ preterm vs. term length of
gestation/ parity/ father’s occupational status in subject’s childhood/’ were not
significant in tests of mental disorders (ps > 0.07).
Figure 4. Panel A: The interaction ‘pre-eclampsia vs. normotension x sex’ for any mental disorder (p =
0.04)
Panel B: The interaction ‘pre-eclampsia vs. normotension x sex’ for substance use disorder (p = 0.06)
Note. Analyses were stratified for sex and year of birth and adjusted for gestational age, weight at birth,
father’s occupational status in childhood, parity, mother’s age and BMI at delivery.
% refers to the cumulative incidence of any mental disorder and substance use disorder according to
mothers’ hypertensive disorder (pre-eclampsia vs. normotension) during pregnancy derived from models
adjusting for year of birth and father’s occupational status in childhood.
(Tuovinen et al., 2012. Hypertensive disorders in pregnancy and risk of severe mental disorders in the
offspring in adulthood: the Helsinki Birth Cohort Study. The Journal of Psychiatric Research, 46, 303-
310, reprinted with permission.)
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4.2 Maternal hypertensive disorders during pregnancy and the
cognitive functioning of the offspring (Studies III, IV and V)
4.2.1 Cognitive ability in young adulthood (Study III)
In comparison to the offspring born after normotensive pregnancies, offspring born after
pregnancies complicated by any maternal hypertensive disorder scored 0.13 (95% CI: -
0.25 to -0.01, p = 0.03) SD units lower on the verbal reasoning test and had 0.12 (95%
CI: -0.24 to -0.00, p = 0.04) SD units lower total  cognitive test  score at  a mean age of
20.1 years. The MDs in visuospatial and arithmetic reasoning tests were -0.09 (95% CI:
-0.21 to 0.04, p = 0.17) and -0.10 (95% CI: -0.22 to 0.03, p = 0.13), respectively, not
reaching the formal statistical significance. The associations were adjusted for
gestational age, weight, and head circumference at birth, year of birth, childhood socio-
economic status, and parity, mother’s age, and BMI at delivery, and age, and height at
military service.
Modifying effects of preterm/term length of gestation, LBW/NBW, parity and
childhood socio-economic status
The following interactions were significant (Figure 5, Panel A and B). In comparison to
the offspring born after primiparous and normotensive pregnancies (n = 366), offspring
born after primiparous pregnancies complicated by any maternal hypertensive disorder
(n = 236), scored 0.24 (95% CI: -0.41 to -0.08, p = 0.004) SD units lower on verbal
reasoning test (p = 0.89 for multiparous offspring) (p = 0.04 for any hypertensive
disorder vs. normotension x parity -interaction). In comparison to the offspring of
junior/senior clerical fathers born after normotensive pregnancies (n = 260), offspring of
junior/senior clerical fathers born after pregnancies complicated by any maternal
hypertensive disorder (n = 142) scored 0.32 (95% CI: -0.53 to -0.10, p = 0.004) SD
units lower on verbal reasoning test (p = 0.58 for offspring of manual working fathers;
offspring of manual working fathers scored the lowest on cognitive tests regardless of
hypertensive disorders) (p = 0.04 for any hypertensive disorder vs. normotension x
father’s occupational status subject’s childhood -interaction). Prematurity, low birth
weight, parity, father’s occupational status in subject’s childhood did not modulate any
other associations (ps > 0.09 for interactions).
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Figure 5. Panel A: The interaction ‘any hypertensive disorder vs. normotension x parity’ for verbal
reasoning (p = 0.04)
Panel B: The interaction ‘any hypertensive disorder vs. normotension x childhood socio-economic status’
for verbal reasoning (p = 0.04)
Note. Derived from models including the corresponding interaction term and adjusted for gestational age,
weight, and head circumference at birth, year of birth, childhood socio-economic status (Panel A), and
parity (Panel B), mother’s age and BMI at delivery, and age and height at military service.
(Tuovinen et al., 2012. Hypertensive disorders in pregnancy and intellectual abilities in the offspring in
young adulthood: the Helsinki Birth Cohort Study. Annals of Medicine, 44, 394-403, reproduced with
permission.)
4.2.2 Cognitive change up to late adulthood (Study IV)
Table 12 shows that men born after pregnancies complicated by any maternal
hypertensive disorder, compared with men born after normotensive pregnancies, scored
lower on arithmetic and total cognitive ability at the mean age of 68.5 years (ps in
unadjusted and adjusted models < 0.05). They also displayed a greater decline in
arithmetic and total cognitive ability after age 20.1 years (Table 12). Prematurity, parity,
or father’s occupational status in subject’s childhood did not modulate the associations
(ps > 0.10 for interactions).
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Table 12. Cognitive ability at the ages of 20.1 and 68.5 years in the offspring who were born after pregnancies complicated by hypertensive disorders (n = 146) and
normotensive pregnancies (n = 252, referent)
Normotension Hypertensive disorders Hypertensive disorders vs. normotension
Ma at 20.1 years
(95% CI)
Ma at 68.5 years
(95% CI)
Ma at 20.1 years
(95% CI)
Ma at 68.5 years
(95% CI)
MDb at 68.5 years
(95 % CI)
MDb,c of change
(95 % CI)
Unadjusted model
Verbal 28.45
(27.47 to 29.44)
31.36
(30.56 to 32.16)
27.64
(26.35 to 28.94)
30.26
(29.21 to 31.31)
-2.67
(-5.67 to 0.33)
-1.54
(-3.85 to 0.77)
Visuospatial 25.64
(24.94 to 26.34)
23.43
(22.81 to 24.05)
25.70
(24.78 to 26.62)
22.52
(21.70 to 23.34)
-2.62
(-5.60 to 0.35)
-2.70
(-5.17 to -0.23)*
Arithmetic 28.61
(27.50 to 29.71)
27.76
(26.59 to 28.94)
27.00
(25.55 to 28.45)
25.31
(23.76 to 26.86)
-4.27
(-7.28 to -1.25)**
-2.30
(-4.43 to -0.18)*
Total 27.57
(26.76 to 28.38)
27.52
(26.79 to 28.25)
26.78
(25.72 to 27.85)
26.03
(25.07 to 26.99)
-3.71
(-6.67 to -0.74)*
-2.23
(-4.24 to -0.22)*
Adjusted modeld,e
Verbal 29.48
(28.15 to 30.81)
32.03
(30.96 to 33.09)
28.87
(27.24 to 30.50)
30.68
(29.38 to 31.98)
-3.35
(-6.54 to -0.17)*e
-2.32
(-4.79 to 0.16)
Visuospatial 26.36
(25.41 to 27.30)
23.51
(22.63 to 24.39)
26.47
(25.31 to 27.63)
22.53
(21.45 to 23.60)
-2.83
(-6.15 to 0.49)
-2.64
(-5.37 to 0.10)
Arithmetic 29.30
(27.85 to 30.75)
28.20
(26.60 to 29.80)
27.97
(26.19 to 29.74)
25.14
(23.18 to 27.10)
-4.91
(-8.17 to -1.65)**
-3.14
(-5.51 to -0.77)**
Total 28.38
(27.31 to 29.45)
27.91
(26.92 to 28.91)
27.77
(26.46 to 29.08)
26.11
(24.90 to 27.33)
-4.36
(-7.55 to -1.17)**
-2.88
(-5.06 to -0.70)*
Footnotes are on page 86.
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Footnotes for Table 12.
*p < 0.05; **p  < 0.01against the normotension group
aMean level of cognitive ability in raw test scores (0-40 points).
bMean difference in standardized (mean = 100, SD = 15) cognitive ability test scores.
cChange is modeled in a linear regression analysis where cognitive ability at age 68 years is predicted by
cognitive ability at age 20 years.
dThe adjusted model refers to adjustments made for length of gestation, weight and head circumference at
birth, father’s occupational status in childhood, parity, mother’s age and BMI at delivery, age at testing
cognitive ability at 20 years, time interval between tests of cognitive ability from 20 to 68 years, height at
testing of cognitive ability in late adulthood and blood pressure medication.
eFurther model adjusted as in footnote d, above, plus highest own achieved level of education and
diagnoses of stroke and coronary heart disease. The marked associations were rendered nonsignificant.
Unmarked associations remained as in the adjusted model in footnote d.
4.2.3 Self-reported cognitive impairment (Study V)
In comparison to the participants who were born after normotensive pregnancies,
participants who were born after pregnancies that were complicated by pre-eclampsia
reported more frequent complaints of cognitive failures, distractibility, and false
triggering. These associations remained significant in the unadjusted and adjusted
models (Table 13). In comparison to the participants who were born after normotensive
pregnancies, participants who were born after pregnancies that were complicated by
pre-eclampsia reported also more frequent complaints of dysexecutive functioning and
executive cognition. These associations were significant in the unadjusted model, but
were rendered nonsignificant in the adjusted models (Table 13). Participants who were
born after hypertensive pregnancies without proteinuria and normotensive pregnancies
did not differ from each other in cognitive failures or dysexecutive functioning (Table
13).
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Table 13. Comparison of the CFQ and DEX scores in the offspring born after pregnancies complicated by hypertension without
proteinuria (n = 292) or pre-eclampsia (n = 31) versus normotensive pregnancies (n = 553, referent)
Data presented as mean difference in SD units (95% CI)
Hypertension vs. normotension Pre-eclampsia vs. normotension
Unadjusted model Adjusted modela Unadjusted model Adjusted modela
CFQ
Total score 0.09 (-0.05, 0.23) 0.12 (-0.04, 0.27) 0.48 (0.12, 0.84)* 0.45 (0.02, 0.87)*
Forgetfulness 0.08 (-0.06, 0.22) 0.13 (-0.02, 0.28) 0.32 (-0.04, 0.68) 0.18 (-0.25, 0.60)
Distractibility 0.07 (-0.07, 0.21) 0.09 (-0.06, 0.24) 0.46 (0.11, 0.82)* 0.51 (0.08, 0.93)*
False triggering 0.12 (-0.02, 0.26) 0.13 (-0.02, 0.29) 0.42 (0.06, 0.78)* 0.48 (0.06, 0.90)*
DEX
Total score 0.09 (-0.05, 0.23) 0.07 (-0.08, 0.22) 0.36 (0.004, 0.71)* 0.31 (-0.11, 0.73)
Behavioural-emotional self-
regulation
0.08 (-0.05, 0.21) 0.06 (-0.08, 0.20) 0.28 (-0.05, 0.61) 0.31 (-0.08, 0.70)
Metacognition 0.05 (-0.08, 0.18) 0.04 (-0.10, 0.19) 0.34 (-0.002, 0.67) 0.23 (-0.17, 0.63)
Executive cognition 0.07 (-0.06, 0.20) 0.06 (-0.08, 0.20) 0.35 (0.01, 0.68)* 0.37 (-0.02, 0.76)
*p < 0.05 against the normotension group
aThe adjusted model refers to adjustments made for sex, length of gestation, weight and head circumference at birth, father’s occupational
status in childhood, parity, mother’s age and BMI at delivery, and age at completing the questionnaires
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Modifying effects of sex, preterm/term length of gestation, parity and childhood
socio-economic status
Sex,  prematurity,  parity  or  father’s  occupational  status  in  subject’s  childhood  did  not
modulate the associations between pre-eclampsia and complaints of cognitive
failures/dysexecutive functioning (p for interactions > 0.10). Analyses that tested
modulation by sex revealed, however, that, in comparison with women who were born
after normotensive pregnancies (n = 238), women who were born after pregnancies that
were complicated by hypertension without proteinuria (n = 125) reported more frequent
complaints of cognitive failures, forgetfulness, and false triggering (Figure 6). There
were no differences between men born after normotensive (n = 315) and hypertensive
pregnancies without proteinuria (n = 167) in complaints of cognitive failures (Figure 6).
Sex did not modulate the associations between hypertensive pregnancy disorders
without proteinuria and dysexecutive functioning, and there were no significant
interactions with prematurity, parity or father’s occupational status in subject’s
childhood (ps  for  interactions  >  0.15).  Further  adjustment  for  highest  attained  level  of
education in adulthood had little effect on any of the reported results. The adjustment
for father’s highest occupation (vs. latest available data on father’s occupation) did not
change any of the reported results.
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Figure 6. Comparison of the CFQ scores among men and women who were born after pregnancies that
were complicated by hypertension without proteinuria versus normotensive pregnancies (referent; zero
line)
The horizontal lines represent unstandardized regression coefficients (i.e., difference in standard
deviations), and the vertical lines represent the upper and lower bounds of the 95% confidence intervals.
aThe adjusted model refers to adjustments made for length of gestation, weight, and head circumference
at birth, father’s occupational status in childhood, parity, mother’s age and body mass index at delivery,
and age at completion of the questionnaires.
bA significant interaction (sex and maternal hypertension without proteinuria) was found for total score (p
= 0.01), forgetfulness (p = 0.03), and false triggering (p = 0.01).
(Tuovinen et al. 2013. Maternal hypertensive disorders in pregnancy and self-reported cognitive
impairment of the offspring 70 years later: the Helsinki Birth Cohort Study. American Journal of
Obstetrics and Gynecology, 208, 200.e1-9, reprinted with permission.)
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5 DISCUSSION
The primary aim of this thesis was to test whether maternal hypertensive disorders
during pregnancy were associated with the mental health and cognitive functioning in
the offspring from early to late adulthood. The study capitalised on the large and well-
characterised HBCS from 1934–44. The main results confirmed that maternal pre-
eclampsia and/or hypertension without proteinuria during pregnancy have a negative
effect on a wide spectrum of psychological outcomes in the offspring. A secondary aim
was to test whether any potential associations differ according to sex (Studies I, II and
V),  length  of  gestation,  parity  and  childhood  socio-economic  status.  Overall,  some
evidence was found that primiparity, female sex and a high socio-economic status may
increase the risk of adverse outcomes, while male sex seemed to decrease the risk of
severe mental disorders.
5.1 Theoretical and mechanistic considerations
Hypothetising why intrauterine exposure to maternal hypertensive disorders should
affect the development of the offspring is of interest. In general, the current findings
proposed that vulnerability to poorer mental health and cognitive functioning was
programmed by prenatal exposure to maternal hypertensive disorders during pregnancy.
These findings can be conceptualised within the framework of DOHaD and the life
cycle model of stress, respectively. According to these theories, early life adversities
may permanently alter organ structure and functioning, and affect developmental
outcomes later in life. In humans, maximal brain growth and most of the
neuroendocrine maturation occurs in utero (Lupien et al., 2009; Dobbing & Sands,
1979). This may explain the importance of prenatal life in developmental programming.
Although the current findings may point to mechanisms by which prenatal adversity
is associated with these problems later in life, the exact mechanisms linking maternal
hypertensive pregnancy disorders with poorer cognitive functioning and mental health
later in life are not yet determined. The pathophysiological changes associated with
hypertensive disorders could reasonably have an adverse effect on offspring
development. As reviewed above, maternal hypertensive pregnancy disorders may
compromise the fetal developmental milieu by resulting in inadequate fetal nutrition and
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hypoxic damage (J. P. Newnham et al., 2002), inducing systemic inflammation
(Redman & Sargent, 2010) or leading to overexposure to maternal glucocorticoids
(Aufdenblatten et al., 2009; Kajantie et al., 2003; McCalla et al., 1998; Schoof et al.,
2001). All of these influences may potentially cause lifelong changes in the offspring at
the epigenomic and transcriptomic levels, and in the organ structure and functioning of
the body and physiological feedback systems.
Contrary to our expectation, the current findings showed that maternal pre-eclampsia
was  associated  with  a  lower  risk  of  severe  mental  disorders  in  male  offspring.  The
possibility that this result was due to chance cannot be excluded. However, the brain
continues to develop after birth. Given that prenatal programming may be moderated by
the early postnatal environment (Buss et al., 2007; Vickers et al., 2005) and that
epigenetic changes are reversible, it is also possible that postnatal factors have
overridden the effects of an adverse prenatal environment. Indeed, not all effects need to
be adverse—it is plausible that the seriousness of pre-eclampsia is associated with more
effective and sensitive parenting (J. P. Newnham et al., 2004) and more extensive
concentration on motherhood in life (Leeners et al., 2009), which explains the
counterintuitive associations of pre-eclampsia (moderation by sex is discussed in
section 5.6). It may be that such a parenting style serves as a buffer from any ill effects
of pre-eclampsia-associated early environmental adversity. This assumption remains,
however, untested in this thesis. Yet, it is of further importance to note that the prenatal
environment may alter individual susceptibility not only to the negative effects of an
adverse environment, but also to the beneficial effects of an enriching environment
(Belsky & Pluess, 2009).
In addition to the theoretical alignment, previous findings agree with our results. The
current findings here are discussed in more detail and compared to previous findings in
the following two sections.
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5.2 Maternal hypertensive disorders during pregnancy and the
mental health of the offspring
Pre-eclampsia
Pre-eclampsia occurring in term primiparous pregnancies was associated with higher
depressive symptom scores in the offspring several decades later. These offspring born
to pre-eclamptic mothers had higher depressive symptom scores and a higher risk of
having depressive symptom scores above the cut-off indicating mild severity compared
to their counterparts born after normotensive pregnancies. Pre-eclampsia did not predict
depressive symptoms among participants born at term after multiparous pregnancies.
Testing associations separately in the offspring born after primiparous and multiparous
pregnancies was deemed necessary since the preliminary findings showed no significant
associations among the entire group of offspring and since pre-eclampsia may be
qualitatively different in primiparous and multiparous pregnancies (Allen et al., 2004;
Luo et al., 2007).
Offspring born preterm were excluded from the analyses. This differed from the
analyses carried out for the other original publications included as a part of this thesis.
However, the overall pattern of the results remained unchanged even after including the
offspring born preterm into the analyses.
In support of our findings, a further study in HBCS showed that maternal pre-
eclampsia carries an increased risk of problems in the adaptive functioning and mental
well-being of the offspring seven decades later (Tuovinen et al., 2014). However, one
previous study reported null associations between maternal pre-eclampsia and psychotic
symptoms in the offspring in childhood (Zammit et al., 2009), while one study reported
maternal pre-eclampsia reducing internalising behaviours, including withdrawal and
anxiety or depressed behaviours and somatic complaints, in the offspring in childhood
(Robinson et al., 2009). The current findings are, thus, not in line with these findings
among children.
Contrary to our expectations, the current findings revealed that maternal pre-
eclampsia was associated with a lower risk of any mental disorder and substance use
disorder among male offspring. These findings are, thus, not in line with our findings
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regarding the severity of depressive symptoms. However, it is of note that, in this latter
study, serious mental  disorders identified from HDR and CDR over four decades were
examined, while in the former study self-ratings assessed at a single time point as tools
to measure sub-clinical symptoms were used. Hence, the former study also addresses
symptoms that do not require hospital treatment or contribute to death.
These findings regarding the risk of mental disorders also disagree with the previous
findings  of  studies  that  have  focused  on  severe  mental  disorders.  Among  them,  one
reported an association between maternal pre-eclampsia and schizophrenia in the
offspring (Eide et al., 2013), and four found no associations with schizophrenia
(Dalman  et  al.,  2001;  Jones  et  al.,  1998;  H.  J.  Sørensen  et  al.,  2003;  Suvisaari  et  al.,
2013) or other mental disorders (Suvisaari et al., 2013). However, the previous studies
did not examine sex-specific associations. When interpreting the correspondence
between the current and previous findings, it should also be emphasised that we
identified disorders over four decades from early to late adulthood. The previous studies
examined disorders in samples that were much younger in age than our sample.
Hypertension without proteinuria
Maternal gestational hypertension did not have any significant effect on depressive
symptoms in the offspring. Contrary to the other original publications forming this
thesis, offspring born to mothers with chronic hypertension were excluded from the
analyses. The exclusion of those offspring born to mothers with chronic hypertension
may be arbitrary since not all women with antenatal data available had blood pressure
records taken before their 20th week of gestation. It may well be that some mothers
diagnosed as having gestational hypertension had elevated blood pressure prior to the
pregnancy or prior to the 20th week of gestation. Therefore, the analyses were re-run
with the inclusion of offspring born to mothers with any hypertension without
proteinuria, and as discussed above, with the offspring born preterm, but the results
remained unchanged.
Two previous studies tested whether maternal hypertension without proteinuria was
associated with sub-clinical symptoms and mental disorders in the offspring. In keeping
with the current findings,  a follow-up study of HBCS, where the offspring were tested
in late adulthood, showed that maternal hypertension without proteinuria was not
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consistently associated with adaptive functioning and psychiatric and psychological
problems in the offspring (Tuovinen et al., 2014). However, contrary to the current
findings, a previous study that followed the offspring up to childhood showed that
maternal gestational hypertension was associated with higher externalising behaviour
and internalising behaviour scores in the offspring (Robinson et al., 2009).
Maternal hypertension without proteinuria was associated with a higher risk for any
mental disorder and for a mood disorder, and also showed an association with a higher
risk  for  anxiety  disorder  in  the  offspring.  These  disorders  were  serious  and  were
identified  from  the  Finnish  nationwide  registers  of  hospitalisations  and  deaths  from
early to late adulthood. The differences in the mental health outcomes from this thesis
are discussed above and, hence, are not repeated here.
Two previous studies have tested the associations between maternal hypertension
without proteinuria during pregnancy and the risk of mental disorders in the offspring
(H. J. Sørensen et al., 2003; Suvisaari et al., 2013). Both studies reported associations
with a higher risk of schizophrenia. Overall, these are in line with the current findings.
5.3 Maternal hypertensive disorders during pregnancy and the
cognitive functioning of the offspring
Pre-eclampsia
Compared with the offspring who were born after normotensive pregnancies, offspring
born after pre-eclamptic pregnancies more frequently reported complaints related to
cognitive failures, distractibility and false triggering in late adulthood. No previous
studies have tested the long-term consequences of maternal pre-eclampsia on the
cognitive functioning of the offspring in late adulthood from a life-course perspective.
In general and in agreement with the findings, the only other study that has tested the
associations in adults reported that maternal pre-eclampsia was associated with poorer
cognitive functioning in the offspring in young adulthood (Ehrenstein et al., 2009).
Thirteen studies tested the associations between maternal pre-eclampsia and the
cognitive functioning of the offspring and followed the offspring up to childhood. In
agreement with our findings, six of these studies reported that maternal pre-eclampsia
was associated with poorer cognitive functioning in the offspring (Cheng et al., 2004;
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Leversen et al., 2011; Many et al., 2003; Morsing & Maršál, 2014; Spinillo et al., 1994;
Szymonowicz & Yu, 1987). However, in disagreement with the current findings, six of
the previous studies reported null associations or that the associations were rendered
non-significant after adjusting for covariates and confounders (Leitner et al., 2012;
Schlapbach et al., 2010; Seidman et al., 1991; Silveira et al., 2007; Whitehouse et al.,
2012), while one reported a potential beneficial effect of maternal pre-eclampsia on the
cognitive functioning of the offspring in childhood (Spinillo et al., 2009). When
interpreting the findings, it should be emphasised that, with the exception of two
analyses (Heikura et al., 2013; Whitehouse et al., 2012), these studies among children
were conducted in samples born preterm or with a small body size. This kind of sample
selection may affect the generalisability of the findings.
Pre-eclampsia was also associated with more frequent complaints of dysexecutive
functioning, behavioural–emotional self-regulation and executive cognition, but the
associations were attenuated or rendered non-significant when controlling for factors
that may increase the risk of pregnancy hypertensive disorders and/or cognitive aging. It
is of note that, whereas CFQ measures lapses in cognition in everyday life, DEX is
designed to measure behavioural executive dysfunctions. Executive functions generally
refer to ‘higher-level’ cognitive functions that are involved in the control and regulation
of ‘lower-level’ cognitive processes and goal-directed, future-oriented behaviour
(Alvarez & Emory, 2006). Our study sample possibly included the healthiest men and
women who were able to take part in the study and complete the self-reported
questionnaire. Our study did not reach those men and women who may have
experienced more frequent and more severe problems related to cognitive functioning.
This was also reflected in the relatively small number of study participants experiencing
stroke and with diagnoses of coronary heart disease.
Hypertension without proteinuria
Among women, maternal hypertension without proteinuria was associated with
cognitive failures, forgetfulness and false triggering. These associations were not seen
in men. Maternal hypertension without proteinuria was not significantly associated with
complaints of dysexecutive functioning.
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In general and in agreement with our findings, the only other study conducted among
adults reported that maternal hypertension without proteinuria was associated with
poorer cognitive functioning among offspring in young adulthood (Ehrenstein et al.,
2009). Four studies testing the associations followed the offspring up to childhood. In
agreement with our findings, three of them reported that maternal hypertension without
proteinuria was associated with poorer cognitive functioning among the offspring
(Heikura et al., 2013; Spinillo et al., 1994; Whitehouse et al., 2012), while one reported
null findings (Leitner et al., 2012).
Maternal hypertensive pregnancy disorders as a single diagnostic entity
In two of the original publications from this thesis, in order to attain more statistical
power, we used maternal hypertensive disorders as a single diagnostic entity as a
predictor variable. Compared with men born after normotensive pregnancies, men who
were born to mothers with any hypertensive disorders fared somewhat poorer on tests
measuring verbal and total cognitive ability in a follow-up conducted on average 20
years later. The offspring who were born to primiparous mothers or with a higher
childhood socio-economic status were particularly vulnerable to the adverse
consequences of maternal hypertensive disorders during pregnancy since their
performances were poorer on the verbal reasoning test than their counterparts born after
normotensive pregnancies.
Furthermore, compared with men born after normotensive pregnancies, men who
were born to mothers with any hypertensive disorders scored lower on tests measuring
arithmetic and total cognitive ability in late adulthood. They also displayed a greater
decline in arithmetic reasoning and total cognitive ability from young up to late
adulthood.
No previous study tested whether maternal hypertensive disorders during pregnancy
were associated with the cognitive ability of the offspring in old age, let alone a decline
in cognitive ability after young adulthood. Three previous studies tested whether
maternal hypertensive pregnancy disorders as a single diagnostic entity were associated
with the cognitive functioning of the offspring, but all followed the offspring up to
childhood. Furthermore, previous studies have been conducted among offspring born
very preterm or growth restricted. The findings from these studies disagree with the
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current findings, given that one reported null findings (Gray et al., 1998) and two found
that maternal hypertension was associated with better cognitive functioning in the
offspring (McCowan et al., 2002; Winer et al., 1982).
5.4 Moderation by sex, prematurity, parity and childhood socio-
economic status
Some  of  the  associations  reported  in  this  thesis  were  modified  by  sex,  parity  or
childhood socio-economic status. No previous studies tested whether some subgroups
were particularly vulnerable to the effects of maternal hypertensive disorders during
pregnancy. Thus, our findings also extend the previous findings in this way. First,
men—but  not  women—who  were  born  to  pre-eclamptic  mothers  had  a  lower  risk  of
mental disorders than their counterparts born to normotensive mothers. As discussed
above, one possibility is that the seriousness of pre-eclampsia is associated with more
effective parenting. It is of note that authoritative parenting (compared with uninvolved)
is more strongly associated with men’s psychological well-being than with women’s
(Rothrauff, Cooney, & An, 2009).
On the other hand, women—but not men—who were born to mothers with
hypertension without proteinuria reported more frequent complaints of cognitive
failures in late adulthood. This is contrary to the proposition that men might be more
vulnerable than women to the consequences of early environmental adversities (Barker,
1998). Although similar studies do not exist, previous research has consistently
demonstrated that women tend to have a higher incidence of dementia than men,
particularly Alzheimer’s disease (Gao, Hendrie, Hall, & Hui, 1998; Katz et al., 2012;
Launer et al., 1999). However, studies that have tested the cognitive functioning of
patients with Alzheimer’s disease have produced conflicting results; some studies report
that women have a higher incidence of cognitive impairment than men (Henderson &
Buckwalter, 1994) and some studies report no differences in cognition between the
sexes (Hebert et al., 2000). Moreover, studies that have tested cognitive aging in healthy
participants have produced conflicting results. Some studies report men showing greater
age-related cognitive decline (Maylor et al., 2007), while others report a faster decline
in  women  (Castro-Costa  et  al.,  2011;  Karlamangla  et  al.,  2009).  In  this  study  sample,
men and women did not differ in the mean frequency of complaints related to cognitive
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failures nor to dysexecutive functioning. This does not rule out developmental pathways
related to brain diseases nor that plausible early behavioural markers may differ based
on sex. It is of interest, however, that, in pregnancies complicated by asthma, a fetal
sex-specific effect on the maternal immune system in those carrying a female, but not a
male, fetus was found with adverse effects on placental functioning including reduced
placental 11β-HSD2 activity and female fetal growth (Murphy et al., 2003).
Second, primiparous offspring appeared to be particularly vulnerable to the adverse
consequences of maternal hypertensive disorders during pregnancy. Primiparous
offspring—but not multiparous offspring—who were born to mothers with pre-
eclampsia had higher depressive symptom scores compared to the offspring of
normotensive mothers. Indeed, there is evidence that pre-eclampsia may be qualitatively
different  in  primiparous  and  multiparous  pregnancies  (Allen  et  al.,  2004;  Luo  et  al.,
2007). However, it is also important to note that we found that pre-eclampsia was more
common among primi- (11%, n = 29) than multiparous pregnancies (3%, n = 8). Thus,
we clearly have more statistical power for detecting differences among primi- than
among multipara. However, the results also showed that primiparous offspring—but not
multiparous offspring—born to mothers with any hypertensive pregnancy disorders
scored lower on verbal reasoning in young adulthood compared to the offspring of
normotensive mothers. These latter analyses were limited to men.
Finally, men born to hypertensive mothers and coming from families with a high
childhood socio-economic status had lower verbal reasoning scores than their
counterparts who were born to normotensive mothers also with a higher childhood
socio-economic background. These associations were not seen among men coming from
families with a lower childhood socio-economic status. This may seem contradictory to
our expectations, but it suggests that a higher socio-economic status may not be
sufficient in buffering offspring from the adversities of the prenatal developmental
milieu.  One  should  also  keep  in  mind  that  men  with  a  low  childhood  socio-economic
position fared the poorest in cognitive tests regardless of their mother’s hypertensive
disorders. Thus, hypertensive disorders may not have additive ‘accumulating adversity’
effects on cognitive functioning above and beyond the effects of a lower social class.
However, because of the small sample sizes, all of these group-specific effects should
be interpreted with caution.
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5.5 Methodological considerations
This study represents the longest follow-up analysis of the consequences of maternal
hypertensive pregnancy disorders reported thus far. The strength of our study is the
large and well-characterised birth cohort. Yet, data on maternal hypertension and
proteinuria were only available for a subpopulation of this cohort. Therefore, sample
attrition may limit the generalisability of our findings if the associations between
maternal hypertensive disorders and the mental health and cognitive functioning of the
offspring were different between those for whom data were available and those for
whom data were missing. This seems unlikely, but cannot be discounted. In addition, it
is inevitable that individuals will be lost to follow-up across decades. This may
introduce a bias, since some of the findings (Study I, IV and V) may apply only to the
healthiest  men  and  women  who  have  survived  to  late  adulthood.  Furthermore,  some
findings  (Study  III  and  IV)  are  limited  to  men.  Moreover,  not  all  men  in  HBCS
underwent  the  cognitive  ability  test.  It  is  possible  that  men  born  to  mothers  with
hypertensive disorders during pregnancy were more likely exempt from military service
because of a chronic condition associated with perinatal events, such as mental
retardation or cerebral palsy. These aspects would, however, simply attenuate the
associations we observed.
Our data did not allow us to require two elevated blood pressure measurements to
establish diagnoses (American College of Obstetricians and Gynecologists & Task
Force on Hypertension in Pregnancy, 2013; National High Blood Pressure Education
Program Working Group on High Blood Pressure in Pregnancy, 2000). It is of note that
there were, on average, 2.0 blood pressure measurements recorded in each pregnancy.
However, as a possible consequence of this, the prevalence of hypertensive disorders of
33.3% was higher than that reported in the literature. Only qualitative measurements of
proteinuria were available for the diagnosis of pre-eclampsia. All the same, the 4.4%
prevalence for maternal pre-eclampsia in our sample is in line with the rates found in
other studies (National High Blood Pressure Education Program Working Group on
High Blood Pressure in Pregnancy, 2000; C. L. Roberts et al., 2005). We had no data on
eclampsia itself, which, when our study subjects were born, was common, with rates of
0.6% at the Helsinki University Central Hospital (Parviainen, 1946), and could be
associated with more severe consequences for the offspring. One of the most obvious
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methodological differences between existing studies is related to the criteria used in the
definition of maternal hypertensive pregnancy disorders. This methodological variation
mainly reflects the difference in birth year of the samples studied, since, as mentioned,
during the 20th and 21st centuries, disease classifications have undergone various
revisions (Bell, 2010). Only three of the studies reviewed in this thesis reported using
current clinical criteria to define pre-eclampsia (Table 1, page 20) (Leversen et al., 2011;
Schlapbach et al., 2010; Silveira et al., 2007).
We were able to compare the offspring born to mothers with pre-eclampsia or
hypertension without proteinuria to the offspring born to normotensive mothers. Of the
studies reviewed focusing on cognitive functioning, seven reported using offspring born
to non-pre-eclamptic mothers as the comparison group (Leversen et al., 2011; Many et
al., 2003; Morsing & Maršál, 2014; Schlapbach et al., 2010; Seidman et al., 1991;
Silveira et al., 2007; Szymonowicz & Yu, 1987). Of those studies focusing on mental
disorders and symptoms, six used offspring born to non-pre-eclamptic mothers as the
comparison group (Dalman et al., 2001; Eide et al., 2013; Jones et al., 1998; H. J.
Sørensen et al., 2003; Suvisaari et al., 2013; Zammit et al., 2009). In these studies, the
comparison group may have included offspring born to mothers with gestational or
chronic hypertension.
We had no data on medication use for individual mothers; however, at that time, the
care given was mainly expectant management. Glucocorticoid treatment was not known;
chloral hydrate was administered to patients at risk for convulsions. A small number, if
any, of the mothers may have received magnesium sulphate, given that the first
treatment was administered in Helsinki in 1943 (Tarkiainen, 1946). We do not have data
on the treatment that the mothers or their babies received. Limited neonatal care, in
addition to the limited availability of medications at that time, may restrict the
generalisability of our findings to babies born in high-resource settings more recently.
The reviewed studies did not systematically report on either the medications or the care
the  mothers  and  the  offspring  may  have  received,  and,  thus,  do  not  allow  for  a
discussion of the possible effects of these factors.
We examined a wide variety of psychological functions with well-validated methods.
However, the results derived from questionnaires (depressive symptoms, Study I;
cognitive impairment, Study V) reflect the subjective views of the respondents. Thus,
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they may not reflect the absolute levels of symptoms and everyday competence, but
only the relative success of individuals’ adaptations to idiosyncratic environments. Yet,
subjective self-ratings may allow us to gain insight into any changes and individual
differences in psychological well-being and functional efficiency in everyday life.
Mental disorders (Study II) were identified from the Finnish nationwide registers of
hospitalisations  and  deaths.  While  HDR  and  CDR  are  valid  and  reliable  tools  for
epidemiological research, this may not pertain to all of the mental disorder diagnoses.
The magnitude of some of the differences in cognitive functioning and mental health
between the offspring who were born to normotensive and hypertensive mothers may be
relatively modest, despite being statistically significant. However, they may translate
into highly significant and meaningful differences over the course of one’s life.
Focusing on different domains of mental health and cognition and variations in the
methods for measuring mental health and cognition may explain the contradictions
between current and previous findings. Among the studies that tested mental disorders
and symptoms, five studies focused on serious mental disorders identified from registers
(Dalman et al., 2001; Eide et al., 2013; Jones et al., 1998; H. J. Sørensen et al., 2003;
Suvisaari et al., 2013), while three studies focused on maternal (Robinson et al., 2009)
and self-ratings (Tuovinen et al., 2014) and psychiatric interviews (Zammit et al., 2009)
as tools to measure sub-clinical symptoms and mental disorders, and, hence, also
address symptoms and disorders that do not require hospital treatment or contribute to
death. The majority of studies—six, in fact—focused mainly on schizophrenia (Dalman
et al., 2001; Eide et al., 2013; Jones et al., 1998; H. J. Sørensen et al., 2003; Suvisaari et
al., 2013) or psychotic symptoms in the offspring (Zammit et al., 2009), while one study
tested a variety of psychiatric and psychological problems and adaptive functioning
(Tuovinen et al., 2014) and one study focused on internalising and externalising
behaviour among the offspring (Robinson et al., 2009). The current studies were the
first to our knowledge to examine cognitive decline and impairment after prenatal
exposure to maternal hypertensive pregnancy disorders. Among previous studies that
tested cognitive functioning, nine studies focused on full-scale or specific domains of
intelligence (Ehrenstein et al., 2009; Gray et al., 1998; Heikura et al., 2013; Leitner et
al., 2012; Leversen et al., 2011; Many et al., 2003; Morsing & Maršál, 2014; Seidman et
al., 1991; Whitehouse et al., 2012), while seven studies focused on the level of mental
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development in the offspring (Cheng et al., 2004; McCowan et al., 2002; Schlapbach et
al., 2010; Silveira et al., 2007; Spinillo et al., 1994; Spinillo et al., 2009; Szymonowicz
& Yu, 1987). Naturally, methods for measuring cognition are also partially age-specific,
making it impossible to utilise the same methods for individuals at different ages. This
complicates comparisons between studies.
The possible mechanisms involved are discussed above. In addition, environmental
factors may contribute to associations between maternal hypertensive pregnancy
disorders and the psychological functioning of the offspring. The risk and protective
factors for pre-eclampsia and hypertension without proteinuria are stated in section
1.2.5.  Among  these  factors,  maternal  obesity  (Van  Lieshout  et  al.,  2011),  smoking
(Braun, Daniels, Kalkbrenner, Zimmerman, & Nicholas, 2009; Heinonen et al., 2011)
and prenatal stress and anxiety (Bergman, Sarkar, O'Connor, Modi, & Glover, 2007;
Buitelaar, Huizink, Mulder, de Medina, & Visser, 2003; Pesonen, Räikkönen,
Strandberg, & Järvenpää, 2005; Van den Bergh, Van Calster, Smits, Huffel, & Lagae,
2008; Watson, Mednick, Huttunen, & Wang, 1999) are, in turn, associated with less
optimal developmental outcomes in the offspring. Maternal age has been associated
with both poorer (Chapman, Scott, & Mason, 2002) and better developmental outcomes
(Fergusson & Lynskey, 1993). Moreover, both low (Silva et al., 2008) and high
(Gudmundsson et al., 1997) socio-economic statuses are associated with a higher risk of
pre-eclampsia. Low childhood socio-economic status is a significant predictor of poorer
cognitive and mental health outcomes among offspring (Hackman & Farah, 2009;
McLaughlin et al., 2011). Furthermore, hypertensive pregnancy disorders often require
preterm delivery and result in a lower birth weight of the babies, and as reviewed,
preterm birth and low birth weight are known risk factors for poorer cognitive
functioning and mental health. Our data allowed us to adjust for a number of covariates
and confounding factors including offspring characteristics at birth and maternal
constitutional factors. With the exception of associations between maternal
hypertension without proteinuria and dysexecutive functioning of the offspring, the
significant findings were virtually identical between the unadjusted and adjusted models.
Thus, in general, the associations were not explained by these factors.
However, we did not have data available on maternal stress and anxiety and smoking
during pregnancy. While we also do not have exact figures, data on the incidence of
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lung cancer in women suggest that smoking during pregnancy between the years of
1934–44 was uncommon in Finland (Finnish Cancer Registry - Institute for Statistical
and Epidemiological Cancer Research, 2009). Furthermore, complications around the
time of birth may increase the risk of postpartum depression (Duley, 2009). Postpartum
depression may compromise maternal sensitivity to the infant’s needs, influence the
developing mother–child attachment relationship and, thereby, increase the risk of
adverse outcomes in the offspring. We did not have data on maternal postpartum
psychopatology nor on paternal psychopatology. Thus, it is possible that, to some extent,
these factors explain the findings.
Most studies reviewed have failed to take into account significant covariates and
confounders. However, some studies have accounted for maternal and/or family
characteristics, while others have accounted for offspring characteristics at birth or at
assessment (see Tables 15–16 in the Appendix). Given that the covariates and
confounders taken into account in studies vary, it is difficult to interpret the effects of
individual covariates and confounders.
Finally, interpreting our findings in relation to previous findings may present a
challenge related to statistical power and publication bias. Statistical power refers to the
probability  that  a  test  will  find  a  statistically  significant  difference  when  such  a
difference actually exists. Many of the studies reviewed were conducted in relatively
small samples. Null findings may, therefore, reflect a lack of statistical power rather
than  a  true  lack  of  association.  In  addition,  in  our  studies,  the  numbers  of  exposed
offspring were relatively small, particularly for subgroup-specific analyses. Publication
bias is also a possibility and should be taken into account when interpreting the findings
between our studies and the studies reviewed. This refers to the bias in what is
published among what is available to publish. This is usually manifest in a bias towards
reporting significant results.
5.6 Implications of the study
The findings reported here conducted in a general population showed that maternal
hypertensive pregnancy disorders carry an increased risk of a wide spectrum of
problems related to the mental well-being and cognitive functioning of offspring several
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decades later. These problems are burdensome because of their chronicity and because
they often result in serious impairment or impact one’s quality of life in multiple ways.
The current findings highlight the importance of preventing hypertensive pregnancy
disorders. The risk factors for pre-eclampsia and other hypertensive pregnancy diseases
are well documented (Duckitt & Harrington, 2005; Poon et al., 2010). However, the
etiology remains unknown. Despite several randomised trials reporting the use of
various methods to reduce the rate or severity (or both) of these conditions, there is no
specific method for preventing these maternal conditions (Abalos, Duley, Steyn, &
Henderson-Smart, 2001; Sibai et al., 2005). That said, a few modifiable risk factors
exist. One of these is maternal BMI; a higher BMI is associated with an increased risk
of both pre-eclampsia and hypertension in pregnancy. According to one overview of
increasing  BMI  and  the  risk  of  pre-eclampsia,  consideration  should  be  given  to  the
potential benefits of pre-pregnancy weight-reduction programmes (O'Brien, Ray, &
Chan, 2003). In addition, psychological risk factors such as stress, depression and
anxiety seem to be positively associated with hypertensive pregnancy disorders (Kurki
et al., 2000; Paarlberg et al., 1995; Qiu et al., 2009). Preventing these risk factors should
be considered. Thus far, adequate and proper prenatal care is the most important factor
in the management of pre-eclampsia and hypertension (Sibai et al., 2005) and mitigating
the consequences for both the mother and the child.
Most of the current findings cannot be directly translated into clinical
recommendations. However, they highlight the role of prenatal events as factors that
may help to identify high-risk children and families who could benefit from targeted
interventions early in life. The postnatal environmental effect can override any prenatal
adversities since the brain continues to develop after birth and ‘the windows of
opportunity’ remain open (Buss et al., 2007; Lupien et al., 2009). Such potential
postnatal environmental effects may include sensitive parenting (C. A. Newnham,
Milgrom, & Skouteris, 2009; Nordhov et al., 2010).
A few protective effects related to maternal hypertensive disorders on the offspring’s
psychological development were found. It should be noted that not all of the effects are
necessarily adverse, and it is important to unravel these developmental pathways.
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The causes of adverse mental health and cognitive outcomes are generally complex
and vary between disorders and individuals. Maternal hypertensive disorders may add
to the known risk factors for these psychological conditions and point to mechanisms by
which prenatal adversity is associated with these problems in subsequent life. This may
be crucial for clinicians in both understanding these conditions and in planning care.
5.7 Future directions
Given that maternal hypertensive pregnancy disorders may be associated with poorer
mental health and cognitive ability among offspring, future studies should focus on
finding a way to prevent these maternal conditions and addressing the impact of
preventive interventions in the treatment of mental health problems and poor cognitive
functioning.
In addition, due to the concerns addressed in this thesis, further studies are needed
that will test the associations between maternal hypertensive pregnancy disorders and
psychological outcomes among offspring in larger samples using the current clinical
criteria of pre-eclampsia and gestational hypertension. Further studies are also needed to
test whether the findings translate into significant improvements among cohorts born
recently, vis-à-vis the treatment of pre-eclampsia and hypertension as well as neonatal
care, accomplished in recent decades. Future studies should assess whether the
associations reflect the true causal effects of hypertensive pregnancy disorders, either
attributed to the complications of hypertensive disorders or across a range of severities
of hypertensive disorders. One challenge for future studies lies in unraveling the
maternal, placental and fetal mechanisms through which maternal hypertensive
pregnancy disorders affect the offspring.
5.8 Conclusions
The findings from this thesis show that the adult offspring born to mothers with pre-
eclampsia or hypertension without proteinuria during pregnancy differ from their peers
born after normotensive pregnancies in several areas of mental health and cognitive
functioning. In comparison to the offspring born to normotensive mothers, offspring
born to pre-eclamptic mothers showed higher cognitive impairment, and offspring born
to mothers with hypertension without proteinuria showed a higher risk of mental
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disorders, although they did not differ in the severity of depressive symptoms. Maternal
hypertensive pregnancy disorders as a diagnostic entity were associated with a lower
cognitive functioning and a higher cognitive decline in the offspring. Sex, parity and
childhood socio-economic status modified some of the associations. Maternal pre-
eclampsia was associated with higher depressive symptom scores in primiparous—but
not in multiparous—offspring and with a lower risk of mental disorders in male—but
not female—offspring. Maternal hypertension without proteinuria was associated with
cognitive impairment in female—but not male—offspring. Finally, the associations
between maternal hypertensive pregnancy disorders as a diagnostic entity and lower
cognitive functioning in young adulthood were most evident in primiparous offspring
and in offspring with a high childhood socio-economic status. The associations were not
explained by factors associated with the risk of maternal hypertensive pregnancy
disorders and/or psychological functioning, such as the mother’s age and obesity, and
socio-economic status in childhood. The associations were identified even after
accounting for birth weight for gestational age and gestational age, suggesting that the
associations are not likely solely explained by these complications related to
hypertensive pregnancy disorders.
These studies contribute significantly to the existing literature given that they
represent the longest follow-up analysis of transgenerational consequences of maternal
hypertensive disorders reported thus far in the literature. The findings highlight the role
of the prenatal environment in developmental programming. Interpretation of the
current findings in relation to previous findings may suggest a causal chain linking
intrauterine exposure to maternal hypertensive pregnancy disorders with a vulnerability
to childhood and adolescent risk factors and, thus, to poorer mental health and cognitive
functioning in adulthood. Alternatively, it is possible that the associations arise during
the course of one’s lifetime.
107
6 REFERENCES
Abalos, E., Duley, L., Steyn, D. W., & Henderson-Smart, D. J. (2001). Antihypertensive drug therapy for
mild to moderate hypertension during pregnancy. The Cochrane Database of Systematic Reviews,
CD002252.
Abel, K. M., Wicks, S., Susser, E. S., Dalman, C., Pedersen, M. G., Mortensen, P. B., & Webb, R. T.
(2010). Birth weight, schizophrenia, and adult mental disorder: Is risk confined to the smallest
babies? Archives of General Psychiatry, 67, 923–930.
Aberg, K. A., McClay, J. L., Nerella, S., Clark, S., Kumar, G., Chen, W., . . . van den Oord, E. J. (2014).
Methylome-wide association study of schizophrenia: Identifying blood biomarker signatures of
environmental insults. JAMA Psychiatry, 71, 255–264.
Alati, R., Lawlor, D. A., Mamun, A. A., Williams, G. M., Najman, J. M., O'Callaghan, M., & Bor, W.
(2007). Is there a fetal origin of depression? evidence from the mater university study of pregnancy
and its outcomes. American Journal of Epidemiology, 165, 575–582.
Ales, K. L., & Charlson, M. E. (1991). Epidemiology of preeclampsia and eclampsia. American Journal
of Obstetrics and Gynecology, 165, 238.
Allen, V. M., Joseph, K., Murphy, K. E., Magee, L. A., & Ohlsson, A. (2004). The effect of hypertensive
disorders in pregnancy on small for gestational age and stillbirth: A population based study. BMC
Pregnancy and Childbirth, 4, 17.
Alvarez, J. A., & Emory, E. (2006). Executive function and the frontal lobes: A meta-analytic review.
Neuropsychology Review, 16, 17–42.
American College of Obstetricians and Gynecologists, & Task Force on Hypertension in Pregnancy.
(2013). Hypertension in pregnancy. Report of the American College of Obstetricians and
Gynecologists' Task Force on Hypertension in Pregnancy. Obstetrics and Gynecology, 122, 1122–
1131.
Ananth, C. V., Savitz, D. A., Luther, E. R., & Bowes, W. A. Jr. (1997). Preeclampsia and preterm birth
subtypes in nova scotia, 1986 to 1992. American Journal of Perinatology, 14, 17–23.
Ananth, C. V., & Vintzileos, A. M. (2006). Maternal-fetal conditions necessitating a medical intervention
resulting in preterm birth. American Journal of Obstetrics and Gynecology, 195, 1557–1563.
108
Aufdenblatten, M., Baumann, M., Raio, L., Dick, B., Frey, B. M., Schneider, H., . . . Mohaupt, M. G.
(2009). Prematurity is related to high placental cortisol in preeclampsia. Pediatric Research, 65,
198–202.
Bakker, R., Steegers, E. A., Hofman, A., & Jaddoe, V. W. (2011). Blood pressure in different gestational
trimesters, fetal growth, and the risk of adverse birth outcomes: The generation R study. American
Journal of Epidemiology, 174, 797–806.
Barker, D. J. (1994). The fetal origins of adult disease. Fetal and Maternal Medicine Review, 6, 71–80.
Barker, D. J. (1995). Fetal origins of coronary heart disease. British Medical Journal (Clinical Research
Ed.), 311, 171–174.
Barker, D. J. (1998). Mothers, babys and health in later life (2nd ed.). Edinburgh: Churchill Livingstone.
Barker, D. J. (2004). Developmental origins of adult health and disease. Journal of Epidemiology and
Community Health, 58, 114–115.
Barker, D. J., & Edwards, J. H. (1967). Obstetric complications and school performance. British Medical
Journal, 3, 695–699.
Barker, D. J., Hales, C. N., Fall, C. H., Osmond, C., Phipps, K., & Clark, P. M. (1993). Type 2 (non-
insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to
reduced fetal growth. Diabetologia, 36, 62–67.
Barker, D. J., & Osmond, C. (1986). Infant mortality, childhood nutrition, and ischaemic heart disease in
england and wales. Lancet, 1, 1077–1081.
Barker, D. J., Osmond, C., Forsén, T. J., Kajantie, E., & Eriksson, J. G. (2005). Trajectories of growth
among children who have coronary events as adults. The New England Journal of Medicine, 353,
1802–1809.
Barker, D. J., Winter, P. D., Osmond, C., Margetts, B., & Simmonds, S. J. (1989). Weight in infancy and
death from ischaemic heart disease. Lancet, 2, 577–580.
Basso, O., Rasmussen, S., Weinberg, C. R., Wilcox, A. J., Irgens, L. M., & Skjærven, R. (2006). Trends
in fetal and infant survival following preeclampsia. The Journal of the American Medical
Association, 296, 1357–1362.
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988). Psychometric properties of the beck depression
inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8, 77–100.
109
Bell, M. J. (2010). A historical overview of preeclampsia-eclampsia. Journal of Obstetric, Gynecologic,
and Neonatal Nursing, 39, 510–518.
Belsky, J., & Pluess, M. (2009). Beyond diathesis stress: Differential susceptibility to environmental
influences. Psychological Bulletin, 135, 885–908.
Benediktsson, R., Calder, A. A., Edwards, C. R., & Seckl, J. R. (1997). Placental 11 beta-hydroxysteroid
dehydrogenase: A key regulator of fetal glucocorticoid exposure. Clinical Endocrinology, 46, 161–
166.
Bergman, K., Sarkar, P., O'Connor, T. G., Modi, N., & Glover, V. (2007). Maternal stress during
pregnancy predicts cognitive ability and fearfulness in infancy. Journal of the American Academy of
Child and Adolescent Psychiatry, 46, 1454–1463.
Berle, J. O., Mykletun, A., Daltveit, A. K., Rasmussen, S., & Dahl, A. A. (2006). Outcomes in adulthood
for children with foetal growth retardation. A linkage study from the nord-trondelag health study
(HUNT) and the medical birth registry of norway. Acta Psychiatrica Scandinavica, 113, 501–509.
Bertram, C. E., & Hanson, M. A. (2001). Animal models and programming of the metabolic syndrome.
British Medical Bulletin, 60, 103–121.
Bhutta, A. T., Cleves, M. A., Casey, P. H., Cradock, M. M., & Anand, K. J. (2002). Cognitive and
behavioral outcomes of school-aged children who were born preterm: A meta-analysis.  The Journal
of the American Medical Association, 288, 728–737.
Bijl, R. V., Ravelli, A., & van Zessen, G. (1998). Prevalence of psychiatric disorder in the general
population: Results of the netherlands mental health survey and incidence study (NEMESIS). Social
Psychiatry and Psychiatric Epidemiology, 33, 587–595.
Blazer, D. G. (2003). Depression in late life: Review and commentary. The Journals of
Gerontology.Series A, Biological Sciences and Medical Sciences, 58, 249–265.
Bogren, M., Mattisson, C., Isberg, P. E., & Nettelbladt, P. (2009). How common are psychotic and
bipolar disorders? A 50-year follow-up of the lundby population. Nordic Journal of Psychiatry, 63,
336–346.
Boyce, W. T., & Ellis, B. J. (2005). Biological sensitivity to context: I. an evolutionary-developmental
theory of the origins and functions of stress reactivity. Development and Psychopathology, 17, 271–
301.
110
Braun, J. M., Daniels, J. L., Kalkbrenner, A., Zimmerman, J., & Nicholas, J. S. (2009). The effect of
maternal smoking during pregnancy on intellectual disabilities among 8-year-old children.
Paediatric and Perinatal Epidemiology, 23, 482–491.
Broadbent, D. E., Cooper, P. F., FitzGerald, P., & Parkes, K. R. (1982). The cognitive failures
questionnaire (CFQ) and its correlates. The British Journal of Clinical Psychology / the British
Psychological Society, 21, 1–16.
Brusse, I., Duvekot, J., Jongerling, J., Steegers, E., & De Koning, I. (2008). Impaired maternal cognitive
functioning after pregnancies complicated by severe pre-eclampsia: A pilot case-control study.  Acta
Obstetricia Et Gynecologica Scandinavica, 87, 408–412.
Buchbinder, A., Sibai, B. M., Caritis, S., Macpherson, C., Hauth, J., Lindheimer, M. D., . . . National
Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
(2002). Adverse perinatal outcomes are significantly higher in severe gestational hypertension than
in mild preeclampsia. American Journal of Obstetrics and Gynecology, 186, 66–71.
Buitelaar, J. K., Huizink, A. C., Mulder, E. J., de Medina, P. G., & Visser, G. H. (2003). Prenatal stress
and cognitive development and temperament in infants. Neurobiology of Aging, 24 Suppl 1, 53–60;
discussion 67–68.
Burgess, P. W., Alderman, N., Evans, J., Emslie, H., & Wilson, B. A. (1998). The ecological validity of
tests of executive function. Journal of the International Neuropsychological Society , 4, 547–558.
Buss, C., Lord, C., Wadiwalla, M., Hellhammer, D. H., Lupien, S. J., Meaney, M. J., & Pruessner, J. C.
(2007). Maternal care modulates the relationship between prenatal risk and hippocampal volume in
women but not in men. The Journal of Neuroscience: The Official Journal of the Society for
Neuroscience, 27, 2592–2595.
Byrne, M., Agerbo, E., Bennedsen, B., Eaton, W. W., & Mortensen, P. B. (2007). Obstetric conditions
and risk of first admission with schizophrenia: A danish national register based study.
Schizophrenia Research, 97, 51–59.
Cannon, M., Jones, P. B., & Murray, R. M. (2002). Obstetric complications and schizophrenia: Historical
and meta-analytic review. The American Journal of Psychiatry, 159, 1080–1092.
Carty, D. M., Delles, C., & Dominiczak, A. F. (2010). Preeclampsia and future maternal health.  Journal
of Hypertension, 28, 1349–1355.
Castro-Costa, E., Dewey, M. E., Uchoa, E., Firmo, J. O., Lima-Costa, M. F., & Stewart, R. (2011).
Trajectories of cognitive decline over 10 years in a brazilian elderly population: The Bambui Cohort
111
Study of Aging. Cadernos De Saude Publica / Ministerio Da Saude, Fundacao Oswaldo Cruz,
Escola Nacional De Saude Publica, 27 Suppl 3, 345–350.
Central Statistical Office of Finland. (1939). 6 väestötilastoa : 90 kuolemansyyt vuosina 1936–1937.
[causes of death in 1936–1937, in Finnish]. Helsinki [Tilastollinen päätoimisto]: Valtioneuvoston
kirjapaino. Retrieved January 30, 2014, from Central Statistical Office of Finland website:
http://www.doria.fi/bitstream/handle/10024/67225/ksyyt90_1936–1937.pdf?sequence=1.
Cervilla, J., Prince, M., Joels, S., Lovestone, S., & Mann, A. (2004). Premorbid cognitive testing predicts
the onset of dementia and alzheimer's disease better than and independently of APOE genotype.
Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1100–1106.
Chapman, D. A., Scott, K. G., & Mason, C. A. (2002). Early risk factors for mental retardation: Role of
maternal age and maternal education. American Journal of Mental Retardation , 107, 46–59.
Cheng, S. W., Chou, H. C., Tsou, K. I., Fang, L. J., & Tsao, P. N. (2004). Delivery before 32 weeks of
gestation for maternal pre-eclampsia: Neonatal outcome and 2-year developmental outcome.  Early
Human Development, 76, 39–46.
Chesley, L. C. (1984). History and epidemiology of preeclampsia-eclampsia. Clinical Obstetrics and
Gynecology, 27, 801–820.
Cheung, Y. B., Khoo, K. S., Karlberg, J., & Machin, D. (2002). Association between psychological
symptoms in adults and growth in early life: Longitudinal follow up study. British Medical Journal
(Clinical Research Ed.), 325, 749.
Collins, P. Y., Patel, V., Joestl, S. S., March, D., Insel, T. R., Daar, A. S., . . . Stein, D. J. (2011). Grand
challenges in global mental health. Nature, 475, 27–30.
Conde-Agudelo, A., Althabe, F., Belizan, J. M., & Kafury-Goeta, A. C. (1999). Cigarette smoking during
pregnancy and risk of preeclampsia: A systematic review. American Journal of Obstetrics and
Gynecology, 181, 1026–1035.
Conradt, E., Lester, B. M., Appleton, A. A., Armstrong, D. A., & Marsit, C. J. (2013). The roles of DNA
methylation of NR3C1 and 11beta-HSD2 and exposure to maternal mood disorder in utero on
newborn neurobehavior. Epigenetics: Official Journal of the DNA Methylation Society, 8, 1321–
1329.
Conti, E., Zezza, L., Ralli, E., Caserta, D., Musumeci, M. B., Moscarini, M., . . . Volpe, M. (2013).
Growth factors in preeclampsia: A vascular disease model. A failed vasodilation and angiogenic
challenge from pregnancy onwards? Cytokine & Growth Factor Reviews, 24, 411–425.
112
Cooper, C., Javaid, M. K., Taylor, P., Walker-Bone, K., Dennison, E., & Arden, N. (2002). The fetal
origins of osteoporotic fracture. Calcified Tissue International, 70, 391–394.
Costello, E. J., Worthman, C., Erkanli, A., & Angold, A. (2007). Prediction from low birth weight to
female adolescent depression: A test of competing hypotheses.  Archives of General Psychiatry, 64,
338–344.
Dalman, C., Allebeck, P., Cullberg, J., Grunewald, C., & Koster, M. (1999). Obstetric complications and
the risk of schizophrenia: A longitudinal study of a national birth cohort. Archives of General
Psychiatry, 56, 234–240.
Dalman, C., Thomas, H. V., David, A. S., Gentz, J., Lewis, G., & Allebeck, P. (2001). Signs of asphyxia
at birth and risk of schizophrenia. population-based case-control study. The British Journal of
Psychiatry: The Journal of Mental Science, 179, 403–408.
Davis, E. P., Sandman, C. A., Buss, C., Wing, D. A., & Head, K. (2013). Fetal glucocorticoid exposure is
associated with preadolescent brain development. Biological Psychiatry, 74, 647–655.
Deary, I. J., Strand, S., Smith, P., & Fernandes, C. (2007). Intelligence and educational achievement.
Intelligence, 35, 13–21.
Demyttenaere, K., Bruffaerts, R., Posada-Villa, J., Gasquet, I., Kovess, V., Lepine, J. P., . . . WHO World
Mental Health Survey Consortium. (2004). Prevalence, severity, and unmet need for treatment of
mental disorders in the world health organization world mental health surveys. The Journal of the
American Medical Association, 291, 2581–2590.
Dobbing, J., & Sands, J. (1979). Comparative aspects of the brain growth spurt. Early Human
Development, 3, 79–83.
Duckitt, K., & Harrington, D. (2005). Risk factors for pre-eclampsia at antenatal booking: Systematic
review of controlled studies. British Medical Journal (Clinical Research Ed.), 330, 565.
Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 33, 130–
137.
Edwards, C. A., Osman, L. M., Godden, D. J., Campbell, D. M., & Douglas, J. G. (2003). Relationship
between birth weight and adult lung function: Controlling for maternal factors. Thorax, 58, 1061–
1065.
113
Ehrenstein, V., Rothman, K. J., Pedersen, L., Hatch, E. E., & Sørensen, H. T. (2009). Pregnancy-
associated hypertensive disorders and adult cognitive function among danish conscripts. American
Journal of Epidemiology, 170, 1025–1031.
Eide, M. G., Moster, D., Irgens, L. M., Reichborn-Kjennerud, T., Stoltenberg, C., Skjærven, R., . . . Abel,
K. (2013). Degree of fetal growth restriction associated with schizophrenia risk in a national cohort.
Psychological Medicine, 43, 2057–2066.
Erickson, K., Kritz-Silverstein, D., Wingard, D. L., & Barrett-Connor, E. (2010). Birth weight and
cognitive performance in older women: The rancho bernardo study. Archives of Women's Mental
Health, 13, 141–146.
Eriksson, J. G., Forsén, T., Tuomilehto, J., Osmond, C., & Barker, D. J. (2000). Early growth, adult
income, and risk of stroke. Stroke; a Journal of Cerebral Circulation, 31, 869–874.
Eskild, A., Romundstad, P. R., & Vatten, L. J. (2009). Placental weight and birthweight: Does the
association differ between pregnancies with and without preeclampsia? American Journal of
Obstetrics and Gynecology, 201, 595.e1–595.e5.
Fazel, S., Bakiyeva, L., Cnattingius, S., Grann, M., Hultman, C. M., Lichtenstein, P., & Geddes, J. R.
(2012). Perinatal risk factors in offenders with severe personality disorder: A population-based
investigation. Journal of Personality Disorders, 26, 737–750.
Fergusson, D. M., & Lynskey, M. T. (1993). Maternal age and cognitive and behavioural outcomes in
middle childhood. Paediatric and Perinatal Epidemiology, 7, 77–91.
Ferrazzani, S., Luciano, R., Garofalo, S., D'Andrea, V., De Carolis, S., De Carolis, M. P., . . . Caruso, A.
(2011). Neonatal outcome in hypertensive disorders of pregnancy. Early Human Development, 87,
445–449.
Finnish Cancer Registry - Institute for Statistical and Epidemiological Cancer Research. (2009). Cancer
in Finland 2006 and 2007. Cancer statistics of the national institute for health and welfare (THL).
Helsinki: Cancer Society of Finland.
Flenady, V., Koopmans, L., Middleton, P., Froen, J. F., Smith, G. C., Gibbons, K., . . . Ezzati, M. (2011).
Major risk factors for stillbirth in high-income countries: A systematic review and meta-analysis.
Lancet, 377, 1331–1340.
Forsdahl, A. (1977). Are poor living conditions in childhood and adolescence an important risk factor for
arteriosclerotic heart disease? British Journal of Preventive & Social Medicine, 31, 91–95.
114
Frankel, S., Elwood, P., Sweetnam, P., Yarnell, J., & Smith, G. D. (1996). Birthweight, body-mass index
in middle age, and incident coronary heart disease. Lancet, 348, 1478–1480.
Gale, C. R., & Martyn, C. N. (2004). Birth weight and later risk of depression in a national birth cohort.
The British Journal of Psychiatry: The Journal of Mental Science, 184, 28–33.
Gao, S., Hendrie, H. C., Hall, K. S., & Hui, S. (1998). The relationships between age, sex, and the
incidence of dementia and alzheimer disease: A meta-analysis. Archives of General Psychiatry, 55,
809–815.
Geddes, J. R., Verdoux, H., Takei, N., Lawrie, S. M., Bovet, P., Eagles, J. M., . . . Murray, R. M. (1999).
Schizophrenia and complications of pregnancy and labor: An individual patient data meta-analysis.
Schizophrenia Bulletin, 25, 413–423.
Geerlings, M. I., Jonker, C., Bouter, L. M., Ader, H. J., & Schmand, B. (1999). Association between
memory complaints and incident alzheimer's disease in elderly people with normal baseline
cognition. The American Journal of Psychiatry, 156, 531–537.
Gennser, G., Rymark, P., & Isberg, P. E. (1988). Low birth weight and risk of high blood pressure in
adulthood. British Medical Journal (Clinical Research Ed.), 296, 1498–1500.
Gluckman, P. D., & Hanson, M. A. (2004). Developmental origins of disease paradigm: A mechanistic
and evolutionary perspective. Pediatric Research, 56, 311–317.
Gray, P. H., O'Callaghan, M. J., Mohay, H. A., Burns, Y. R., & King, J. F. (1998). Maternal hypertension
and neurodevelopmental outcome in very preterm infants. Archives of Disease in Childhood.Fetal
and Neonatal Edition, 79, 88–93.
Gudmundsson, S., Björgvinsdóttir, L., Molin, J., Gunnarsson, G., & Maršál, K. (1997). Socioeconomic
status and perinatal outcome according to residence area in the city of malmo. Acta Obstetricia Et
Gynecologica Scandinavica, 76, 318–323.
Hackman, D. A., & Farah, M. J. (2009). Socioeconomic status and the developing brain. Trends in
Cognitive Sciences, 13, 65–73.
Hales, C. N., & Barker, D. J. (1992). Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty
phenotype hypothesis. Diabetologia, 35, 595–601.
Harris, A., & Seckl, J. (2011). Glucocorticoids, prenatal stress and the programming of disease.
Hormones and Behavior, 59, 279–289.
115
Hart, C. L., Taylor, M. D., Smith, G. D., Whalley, L. J., Starr, J. M., Hole, D. J., . . . Deary, I. J. (2004).
Childhood IQ and cardiovascular disease in adulthood: Prospective observational study linking the
scottish mental survey 1932 and the midspan studies. Social Science & Medicine, 59, 2131–2138.
Hebert, L. E., Wilson, R. S., Gilley, D. W., Beckett, L. A., Scherr, P. A., Bennett, D. A., & Evans, D. A.
(2000). Decline of language among women and men with alzheimer's disease.  The Journals of
Gerontology.Series B, Psychological Sciences and Social Sciences, 55, 354–60.
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., . . . Lumey, L. H. (2008).
Persistent epigenetic differences associated with prenatal exposure to famine in humans.
Proceedings of the National Academy of Sciences of the United States of America, 105, 17046–
17049.
Heikura, U., Hartikainen, A. L., Nordstrom, T., Pouta, A., Taanila, A., & Jarvelin, M. R. (2013). Maternal
hypertensive disorders during pregnancy and mild cognitive limitations in the offspring. Paediatric
and Perinatal Epidemiology, 27, 188–198.
Heinonen, K., Räikkönen, K., Pesonen, A. K., Andersson, S., Kajantie, E., Eriksson, J. G., . . . Lano, A.
(2011). Longitudinal study of smoking cessation before pregnancy and children's cognitive abilities
at 56 months of age. Early Human Development, 87, 353–359.
Henderson, V. W., & Buckwalter, J. G. (1994). Cognitive deficits of men and women with alzheimer's
disease. Neurology, 44, 90–96.
Himmelmann, K., Himmelmann, A., Niklasson, A., & Svensson, A. (1996). Hypertension in pregnancy
and size at birth. Blood Pressure, 5, 278–284.
Hirshfeld-Becker, D. R., Biederman, J., Faraone, S. V., Robin, J. A., Friedman, D., Rosenthal, J. M., &
Rosenbaum, J. F. (2004). Pregnancy complications associated with childhood anxiety disorders.
Depression and Anxiety, 19, 152–162.
Hoek, H. W., Susser, E., Buck, K. A., Lumey, L. H., Lin, S. P., & Gorman, J. M. (1996). Schizoid
personality disorder after prenatal exposure to famine. The American Journal of Psychiatry, 153,
1637–1639.
Hogg, K., Blair, J. D., von Dadelszen, P., & Robinson, W. P. (2013). Hypomethylation of the LEP gene
in placenta and elevated maternal leptin concentration in early onset pre-eclampsia. Molecular and
Cellular Endocrinology, 367, 64–73.
Holmes, M. C., Abrahamsen, C. T., French, K. L., Paterson, J. M., Mullins, J. J., & Seckl, J. R. (2006).
The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence
116
for direct fetal programming of behavior by endogenous glucocorticoids.  The Journal of
Neuroscience: The Official Journal of the Society for Neuroscience, 26, 3840–3844.
Holmes, M. C., & Seckl, J. R. (2006). The role of 11beta-hydroxysteroid dehydrogenases in the brain.
Molecular and Cellular Endocrinology, 248, 9–14.
Huang, Y., Kotov, R., de Girolamo, G., Preti, A., Angermeyer, M., Benjet, C., . . . Kessler, R. C. (2009).
DSM-IV personality disorders in the WHO world mental health surveys. The British Journal of
Psychiatry: The Journal of Mental Science, 195, 46–53.
Hunter, J. E., & Schmidt, F. L. (1996). Intelligence and job performance: Economic and social
implications. Psychology, Public Policy, and Law, 2, 447–472.
Hyppönen, E., Leon, D. A., Kenward, M. G., & Lithell, H. (2001). Prenatal growth and risk of occlusive
and haemorrhagic stroke in swedish men and women born 1915–29: Historical cohort study.  British
Medical Journal (Clinical Research Ed.), 323, 1033–1034.
Jensen Pena, C., Monk, C., & Champagne, F. A. (2012). Epigenetic effects of prenatal stress on 11beta-
hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PloS One, 7, e39791.
Jones, P. B., Rantakallio, P., Hartikainen, A. L., Isohanni, M., & Sipila, P. (1998). Schizophrenia as a
long-term outcome of pregnancy, delivery, and perinatal complications: A 28-year follow-up of the
1966 north finland general population birth cohort. The American Journal of Psychiatry, 155, 355–
364.
Kaaja, R., Kinnunen, T., & Luoto, R. (2005). Regional differences in the prevalence of pre-eclampsia in
relation to the risk factors for coronary artery disease in women in Finland. European Heart Journal,
26, 44–50.
Kaaja, R., & Luoto, R. (2004). Raskauskomplikaatiot [pregnancy complications, in finnish]. In P.
Koponen, & R. Luoto (Eds.), Lisääntymisterveys suomessa: Terveys 2000 -tutkimus [reproductive
health in finland: The health 2000 survey, in Finnish]. Helsinki: National Public Health Institute.
Kajantie, E., Dunkel, L., Turpeinen, U., Stenman, U. H., Wood, P. J., Nuutila, M., & Andersson, S.
(2003). Placental 11 beta-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in
small preterm infants. The Journal of Clinical Endocrinology and Metabolism, 88, 493–500.
Kajantie, E., Eriksson, J. G., Osmond, C., Thornburg, K., & Barker, D. J. (2009). Pre-eclampsia is
associated with increased risk of stroke in the adult offspring: The Helsinki Birth Cohort Study.
Stroke; a Journal of Cerebral Circulation, 40, 1176–1180.
117
Kajantie, E., & Räikkönen, K. (2010). Early life predictors of the physiological stress response later in
life. Neuroscience and Biobehavioral Reviews, 35, 23–32.
Karlamangla, A. S., Miller-Martinez, D., Aneshensel, C. S., Seeman, T. E., Wight, R. G., & Chodosh, J.
(2009). Trajectories of cognitive function in late life in the united states: Demographic and
socioeconomic predictors. American Journal of Epidemiology, 170, 331–342.
Katz, M. J., Lipton, R. B., Hall, C. B., Zimmerman, M. E., Sanders, A. E., Verghese, J., . . . Derby, C. A.
(2012). Age-specific and sex-specific prevalence and incidence of mild cognitive impairment,
dementia, and alzheimer dementia in blacks and whites: A report from the einstein aging study.
Alzheimer Disease and Associated Disorders, 26, 335–343.
Kendell, R. E., McInneny, K., Juszczak, E., & Bain, M. (2000). Obstetric complications and
schizophrenia. two case-control studies based on structured obstetric records. The British Journal of
Psychiatry: The Journal of Mental Science, 176, 516–522.
Kermack, W. O., McKendrick, A. G., & McKinlay, P. L. (1934). Death rates in great britain and sweden:
Some general regularities and their significance. Lancet, 226, 698–703.
Keskimäki, I., & Aro, S. (1991). Accuracy of data on diagnoses, procedures and accidents in the Finnish
hospital discharge register. International Journal of Health Services, 2, 15–21.
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., . . . Kendler, K. S.
(1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States.
results from the national comorbidity survey. Archives of General Psychiatry, 51, 8–19.
Khulan, B., & Drake, A. J. (2012). Glucocorticoids as mediators of developmental programming effects.
Best Practice & Research.Clinical Endocrinology & Metabolism, 26, 689–700.
Kieseppä, T., Partonen, T., Kaprio, J., & Lönnqvist, J. (2000). Accuracy of register- and record-based
bipolar I diagnoses in finland—a study of twins. Acta Neuropsychiatrica, 12, 106–109.
King, J. C. (2006). Maternal obesity, metabolism, and pregnancy outcomes. Annual Review of Nutrition,
26, 271–291.
Koren, G. (2013). Systematic review of the effects of maternal hypertension in pregnancy and
antihypertensive therapies on child neurocognitive development. Reproductive Toxicology, 39, 1–5.
Kurki, T., Hiilesmaa, V., Raitasalo, R., Mattila, H., & Ylikorkala, O. (2000). Depression and anxiety in
early pregnancy and risk for preeclampsia. Obstetrics and Gynecology, 95, 487–490.
118
Lahti, M., Räikkönen, K., Wahlbeck, K., Heinonen, K., Forsén, T., Kajantie, E., . . . Eriksson, J. G.
(2010). Prenatal origins of hospitalization for personality disorders: The Helsinki Birth Cohort
Study. Psychiatry Research, 179, 226–230.
Lahti, R. A., & Penttila, A. (2001). The validity of death certificates: Routine validation of death
certification and its effects on mortality statistics. Forensic Science International, 115, 15–32.
Langley-Evans, S. C., Phillips, G. J., Benediktsson, R., Gardner, D. S., Edwards, C. R., Jackson, A. A., &
Seckl, J. R. (1996). Protein intake in pregnancy, placental glucocorticoid metabolism and the
programming of hypertension in the rat. Placenta, 17, 169–172.
Lanz, B., Kadereit, B., Ernst, S., Shojaati, K., Causevic, M., Frey, B. M., . . . Mohaupt, M. G. (2003).
Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors. Kidney
International, 64, 970–977.
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., . . . Hofman, A.
(1999). Rates and risk factors for dementia and alzheimer's disease: Results from EURODEM
pooled analyses. EURODEM incidence research group and work groups. european studies of
dementia. Neurology, 52, 78–84.
Lawlor, D. A., Batty, G. D., Morton, S. M., Deary, I. J., Macintyre, S., Ronalds, G., & Leon, D. A. (2005).
Early life predictors of childhood intelligence: Evidence from the aberdeen children of the 1950s
study. Journal of Epidemiology and Community Health, 59, 656–663.
Lawlor, D. A., Ronalds, G., Clark, H., Smith, G. D., & Leon, D. A. (2005). Birth weight is inversely
associated with incident coronary heart disease and stroke among individuals born in the 1950s:
Findings from the aberdeen children of the 1950s prospective cohort study. Circulation, 112, 1414–
1418.
Leao, P., Sousa, J. C., Oliveira, M., Silva, R., Almeida, O. F., & Sousa, N. (2007). Programming effects
of antenatal dexamethasone in the developing mesolimbic pathways. Synapse, 61, 40–49.
Leeners, B., Neumaier-Wagner, P., Kuse, S., Merki, S., Stiller, R., Neises, M., . . . Rath, W. (2009).
Motivation for motherhood in women with hypertensive diseases in pregnancy.  Journal of
Psychosomatic Obstetrics and Gynaecology, 30, 133–140.
Leitner, Y., Harel, S., Geva, R., Eshel, R., Yaffo, A., & Many, A. (2012). The neurocognitive outcome of
IUGR children born to mothers with and without preeclampsia. The Journal of Maternal-Fetal &
Neonatal Medicine : The Official Journal of the European Association of Perinatal Medicine, the
119
Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal
Obstetricians, 25, 2206–2208.
Leon, D. A., Lithell, H. O., Vagero, D., Koupilova, I., Mohsen, R., Berglund, L., . . . McKeigue, P. M.
(1998). Reduced fetal growth rate and increased risk of death from ischaemic heart disease: Cohort
study of 15 000 swedish men and women born 1915–29. British Medical Journal (Clinical
Research Ed.), 317, 241–245.
Leray, E., Camara, A., Drapier, D., Riou, F., Bougeant, N., Pelissolo, A., . . . Millet, B. (2011).
Prevalence, characteristics and comorbidities of anxiety disorders in france: Results from the
"mental health in general population" survey (MHGP). European Psychiatry: The Journal of the
Association of European Psychiatrists, 26,339–345.
Lester, B. M., Conradt, E., & Marsit, C. J. (2013). Epigenetic basis for the development of depression in
children. Clinical Obstetrics and Gynecology, 56, 556–565.
Leversen, K. T., Sommerfelt, K., Ronnestad, A., Kaaresen, P. I., Farstad, T., Skranes, J., . . . Markestad, T.
(2011). Prediction of neurodevelopmental and sensory outcome at 5 years in norwegian children
born extremely preterm. Pediatrics, 127, e630–8.
Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., . . . CPEP Study Group. (2006).
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. The New England
Journal of Medicine, 355, 992–1005.
Liggins, G. C., & Howie, R. N. (1972). A controlled trial of antepartum glucocorticoid treatment for
prevention of the respiratory distress syndrome in premature infants. Pediatrics, 50, 515–525.
Luo, Z. C., An, N., Xu, H. R., Larante, A., Audibert, F., & Fraser, W. D. (2007). The effects and
mechanisms of primiparity on the risk of pre-eclampsia: A systematic review. Paediatric and
Perinatal Epidemiology, 21 Suppl 1, 36–45.
Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress throughout the lifespan
on the brain, behaviour and cognition. Nature Reviews Neuroscience, 10, 434–445.
Mäkikyrö, T., Isohanni, M., Moring, J., Hakko, H., Hovatta, I., & Lönnqvist, J. (1998). Accuracy of
register-based schizophrenia diagnoses in a genetic study. European Psychiatry: The Journal of the
Association of European Psychiatrists, 13, 57–62.
Mallen, C., Mottram, S., & Thomas, E. (2008). Birth factors and common mental health problems in
young adults: A population-based study in north staffordshire. Social Psychiatry and Psychiatric
Epidemiology, 43, 325–330.
120
Many, A., Fattal, A., Leitner, Y., Kupferminc, M. J., Harel, S., & Jaffa, A. (2003). Neurodevelopmental
and cognitive assessment of children born growth restricted to mothers with and without
preeclampsia. Hypertension in Pregnancy: Official Journal of the International Society for the
Study of Hypertension in Pregnancy, 22, 25–29.
Many, A., Fattal-Valevski, A., & Leitner, Y. (2005). Neurodevelopmental and cognitive assessment of 6-
year-old children born growth restricted. International Journal of Gynaecology and Obstetrics: The
Official Organ of the International Federation of Gynaecology and Obstetrics, 89, 55–56.
Marsit, C. J., Maccani, M. A., Padbury, J. F., & Lester, B. M. (2012). Placental 11-beta hydroxysteroid
dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral
outcome. PloS One, 7, e33794.
Martyn, C. N., Barker, D. J., & Osmond, C. (1996). Mothers' pelvic size, fetal growth, and death from
stroke and coronary heart disease in men in the UK. Lancet, 348, 1264–1268.
Martyn, C. N., Gale, C. R., Sayer, A. A., & Fall, C. (1996). Growth in utero and cognitive function in
adult life: Follow up study of people born between 1920 and 1943. British Medical Journal
(Clinical Research Ed.), 312, 1393–1396.
Matte, T. D., Bresnahan, M., Begg, M. D., & Susser, E. (2001). Influence of variation in birth weight
within normal range and within sibships on IQ at age 7 years: Cohort study. British Medical Journal
(Clinical Research Ed.), 323, 310–314.
Maylor, E. A., Reimers, S., Choi, J., Collaer, M. L., Peters, M., & Silverman, I. (2007). Gender and
sexual orientation differences in cognition across adulthood: Age is kinder to women than to men
regardless of sexual orientation. Archives of Sexual Behavior, 36, 235–249.
McCalla, C. O., Nacharaju, V. L., Muneyyirci-Delale, O., Glasgow, S., & Feldman, J. G. (1998).
Placental 11 beta-hydroxysteroid dehydrogenase activity in normotensive and pre-eclamptic
pregnancies. Steroids, 63, 511–515.
McCowan, L. M., Pryor, J., & Harding, J. E. (2002). Perinatal predictors of neurodevelopmental outcome
in small-for-gestational-age children at 18 months of age. American Journal of Obstetrics and
Gynecology, 186, 1069–1075.
McGurn, B., Deary, I. J., & Starr, J. M. (2008). Childhood cognitive ability and risk of late-onset
alzheimer and vascular dementia. Neurology, 71, 1051–1056.
121
McLaughlin, K. A., Breslau, J., Green, J. G., Lakoma, M. D., Sampson, N. A., Zaslavsky, A. M., &
Kessler, R. C. (2011). Childhood socio-economic status and the onset, persistence, and severity of
DSM-IV mental disorders in a US national sample. Social Science & Medicine, 73, 1088–1096.
McMillen, I. C., & Robinson, J. S. (2005). Developmental origins of the metabolic syndrome: Prediction,
plasticity, and programming. Physiological Reviews, 85, 571–633.
Mistry, H. D., Kurlak, L. O., & Broughton Pipkin, F. (2013). The placental renin-angiotensin system and
oxidative stress in pre-eclampsia. Placenta, 34, 182–186.
Monroe, S. M., & Simons, A. D. (1991). Diathesis-stress theories in the context of life stress research:
Implications for the depressive disorders. Psychological Bulletin, 110, 406–425.
Morsing, E., & Maršál, K. (2014). Pre-eclampsia- an additional risk factor for cognitive impairment at
school age after intrauterine growth restriction and very preterm birth. Early Human Development,
90, 99–101.
Mueller, B. R., & Bale, T. L. (2008). Sex-specific programming of offspring emotionality after stress
early in pregnancy. The Journal of Neuroscience: The Official Journal of the Society for
Neuroscience, 28, 9055–9065.
Murphy, V. E., Gibson, P. G., Giles, W. B., Zakar, T., Smith, R., Bisits, A. M., . . . Clifton, V. L. (2003).
Maternal asthma is associated with reduced female fetal growth. American Journal of Respiratory
and Critical Care Medicine, 168, 1317–1323.
Murray, C. J. L., & Lopez, A. D. (1996). The global burden of disease: A comprehensive assessment of
mortality and disability from disease, injuries, and risk factors in 1990 and projected to 2020.
Cambridge: Mass Harvard University Press.
Mutch, L. M., Moar, V. A., Ounsted, M. K., & Redman, C. W. (1977). Hypertension during pregnancy,
with and without specific hypotensive treatment. II. the growth and development of the infant in the
first year of life. Early Human Development, 1, 59–67.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.
(2000). Report of the National High Blood Pressure Education Program Working Group on High
Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology, 183, 1–22.
Ness, R. B., & Roberts, J. M. (2009). Epidemiology of pregnancy-related hypertension. In M. D.
Lindheimer, J. M. Roberts & F. G. Gunningham (Eds.), Chesley’s hypertensive disorders in
pregnancy (3rd ed.). USA: Academic Press.
122
Neugebauer, R., Hoek, H. W., & Susser, E. (1999). Prenatal exposure to wartime famine and
development of antisocial personality disorder in early adulthood. The Journal of the American
Medical Association, 282, 455–462.
Newnham, C. A., Milgrom, J., & Skouteris, H. (2009). Effectiveness of a modified mother-infant
transaction program on outcomes for preterm infants from 3 to 24 months of age.  Infant Behavior &
Development, 32, 17–26.
Newnham, J. P., Doherty, D. A., Kendall, G. E., Zubrick, S. R., Landau, L. L., & Stanley, F. J. (2004).
Effects of repeated prenatal ultrasound examinations on childhood outcome up to 8 years of age:
Follow-up of a randomised controlled trial. Lancet, 364, 2038–2044.
Newnham, J. P., Moss, T. J., Nitsos, I., Sloboda, D. M., & Challis, J. R. (2002). Nutrition and the early
origins of adult disease. Asia Pacific Journal of Clinical Nutrition, 11 Suppl 3, 537–542.
Nilsson, E., Stalberg, G., Lichtenstein, P., Cnattingius, S., Olausson, P. O., & Hultman, C. M. (2005).
Fetal growth restriction and schizophrenia: A swedish twin study. Twin Research and Human
Genetics: The Official Journal of the International Society for Twin Studies, 8, 402–408.
Nomura, Y., Wickramaratne, P. J., Pilowsky, D. J., Newcorn, J. H., Bruder-Costello, B., Davey, C., . . .
Weissman, M. M. (2007). Low birth weight and risk of affective disorders and selected medical
illness in offspring at high and low risk for depression. Comprehensive Psychiatry, 48, 470–478.
Nordhov, S. M., Ronning, J. A., Dahl, L. B., Ulvund, S. E., Tunby, J., & Kaaresen, P. I. (2010). Early
intervention improves cognitive outcomes for preterm infants: Randomized controlled trial.
Pediatrics, 126, e1088–1094.
Nuyt, A. M., & Alexander, B. T. (2009). Developmental programming and hypertension. Current
Opinion in Nephrology and Hypertension, 18, 144–152.
Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. (2008). Prenatal
exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene
(NR3C1) and infant cortisol stress responses. Epigenetics: Official Journal of the DNA Methylation
Society, 3, 97–106.
O'Brien, T. E., Ray, J. G., & Chan, W. S. (2003). Maternal body mass index and the risk of preeclampsia:
A systematic overview. Epidemiology, 14, 368–374.
O'Connor, T. G., Bergman, K., Sarkar, P., & Glover, V. (2013). Prenatal cortisol exposure predicts infant
cortisol response to acute stress. Developmental Psychobiology, 55, 145–155.
123
O'Dwyer, J. M. (1997). Schizophrenia in people with intellectual disability: The role of pregnancy and
birth complications. Journal of Intellectual Disability Research, 41, 238–251.
Osmond, C., Barker, D. J., Winter, P. D., Fall, C. H., & Simmonds, S. J. (1993). Early growth and death
from cardiovascular disease in women.  British Medical Journal (Clinical Research Ed.), 307,
1519–1524.
Ounsted, M. K., Moar, V. A., Good, F. J., & Redman, C. W. (1980). Hypertension during pregnancy with
and without specific treatment; the development of the children at the age of four years. British
Journal of Obstetrics and Gynaecology, 87, 19–24.
Ounsted, M. K., Moar, V. A., & Scott, A. (1986). Factors affecting development: Similarities and
differences among children who were small, average, and large for gestational age at birth.  Acta
Paediatrica Scandinavica, 75, 261–266.
Paarlberg, K. M., Vingerhoets, A. J., Passchier, J., Dekker, G. A., & Van Geijn, H. P. (1995).
Psychosocial factors and pregnancy outcome: A review with emphasis on methodological issues.
Journal of Psychosomatic Research, 39, 563–595.
Paile-Hyvärinen, M., Räikkönen, K., Forsén, T., Kajantie, E., Ylihärsilä, H., Salonen, M. K., . . . Eriksson,
J. G. (2007). Depression and its association with diabetes, cardiovascular disease, and birth weight.
Annals of Medicine, 39, 634–640.
Parviainen, S. (1946). Fréquence de la néphrogestose pendant les années de guerre [the incidence of
nephrogestosis during the years of the war; in french]. Acta Obstet Gynecol Scand, 26, 171–192.
Patton, G. C., Coffey, C., Carlin, J. B., Olsson, C. A., & Morley, R. (2004). Prematurity at birth and
adolescent depressive disorder. The British Journal of Psychiatry: The Journal of Mental Science,
184, 446–447.
Pelkonen, E. (1940). Untersuchungen über die frequenzschwankungen der nierengestosen in finnland und
die auf sie einwirkenden faktoren [studies on changes in the incidence of renal gestoses in finland
and on factors affecting these changes; in german]. Acta Societatis Medicorum Fennicae Duodecim
Series B, , 1–139.
Peltoniemi, O. M., Kari, M. A., & Hallman, M. (2011). Repeated antenatal corticosteroid treatment: A
systematic review and meta-analysis. Acta Obstetricia Et Gynecologica Scandinavica, 90, 719–727.
Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., . . . Lönnqvist, J. (2007).
Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of
General Psychiatry, 64, 19–28.
124
Perrig-Chiello, P., & Hutchison, S. (2010). Health and well-being in old age: The pertinence of a gender
mainstreaming approach in research. Gerontology, 56, 208–213.
Pesonen, A.-K., Räikkönen, K., Strandberg, T. E., & Järvenpää, A.-L. (2005). Continuity of maternal
stress from the pre- to the postnatal period: Associations with infant’s positive, negative and overall
temperamental reactivity. Infant Behavior & Development, 28, 36–47.
Pihlajamaa, J., Suvisaari, J., Henriksson, M., Heila, H., Karjalainen, E., Koskela, J., . . . Lönnqvist, J.
(2008). The validity of schizophrenia diagnosis in the finnish hospital discharge register: Findings
from a 10-year birth cohort sample. Nordic Journal of Psychiatry, 62, 198–203.
Pluess, M., & Belsky, J. (2011). Prenatal programming of postnatal plasticity? Development and
Psychopathology, 23, 29–38.
Poikolainen, K. (1983). Accuracy of hospital discharge data: Five alcohol-related diseases. Drug and
Alcohol Dependence, 12, 315–322.
Poon, L. C., Kametas, N. A., Chelemen, T., Leal, A., & Nicolaides, K. H. (2010). Maternal risk factors
for hypertensive disorders in pregnancy: A multivariate approach. Journal of Human Hypertension,
24, 104–110.
Price, T. D., Qvarnstrom, A., & Irwin, D. E. (2003). The role of phenotypic plasticity in driving genetic
evolution. Proceedings.Biological Sciences / the Royal Society, 270, 1433–1440.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013). The global prevalence
of dementia: A systematic review and metaanalysis. Alzheimer's & Dementia: The Journal of the
Alzheimer's Association, 9, 63–75.e2.
Pyhälä, R., Lahti, J., Heinonen, K., Pesonen, A.-K., Strang-Karlsson, S., Hovi, P., . . . Räikkönen, K.
(2011). Neurocognitive abilities in young adults with very low birth weight. Neurology, 77, 2052–
2060.
Qiu, C., Williams, M.A., Calderon-Margalit, R., Cripe, S. M., & Sorensen, T. K. (2009). Preeclampsia
risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy.
The American Journal of Hypertension, 22, 397–402.
Räikkönen, K., Forsén, T., Henriksson, M., Kajantie, E., Heinonen, K., Pesonen, A. K., . . . Eriksson, J. G.
(2009). Growth trajectories and intellectual abilities in young adulthood: The Helsinki Birth Cohort
Study. American Journal of Epidemiology, 170, 447–455.
125
Räikkönen, K., Kajantie, E., Pesonen, A.-K., Heinonen, K., Alastalo, H., Leskinen, J. T., . . . Eriksson, J.
G. (2013). Early life origins cognitive decline: Findings in elderly men in the Helsinki Birth Cohort
Study. PloS One, 8, e54707.
Räikkönen, K., Pesonen, A.-K., Heinonen, K., Kajantie, E., Hovi, P., Järvenpää, A.-L., . . . Andersson, S.
(2008). Depression in young adults with very low birth weight: The Helsinki study of very low-
birth-weight adults. Archives of General Psychiatry, 65, 290–296.
Räikkönen, K., Pesonen, A.-K., Heinonen, K., Lahti, J., Komsi, N., Eriksson, J. G., . . . Strandberg, T. E.
(2009). Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in
children. American Journal of Epidemiology, 170, 1137–1146.
Räikkönen, K., Pesonen, A.-K., Kajantie, E., Heinonen, K., Forsén, T., Phillips, D. I., . . . Eriksson, J. G.
(2007). Length of gestation and depressive symptoms at age 60 years. The British Journal of
Psychiatry: The Journal of Mental Science, 190, 469–474.
Rast, P., Zimprich, D., Van Boxtel, M., & Jolles, J. (2009). Factor structure and measurement invariance
of the cognitive failures questionnaire across the adult life span. Assessment, 16, 145–158.
Raven, J., Raven, J. C., & Court, J. H. (2000). Manual for raven’ s progressive matrices and vocabulary
scales (section 3): Standard progressive matrices (including the parallel and plus versions). Oxford:
Oxford Psychologists Press.
Redman, C. W., & Sargent, I. L. (2010). Immunology of pre-eclampsia. American Journal of
Reproductive Immunology, 63, 534–543.
Richards, M., Hardy, R., Kuh, D., & Wadsworth, M. E. (2002). Birthweight, postnatal growth and
cognitive function in a national UK birth cohort. International Journal of Epidemiology, 31, 342–
348.
Riley, K. P., Snowdon, D. A., Desrosiers, M. F., & Markesbery, W. R. (2005). Early life linguistic ability,
late life cognitive function, and neuropathology: Findings from the nun study.  Neurobiology of
Aging, 26, 341–347.
Roberts, C. L., Algert, C. S., Morris, J. M., Ford, J. B., & Henderson-Smart, D. J. (2005). Hypertensive
disorders in pregnancy: A population-based study. The Medical Journal of Australia, 182, 332–335.
Roberts, C. L., Ford, J. B., Algert, C. S., Antonsen, S., Chalmers, J., Cnattingius, S., . . . Weir, C. J.
(2011). Population-based trends in pregnancy hypertension and pre-eclampsia: An international
comparative study. British Medical Journal Open, 1, e000101.
126
Roberts, J. M., Pearson, G., Cutler, J., Lindheimer, M., & NHLBI Working Group on Research on
Hypertension During Pregnancy. (2003). Summary of the NHLBI working group on research on
hypertension during pregnancy. Hypertension, 41, 437–445.
Robinson, M., Mattes, E., Oddy, W. H., de Klerk, N. H., Li, J., McLean, N. J., . . . Newnham, J. P. (2009).
Hypertensive diseases of pregnancy and the development of behavioral problems in childhood and
adolescence: The western australian pregnancy cohort study. The Journal of Pediatrics, 154, 218–
224.
Roseboom, T. J., Painter, R. C., van Abeelen, A. F., Veenendaal, M. V., & de Rooij, S. R. (2011). Hungry
in the womb: What are the consequences? lessons from the dutch famine. Maturitas, 70, 141–145.
Rothrauff, T. C., Cooney, T. M., & An, J. S. (2009). Remembered parenting styles and adjustment in
middle and late adulthood. The Journals of Gerontology.Series B, Psychological Sciences and
Social Sciences, 64, 137–146.
Sabunciyan, S., Aryee, M. J., Irizarry, R. A., Rongione, M., Webster, M. J., Kaufman, W. E., . . .
GenRED Consortium. (2012). Genome-wide DNA methylation scan in major depressive disorder.
PloS One, 7, e34451.
Salmi, M. M., Ekholm, E., Polo, O., & Erkkola, R. (1999). Eklampsia suomessa 1990–94. Duodecim, 115,
797–801.
Sameroff, A. J. (1983). Developmental systems: Contexts and evolution. In P. Mussen (Ed.), Handbook
of child psychology (pp. 237–294). New York: NY: Wiley.
Sarkar, P., Bergman, K., Fisk, N. M., O'Connor, T. G., & Glover, V. (2007). Ontogeny of foetal exposure
to maternal cortisol using midtrimester amniotic fluid as a biomarker. Clinical Endocrinology, 66,
636–640.
Schlapbach, L. J., Ersch, J., Adams, M., Bernet, V., Bucher, H. U., & Latal, B. (2010). Impact of
chorioamnionitis and preeclampsia on neurodevelopmental outcome in preterm infants below 32
weeks gestational age. Acta Paediatrica, 99, 1504–1509.
Schmand, B., Smit, J. H., Geerlings, M. I., & Lindeboom, J. (1997). The effects of intelligence and
education on the development of dementia. A test of the brain reserve hypothesis.  Psychological
Medicine, 27, 1337–1344.
Schoof, E., Girstl, M., Frobenius, W., Kirschbaum, M., Dorr, H. G., Rascher, W., & Dotsch, J. (2001).
Decreased gene expression of 11beta-hydroxysteroid dehydrogenase type 2 and 15-
127
hydroxyprostaglandin dehydrogenase in human placenta of patients with preeclampsia. The Journal
of Clinical Endocrinology and Metabolism, 86, 1313–1317.
Seidman, D. S., Laor, A., Gale, R., Stevenson, D. K., Mashiach, S., & Danon, Y. L. (1991). Pre-
eclampsia and offspring's blood pressure, cognitive ability and physical development at 17-years-of-
age. British Journal of Obstetrics and Gynaecology, 98, 1009–1014.
Shenkin, S. D., Starr, J. M., & Deary, I. J. (2004). Birth weight and cognitive ability in childhood: A
systematic review. Psychological Bulletin, 130, 989–1013.
Shenkin, S. D., Starr, J. M., Pattie, A., Rush, M. A., Whalley, L. J., & Deary, I. J. (2001). Birth weight
and cognitive function at age 11 years: The scottish mental survey 1932. Archives of Disease in
Childhood, 85, 189–196.
Sibai, B., Dekker, G., & Kupferminc, M. (2005). Pre-eclampsia. Lancet, 365, 785–799.
Silva, L. M., Coolman, M., Steegers, E. A., Jaddoe, V. W., Moll, H. A., Hofman, A., . . . Raat, H. (2008).
Low socioeconomic status is a risk factor for preeclampsia: The generation R study.  Journal of
Hypertension, 26, 1200–1208.
Silveira, R. C., Procianoy, R. S., Koch, M. S., Benjamin, A. C., & Schlindwein, C. F. (2007). Growth and
neurodevelopment outcome of very low birth weight infants delivered by preeclamptic mothers.
Acta Paediatrica, 96, 1738–1742.
Simblett, S. K., & Bateman, A. (2011). Dimensions of the dysexecutive questionnaire (DEX) examined
using rasch analysis. Neuropsychological Rehabilitation, 21, 1–25.
Skjærven, R., Vatten, L. J., Wilcox, A. J., Rønning, T., Irgens, L. M., & Lie, R. T. (2005). Recurrence of
pre-eclampsia across generations: Exploring fetal and maternal genetic components in a population
based cohort.  British Medical Journal (Clinical Research Ed.), 331, 877.
Sommerfelt, K., Markestad, T., & Ellertsen, B. (1998). Neuropsychological performance in low birth
weight preschoolers: A population-based, controlled study. European Journal of Pediatrics, 157,
53–58.
Sørensen, H. J., Mortensen, E. L., Reinisch, J. M., & Mednick, S. A. (2003). Do hypertension and diuretic
treatment in pregnancy increase the risk of schizophrenia in offspring? The American Journal of
Psychiatry, 160, 464–468.
128
Sørensen, H. T., Sabroe, S., Olsen, J., Rothman, K. J., Gillman, M. W., & Fischer, P. (1997). Birth weight
and cognitive function in young adult life: Historical cohort study.  British Medical Journal
(Clinical Research Ed.), 315, 401–403.
Spinillo, A., Iasci, A., Capuzzo, E., Egbe, T. O., Colonna, L., & Fazzi, E. (1994). Two-year infant
neurodevelopmental outcome after expectant management and indicated preterm delivery in
hypertensive pregnancies. Acta Obstetricia Et Gynecologica Scandinavica, 73, 625–629.
Spinillo, A., Montanari, L., Gardella, B., Roccio, M., Stronati, M., & Fazzi, E. (2009). Infant sex,
obstetric risk factors, and 2-year neurodevelopmental outcome among preterm infants.
Developmental Medicine and Child Neurology, 51, 518–525.
St Clair, D., Xu, M., Wang, P., Yu, Y., Fang, Y., Zhang, F., . . . He, L. (2005). Rates of adult
schizophrenia following prenatal exposure to the chinese famine of 1959–1961. The Journal of the
American Medical Association, 294, 557–562.
Stearns, S. C. (1992). The evolution of life histories. Oxford: Oxford University Press.
Stearns, S. C. (2000). Life history evolution: Successes, limitations, and prospects. Die
Naturwissenschaften, 87, 476–486.
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010). Pre-eclampsia. Lancet, 376,
631–644.
Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J. W., Patel, V., & Silove, D. (2014). The global
prevalence of common mental disorders: A systematic review and meta-analysis 1980–2013.
International Journal of Epidemiology, 43, 476–493.
Stein, C. E., Fall, C. H., Kumaran, K., Osmond, C., Cox, V., & Barker, D. J. (1996). Fetal growth and
coronary heart disease in south india. Lancet, 348, 1269–1273.
Strang-Karlsson, S., Andersson, S., Paile-Hyvärinen, M., Darby, D., Hovi, P., Räikkönen, K., . . .
Kajantie, E. (2010). Slower reaction times and impaired learning in young adults with birth weight
<1500 g. Pediatrics, 125, e74–82.
Strevens, H., Wide-Swensson, D., Hansen, A., Horn, T., Ingemarsson, I., Larsen, S., . . . Olsen, S. (2003).
Glomerular endotheliosis in normal pregnancy and pre-eclampsia. An International Journal of
Obstetrics and Gynaecology, 110, 831–836.
129
Sundrani, D. P., Reddy, U. S., Joshi, A. A., Mehendale, S. S., Chavan-Gautam, P. M., Hardikar, A. A., . . .
Joshi, S. R. (2013). Differential placental methylation and expression of VEGF, FLT-1 and KDR
genes in human term and preterm preeclampsia. Clinical Epigenetics, 5, 6.
Suvisaari, J. M., Taxell-Lassas, V., Pankakoski, M., Haukka, J. K., Lonnqvist, J. K., & Hakkinen, L. T.
(2013). Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of
mothers with psychotic disorder. Schizophrenia Bulletin, 39, 1056–1066.
Szymonowicz, W., & Yu, V. Y. (1987). Severe pre-eclampsia and infants of very low birth weight.
Archives of Disease in Childhood, 62, 712–716.
Tarkiainen, J. (1946). Kokemuksia  magnesiumsulfaattihoidosta synnytyskouristuksissa ja niitä
edeltävissä  tiloissa [experiences with magnesium sulphate treatment in eclamptic and  preeclamptic
states, in Finnish]. Duodecim, 62, 76–83.
Taylor, R. N., Davidge, S. T., & Roberts, J. M. (2009). Endothelial cell dysfunction and oxidative stress.
In M. D. Lindheimer, J. M. Roberts & F. G. Cunningham (Eds.), Chesley’s hypertensive disorders
in pregnancy (3rd ed., ). USA: Academic Press.
Teräsvuori, H. (1933). Ns. raskaudenaikainenmunuaissairaus. sen tautikuvasta, luonteesta ja hoidosta I–II.
[so-calledprenatalnephrogestosis.aboutitsdescription, nature and treatment I–II; in Finnish].
Midwife-Journal, 6–7.
Thompson, C., Syddall, H., Rodin, I., Osmond, C., & Barker, D. J. (2001). Birth weight and the risk of
depressive disorder in late life. The British Journal of Psychiatry: The Journal of Mental Science,
179, 450–455.
Tiihonen, J., Haukka, J., Henriksson, M., Cannon, M., Kieseppä, T., Laaksonen, I., . . . Lönnqvist, J.
(2005). Premorbid intellectual functioning in bipolar disorder and schizophrenia: Results from a
cohort study of male conscripts. The American Journal of Psychiatry, 162, 1904–1910.
Trautman, P. D., Meyer-Bahlburg, H. F., Postelnek, J., & New, M. I. (1995). Effects of early prenatal
dexamethasone on the cognitive and behavioral development of young children: Results of a pilot
study. Psychoneuroendocrinology, 20, 439–449.
Tuovinen, S., Aalto-Viljakainen, T., Eriksson, J., Kajantie, E., Lahti, J., Pesonen, A.-K., . . . Räikkönen,
K. (2014). Maternal hypertensive disorders during pregnancy: Adaptive functioning and psychiatric
and psychological problems of the older offspring. An International Journal of Obstetrics and
Gynaecology, Epub ahead of print Apr 7.
130
Twisk, J. W. R. (2003). Applied longitudinal data analysis of epidemiology. Cambridge, UK: Cambridge
University Press.
Tyrka, A. R., Price, L. H., Marsit, C., Walters, O. C., & Carpenter, L. L. (2012). Childhood adversity and
epigenetic modulation of the leukocyte glucocorticoid receptor: Preliminary findings in healthy
adults. PloS One, 7, e30148.
Vallee, M., MacCari, S., Dellu, F., Simon, H., Le Moal, M., & Mayo, W. (1999). Long-term effects of
prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive
performance: A longitudinal study in the rat. The European Journal of Neuroscience, 11, 2906–
2916.
Van den Bergh, B. R., Van Calster, B., Smits, T., Huffel, S. V., & Lagae, L. (2008). Antenatal maternal
anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence:
A prospective study on the fetal origins of depressed mood. Neuropsychopharmacology, 33, 536–
545.
Van Lieshout, R. J., Taylor, V. H., & Boyle, M. H. (2011). Pre-pregnancy and pregnancy obesity and
neurodevelopmental outcomes in offspring: A systematic review. Obesity Reviews: An Official
Journal of the International Association for the Study of Obesity, 12, e548–59.
van Oijen, M., de Jong, F. J., Hofman, A., Koudstaal, P. J., & Breteler, M. M. (2007). Subjective memory
complaints, education, and risk of alzheimer's disease. Alzheimer's & Dementia: The Journal of the
Alzheimer's Association, 3, 92–97.
Verdonk, K., Visser, W., Van Den Meiracker, A. H., & Danser, A. H. (2014). The renin-angiotensin-
aldosterone system in pre-eclampsia: The delicate balance between good and bad. Clinical Science
(London, England : 1979), 126, 537–544.
Vianna, P., Bauer, M. E., Dornfeld, D., & Chies, J. A. (2011). Distress conditions during pregnancy may
lead to pre-eclampsia by increasing cortisol levels and altering lymphocyte sensitivity to
glucocorticoids. Medical Hypotheses, 77, 188–191.
Vickers, M. H., Gluckman, P. D., Coveny, A. H., Hofman, P. L., Cutfield, W. S., Gertler, A., . . . Harris,
M. (2005). Neonatal leptin treatment reverses developmental programming. Endocrinology, 146,
4211–4216.
Villar, J., Carroli, G., Wojdyla, D., Abalos, E., Giordano, D., Ba'aqeel, H., . . . World Health Organization
Antenatal Care Trial Research Group. (2006). Preeclampsia, gestational hypertension and
131
intrauterine growth restriction, related or independent conditions? American Journal of Obstetrics
and Gynecology, 194, 921–931.
Wadsworth, M. E., Cripps, H. A., Midwinter, R. E., & Colley, J. R. (1985). Blood pressure in a national
birth cohort at the age of 36 related to social and familial factors, smoking, and body mass. British
Medical Journal (Clinical Research Ed.), 291, 1534–1538.
Wahlbeck, K., Forsén, T., Osmond, C., Barker, D. J., & Eriksson, J. G. (2001). Association of
schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood.
Archives of General Psychiatry, 58, 48–52.
Wallis, A. B., Saftlas, A. F., Hsia, J., & Atrash, H. K. (2008). Secular trends in the rates of preeclampsia,
eclampsia, and gestational hypertension, united states, 1987–2004. American Journal of
Hypertension, 21, 521–526.
Wang, X. D., Labermaier, C., Holsboer, F., Wurst, W., Deussing, J. M., Muller, M. B., & Schmidt, M. V.
(2012). Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain
corticotropin-releasing hormone receptor 1. The European Journal of Neuroscience, 36, 2360–2367.
Ward, A., Arrighi, H. M., Michels, S., & Cedarbaum, J. M. (2012). Mild cognitive impairment: Disparity
of incidence and prevalence estimates. Alzheimer's & Dementia: The Journal of the Alzheimer's
Association, 8, 14–21.
Waterland, R. A., & Michels, K. B. (2007). Epigenetic epidemiology of the developmental origins
hypothesis. Annual Review of Nutrition, 27, 363–388.
Watson, J. B., Mednick, S. A., Huttunen, M., & Wang, X. (1999). Prenatal teratogens and the
development of adult mental illness. Development and Psychopathology, 11, 457–466.
Weaver, I. C., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., . . . Meaney, M.
J. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7, 847–854.
Weaver, I. C., Meaney, M. J., & Szyf, M. (2006). Maternal care effects on the hippocampal transcriptome
and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proceedings of the
National Academy of Sciences of the United States of America, 103, 3480–3485.
Welberg, L. A., Seckl, J. R., & Holmes, M. C. (2000). Inhibition of 11beta-hydroxysteroid dehydrogenase,
the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA
expression and anxiety-like behaviour in the offspring. The European Journal of Neuroscience, 12,
1047–1054.
132
Whalley, L. J., & Deary, I. J. (2001). Longitudinal cohort study of childhood IQ and survival up to age 76.
British Medical Journal (Clinical Research Ed.), 322, 819.
Whalley, L. J., Starr, J. M., Athawes, R., Hunter, D., Pattie, A., & Deary, I. J. (2000). Childhood mental
ability and dementia. Neurology, 55, 1455–1459.
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., . . . Vos, T. (2013).
Global burden of disease attributable to mental and substance use disorders: Findings from the
global burden of disease study 2010. Lancet, 382, 1575–1586.
Whitehouse, A. J., Robinson, M., Newnham, J. P., & Pennell, C. E. (2012). Do hypertensive diseases of
pregnancy disrupt neurocognitive development in offspring? Paediatric and Perinatal
Epidemiology, 26, 101–108.
WHO International Consortium in Psychiatric Epidemiology. (2000). Cross-national comparisons of the
prevalences and correlates of mental disorders. Bulletin of the World Health Organization, 78, 413–
426.
Wiles, N. J., Peters, T. J., Leon, D. A., & Lewis, G. (2005). Birth weight and psychological distress at age
45–51 years: Results from the Aberdeen Children of the 1950s cohort study. The British Journal of
Psychiatry: The Journal of Mental Science, 187, 21–28.
Wilson, B. A., Alderman, N., Burgess, P. W., Emslie, H., & Evans, J. J. (1996). Behavioural assessment
of the dysexecutive syndrome: Test manual. Bury St. Edmonds, UK: Thames Valley Test Company.
Winer, E. K., Tejani, N. A., Atluru, V., DiGiuseppe, R., & Borofsky, L. G. (1982). Four- to seven-year
evaluation in two groups of small-for-gestational age infants. American Journal of Obstetrics and
Gynecology, 143, 425–429.
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jonsson, B., . . . Steinhausen, H. C.
(2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010.
European Neuropsychopharmacology: The Journal of the European College of
Neuropsychopharmacology, 21, 655–679.
Wyrwoll, C. S., & Holmes, M. C. (2012). Prenatal excess glucocorticoid exposure and adult affective
disorders: A role for serotonergic and catecholamine pathways. Neuroendocrinology, 95, 47–55.
Xiong, X., Demianczuk, N. N., Buekens, P., & Saunders, L. D. (2000). Association of preeclampsia with
high birth weight for age. American Journal of Obstetrics and Gynecology, 183, 148–155.
133
Xiong, X., Demianczuk, N. N., Saunders, L. D., Wang, F. L., & Fraser, W. D. (2002). Impact of
preeclampsia and gestational hypertension on birth weight by gestational age.  American Journal of
Epidemiology, 155, 203–209.
Ylihärsilä, H., Kajantie, E., Osmond, C., Forsén, T., Barker, D. J., & Eriksson, J. G. (2007). Birth size,
adult body composition and muscle strength in later life. International Journal of Obesity, 31,
1392–1399.
Zammit, S., Odd, D., Horwood, J., Thompson, A., Thomas, K., Menezes, P., . . . Harrison, G. (2009).
Investigating whether adverse prenatal and perinatal events are associated with non-clinical
psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychological Medicine, 39,
1457–1467.
Zhang, J., Klebanoff, M. A., & Roberts, J. M. (2001). Prediction of adverse outcomes by common
definitions of hypertension in pregnancy. Obstetrics and Gynecology, 97, 261–267.
Zuckerman, M. (1999). Vulnerability to psychopathology: A biosocial model. Washington, DC: American
Psychological Association.
134
APPENDIX
Data collection for the systematic review
Search strategy
I searched the database MEDLINE in February 2013 and February 2014 and evaluated
the results systematically. I looked for articles whose main focus was maternal
hypertensive disorders but also mentioned cognition (or any of its synonyms) or
cognitive tests (or any of its synonyms) or mental health (or any of its synonyms) or
whose main focus was on cognition (or any of its synonyms) or cognitive tests (or any
of its synonyms) or mental health (or any of its synonyms) but also mentioned maternal
hypertensive disorders. For specific search items see Table 14. This search strategy had
high sensitivity but low specificity. I read through a large number of article titles of
which a large proportion turned out to be irrelevant. This was necessary owing to the
lack of a specific search term to identify relevant studies. Also, I used Web of
Knowledge - Citation information to find any additional studies citing primary articles.
Further, I checked that I included relevant studies cited by primary articles.
Study selection
The database searches produced 2805 article titles (Figure 7). Several publications were
rejected at the first stage after reading the title. After retrieving 82 of these articles I
ended up with 36 articles that met our selection criteria. Thirty-four articles were
rejected, five because the articles was a review or summary, 22 because the outcomes
variables fell out the scope of this review, five because the independent variable lacked
clear specificity, 11 because a control group was lacking or its characteristics remained
unclear, one because it was published in other languages than English, and one because
a replication of the study was published in authors’ later study. Three additional studies
were identified from an extended search and were included in the final review. I double-
checked the performance of the search strategy; I ensured that the strategy results in a
collection of the most important articles that I was aware of beforehand.
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Table 14. Search items
Maternal hypertensive disorders
preeclampsia
pre-eclampsia
eclampsia
gestosis
toxemia
maternal pregnancy hypertension
maternal chronic hypertension
gestational hypertension
hypertensive pregnancy disorders
Cognition
cogniti*
intell*
neurodevelopment*
mental development*
cognitive test
intelligence test
neuropsychological test
child development
Mental health
mental health
mental processes
mental disease
mental disorder
mental illness
psychological disease
psychological disorder
psychological illness
psychological development
psychopatology
depression
anxiety
schizophrenia
mood
neurotic
personality
psychotic
substance use
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Figure 7. Selection of studies focusing on maternal hypertensive pregnancy disorders and the mental
health and cognitive functioning of the offspring
2805
titles read
82
articles retrieved
36
articles met the criteria
39
articles included in review
34 articles rejected:
5 review or summary
22 no targeting outcome
5 no adequate predictive
variable
11 no adequate control
group
1 no English
1 replication published later
on3
articles from
extended search
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Table 15. Covariates and confounders available in the reviewed studies focusing on the mental health of the offspring
First author, publishing
year/ Reference
GA BWT SGA
status
Neonatal
health
factors
Sex Parity Maternal
BMI
Maternal
age
Childhood
socio-economic
status
Maternal
education
Maternal
life-style
behaviours
Maternal
psychological
functioning
Dalman et al., 2001 x x x x
Eide et al., 2013 x x x x
Jones et al., 1998 x x x x
Robinson et al., 2009 x x x x x x x x
Suvisaari et al., 2013 x x
Sørensen et al., 2003 x x x
Tuovinen et al., 2014 x x x x x x x
Zammit et al., 2009 x x x x
BWT, birth weight; GA, gestational age; SGA, small for gestational age; BMI, body mass index
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Table 16. Covariates and confounders available in the reviewed studies focusing on the cognitive functioning of the offspring
First author, publishing
year/ Reference
GA BWT SGA
status
Neonatal
health
factors
Sex Parity Maternal
BMI
Maternal
age
Childhood
socio-economic
status
Maternal
education
Maternal
life-style
behaviours
Maternal
psychological
functioning
Cheng et al., 2004 x x x x x
Ehrenstein et al., 2009 x x x x
Gray et al., 1998 x x
Heikura et al., 2012 x x x x x x
Leitner et al., 2012
Leversen et al., 2011 x x x x x
Many et al., 2003 x x x
McCowan et al., 2002
Morsing & Maršál, 2014 x x x
Schlapbach et al., 2010 x x x
Seidman et al., 1991a x x x
Silveira et al., 2007
Spinillo et al., 1994 x x x
Spinillo et al., 2009 x x x
Szymonowicz & Yu, 1987 x x
Whitehouse et al., 2012 x x x x x x x x
aAdjusted associations were not reported as the associations were not significant in the unadjusted model
BWT, birth weight; GA, gestational age; SGA, small for gestational age; BMI, body mass index
